PROJECTS

Project description

Domestic projects

Click title for details.

 

CSFB
Company Project Language
CSFB Financial proposals Korean ->English
CSFB Financial proposals Korean->English Proofreading
CSFB Hyundai Glovis Co., Ltd. financial data Korean ->English
CSFB CSFB/TREMONT INVESTABLE HEDGE FUND INDEX English->Korean
CSFB JINRO CO.,LTD. M&A Proposals Korean ->English
CSFB JINRO CO.,LTD. M&A Proposals Korean->English Proofreading
CSFB Dispatch at the Seoul Finance Center (translation service support) Korean ->English Interpreting
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean ->English
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean ->English
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean ->English
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean->English Proofreading
CSFB Donghae Pulp Co., Ltd. MOU Data Korean->English Proofreading
CSFB Hyundai Glovis Co., Ltd. financial data Korean->English Proofreading
CSFB Korean railway structural reform data Korean ->English
CSFB Dongah Construction Industrial Co., Ltd. M&A Prososals Korean ->English
CSFB Korea Express Co., Ltd. M&A Proposals Korean ->English
CSFB Hana Bank Financial data Korean ->English
CSFB Hana Bank Financial data Korean ->English
CSFB Hana Bank financial statements Korean ->English
CSFB SK Telecom Co., Ltd. financial statements Korean ->English
CSFB Pan Ocean Shipping Co., Ltd. M&A Proposals Korean ->English
CSFB Hyundai Glovis Co., Ltd. financial data Korean ->English
CSFB Kookmin Bank M&A Project data Korean ->English
CSFB Kookmin Bank M&A Project data Korean->English Proofreading
CSFB JINRO CO.,LTD. financial statements Korean ->English
CSFB LG Card M&A proposals Korean ->English
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean->English Proofreading
CSFB Ssangyong Motor M&A Proposals Korean ->English
CSFB Ssangyong Motor M&A Proposals Korean->English Proofreading
CSFB LG Chem, Ltd. financial statements Korean ->English
CSFB LG Chem, Ltd. financial statements Korean->English Proofreading
CSFB KAMCO consulting data English->Korean
CSFB Samyoung Express Newsletter Korean ->English
CSFB Samyoung Express Newsletter Korean->English Proofreading
CSFB Muhak soju M&A Proposals Korean ->English
CSFB Muhak soju M&A Proposals Korean->English Proofreading
CSFB Kumbokju M&A Proposals Korean ->English
CSFB Kumbokju M&A Proposals Korean->English Proofreading
CSFB C&M Communication Audit report Korean ->English
CSFB C&M Communication Audit report Korean->English Proofreading
CSFB Conditions of listing stocks Korean ->English
CSFB Conditions of listing stocks Korean->English Proofreading
CSFB CASH FLOW Korean ->English
CSFB LG Powercom Corp. Financail statements Korean ->English
CSFB LG Powercom Corp. Financail statements Korean->English Proofreading
CSFB Dacom M&A Proposals Korean->English Proofreading
CSFB Dacom M&A Proposals Korean->English Proofreading
CSFB TPS business project strategy Korean ->English
CSFB TPS business project strategy Korean->English Proofreading
CSFB Minimum Cash Policy Korean ->English
CSFB Minimum Cash Policy Korean->English Proofreading
CSFB Company Organization Chart Korean ->English
CSFB Company Organization Chart Korean->English Proofreading
CSFB Dacom business plan Korean ->English
CSFB Dacom business plan Korean->English Proofreading
CSFB Gravity Cross-border listing proposals - a global online game company Korean ->English
CSFB Gravity Cross-border listing proposals - a global online game company Korean->English Proofreading
CSFB Kookmin Bank RFP data Korean ->English
CSFB Kookmin Bank RFP data Korean->English Proofreading
CSFB Korean Peasants League profile Korean ->English
CSFB Korean Peasants League profile Korean->English Proofreading
CSFB Credit Suisse Group - the bylaw of a business company English->Korean
CSFB Doosan Infracore Co., Ltd. M&A Proposals Korean ->English
CSFB Doosan Infracore Co., Ltd. M&A Proposals Korean->English Proofreading
CSFB JINRO CO.,LTD. M&A newsletter Korean ->English
CSFB JINRO CO.,LTD. M&A newsletter Korean->English Proofreading
CSFB Dacom Financial Project Korean ->English
CSFB Dacom Financial Project Korean->English Proofreading
CSFB Dacom goods and services flow chart Korean ->English
CSFB Dacom goods and services flow chart Korean->English Proofreading
CSFB Financial transactions steps Korean ->English
CSFB Financial transactions steps Korean->English Proofreading
CSFB JINRO CO.,LTD. financial statements additional data Korean ->English
CSFB JINRO CO.,LTD. financial statements additional data Korean->English Proofreading
CSFB New York IR Framework - cross-border listing Korean ->English
CSFB New York IR Framework - cross-border listing Korean->English Proofreading
CSFB Oriental Chemical Industries M&A Proposas Korean ->English
CSFB Oriental Chemical Industries M&A Proposas Korean->English Proofreading
CSFB Railroad construction agreement Korean ->English
CSFB Railroad construction agreement Korean->English Proofreading
CSFB Issue of bonds documents Korean ->English
CSFB Issue of bonds documents Korean->English Proofreading
CSFB JINRO CO.,LTD. Audit report Korean ->English
CSFB JINRO CO.,LTD. Audit report Korean->English Proofreading
CSFB Conversation between the management and employees - CSFB English->Korean
CSFB DHIM Supplementary Agreement English->Korean
CSFB Fund Raising data Korean ->English
CSFB Fund Raising data Korean->English Proofreading
CSFB Structuring Menorendom data Korean ->English
CSFB Structuring Menorendom data Korean->English Proofreading
CSFB Economy Outlook Korean ->English
CSFB Text of a speech Korean ->English
CSFB Economy Outlook Korean->English Proofreading
CSFB Mortgage Loan Approval (Revised) Korean ->English
CSFB Mortgage Loan Approval (Revised) Korean->English Proofreading
CSFB Resume of Manangement Korean ->English
CSFB Resume of Manangement Korean->English Proofreading
CSFB Daehan Investment Trust Securities M&A business progress reports Korean ->English
CSFB Daehan Investment Trust Securities M&A business progress reports Korean->English Proofreading
CSFB Dongah Construction Industrial Co., Ltd. M&A Proposals Korean ->English
CSFB Dongah Construction Industrial Co., Ltd. M&A Proposals Korean->English Proofreading
CSFB Risk management data Korean ->English
CSFB Risk management data Korean->English Proofreading
CSFB S&P RATING Data Korean ->English
CSFB S&P RATING Data Korean->English Proofreading
CSFB The steel industry report English->Korean
CSFB SK Telecom Co., Ltd. financial statements Korean ->English
CSFB SK Telecom Co., Ltd. financial statements Korean->English Proofreading
CSFB Wage negotiation requirements Korean ->English
CSFB Wage negotiation requirements Korean->English Proofreading
CSFB Incorporated subsidiary plan Korean ->English
CSFB Incorporated subsidiary plan Korean->English Proofreading
CSFB Lucky Life Insurance Co., Ltd. M&A Proposals Korean ->English
CSFB Lucky Life Insurance Co., Ltd. M&A Proposals Korean->English Proofreading
CSFB Funds borrowing agreement Korean ->English
CSFB Funds borrowing agreement Korean->English Proofreading
CSFB Business plan & board of directors profiles Korean ->English
CSFB Business plan & board of directors profiles Korean->English Proofreading
CSFB Korea National Oil Corporation M&A due diligence qustionnare Korean ->English
CSFB Korea National Oil Corporation M&A due diligence qustionnare Korean->English Proofreading
CSFB Hynix Semiconductor Inc. Report English->Korean
CSFB New loan credit approval report Korean ->English
CSFB New loan credit approval report Korean->English Proofreading
CSFB Origination process manual Korean ->English
CSFB Origination process manual Korean->English Proofreading
CSFB Hana Bank Financial data - read estate Korean ->English
CSFB Hana Bank Financial data - read estate Korean->English Proofreading
CSFB Industry analysis data Korean ->English
CSFB Delinquent loan management manual Korean ->English
CSFB Delinquent loan management manual Korean->English Proofreading
CSFB APLO Provisional settlement of accounts report Korean ->English
CSFB APLO Provisional settlement of accounts report Korean->English Proofreading
CSFB Loan transaction agreements Korean ->English
CSFB Loan transaction agreements Korean->English Proofreading
CSFB POSCO stock public offering proposals Korean ->English
CSFB POSCO stock public offering proposals Korean->English Proofreading
CSFB SK TELECOM reserve proposals Korean ->English
CSFB SK TELECOM reserve proposals Korean->English Proofreading
CSFB Meeting data between the Korea National Oil Corporation & Moody's Corporation English->Korean
CSFB Meeting data between the Korea National Oil Corporation & Moody's Corporation Korean->English Proofreading
CSFB Bond, Universe report Korean ->English
CSFB Bond, Universe report Korean->English Proofreading
CSFB Samsung Total Corp. report Korean ->English
CSFB Samsung Total Corp. report Korean->English Proofreading
CSFB Woori Bank business stratedy report Korean ->English
CSFB Woori Bank business stratedy report Korean->English Proofreading
CSFB BAMBOO confrontational strategy report Korean ->English
CSFB BAMBOO confrontational strategy report Korean->English Proofreading
CSFB Daewoo Electronics proposals Korean ->English
CSFB Daewoo Electronics proposals Korean->English Proofreading
CSFB Financial derivatives peaked data Korean ->English
CSFB Financial derivatives peaked data Korean->English Proofreading
CSFB Korea Stock Exchange financial statements Korean ->English
CSFB Korea Stock Exchange financial statements Korean->English Proofreading
CSFB RBC Program management plan Korean ->English
CSFB RBC Program management plan Korean->English Proofreading
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. financial statements Korean ->English
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. financial statements Korean->English Proofreading
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. Sale - Company presentation data Korean ->English
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. Sale - Company presentation data Korean->English Proofreading
CSFB 00 life insurance company - promotion testimonial plan Korean ->English
CSFB 00 life insurance company - promotion testimonial plan Korean->English Proofreading
CSFB Korea's construction market Q&A data Korean ->English
CSFB Investment briefing presentation data Korean ->English
CSFB Investment briefing presentation data Korean->English Proofreading
CSFB C&M Project Appraisal report Korean ->English
CSFB C&M Project Appraisal report Korean->English Proofreading
CSFB Potential Buyer Profiles English->Korean
CSFB Korea Development Bank report Korean ->English
CSFB Korea Development Bank report Korean->English Proofreading
CSFB Hyundai Steel report Korean ->English
CSFB Hyundai Steel report Korean->English Proofreading
CSFB Hyundai Motor M&A consultation paper Korean ->English
CSFB Hyundai Motor M&A consultation paper Korean->English Proofreading
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. financial statements Korean ->English
CSFB DAEWOO ENGINEERING & CONSTRUCTION CO., LTD. financial statements Korean->English Proofreading
CSFB Promotion testimonial plan Korean ->English
CSFB Promotion testimonial plan Korean->English Proofreading
CSFB 00 life insurance company - promotion testimonial plan Korean ->English
CSFB 00 life insurance company - promotion testimonial plan Korean->English Proofreading
CSFB Hana Bank Financial data Korean ->English
CSFB Hana Bank Financial data Korean->English Proofreading
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean ->English
CSFB Daewoo Heavy Industries & Machinery Ltd. M&A Proposals Korean ->English
CSFB Hyundai Glovis Co., Ltd. financial data Korean ->English
CSFB Hyundai Glovis Co., Ltd. financial data Korean->English Proofreading
CSFB LG Chem, Ltd. financial statements Korean ->English
CSFB LG Chem, Ltd. financial statements Korean->English Proofreading
CSFB LG Card the third quarter account material Korean ->English
CSFB LG Card the third quarter account material Korean ->English Interpreting
CSFB C&M Communication Audit report Korean ->English
CSFB C&M Communication Audit report Korean ->English
CSFB Daehan Investment Trust Securities M&A business progress reports Korean ->English
CSFB Daehan Investment Trust Securities M&A business progress reports Korean ->English Interpreting
CSFB Hynix Semiconductor Inc. M&A Proposals Korean ->English
CSFB Hynix Semiconductor Inc. M&A Proposals Korean->English Proofreading
CSFB Hynix Semiconductor Inc. financial statements Korean ->English
CSFB Hynix Semiconductor Inc. financial statements Korean->English Proofreading
CSFB Himart M&A Proposals Korean ->English
CSFB Himart M&A Proposals Korean->English Proofreading
CSFB Pan Ocean Shipping Co., Ltd. financial statements Korean ->English
CSFB Pan Ocean Shipping Co., Ltd. financial statements Korean->English Proofreading
CSFB Risk management data Korean ->English
CSFB Risk management data Korean->English Proofreading
CSFB Samsung Total Corp. finalcial statements Korean ->English
CSFB Samsung Total Corp. finalcial statements Korean->English Proofreading
CSFB Ssangyong Motor financial statements Korean ->English
CSFB Ssangyong Motor financial statements Korean->English Proofreading
CSFB Hana Bank financial statements Korean ->English
CSFB Hana Bank financial statements Korean->English Proofreading
CSFB Gravity Strategic Report for Global Game Market - a global online game company Korean ->English
CSFB Gravity Strategic Report for Global Game Market - a global online game company Korean->English Proofreading
CSFB MKE statement of accounts for the first half year Korean ->English
CSFB LG Card the second quarter account material Korean ->English
CSFB Glovis Co., Ltd M&A Proposal Korean ->English
CSFB Gravity Strategic Report for Global Game Market - a global online game company Korean ->English
CSFB Dispatch at the Seoul Finance Center (translation service support) Korean ->English
CSFB Management Presentation questionnaire Korean ->English
CSFB Management Presentation questionnaire Korean->English Proofreading
CSFB KIA moters Investor Q&A data Korean ->English
CSFB KIA moters Investor Q&A data Korean->English Proofreading
CSFB KEC business analysis report English->Korean
CSFB Consolidated RFI Review by Workstream Korean ->English
CSFB Phoenix project Korean ->English
CSFB Phoenix project Korean->English Proofreading
CSFB Due diligence regulation & procedure data Korean ->English
CSFB Due diligence regulation & procedure data Korean->English Proofreading
CSFB Phoenix MOU Korean ->English
CSFB Phoenix MOU Korean->English Proofreading
CSFB Bid application Korean ->English
CSFB Bid application Korean->English Proofreading
CSFB MOU Data Korean ->English
CSFB MOU Data Korean->English Proofreading
CSFB Data Room Korean ->English
CSFB Donghae Pulp Co., Ltd. MOU Data Korean ->English
CSFB Donghae Pulp Co., Ltd. MOU Data Korean->English Proofreading
CSFB Information Memorandum Korean ->English
CSFB Information Memorandum Korean->English Proofreading
CSFB Donghae Pulp Co., Ltd. due diligence interpreting - dispatch at Ulsan, Korea Korean ->English Interpreting
CSFB Execution drawing data Korean ->English
CSFB Product Instruction Korean ->English
CSFB U-City plan Korean ->English
CSFB Chelton Hotel observation platform Website G17N Korean ->English
Goldman Sachs Asset Management
Company Project Language
Goldman Sachs Asset Management US Equity Portfolio English ->Korean
Goldman Sachs Asset Management Global fixed income outlook English ->Korean
Goldman Sachs Asset Management RFP Korea Post FOHF Draf t2, October 2007 English ->Korean
Goldman Sachs Asset Management AIMA Fund of Hedge Funds Managers RFP English ->Korean
Goldman Sachs Asset Management Copy of Korea Post_GS GED plc Returns and Contributions English ->Korean
Goldman Sachs Asset Management Final Korea Post RFP Oct 2007(Update) English ->Korean
Goldman Sachs Asset Management Korea Post Global CORE 09 Oct 07 English ->Korean
Goldman Sachs Asset Management Global CORE Performance English ->Korean
Goldman Sachs Asset Management Korea Post Global Core English ->Korean
Goldman Sachs Asset Management Offshore fund menu July 2007 English ->Korean
Goldman Sachs Asset Management Distribution of property ordinance Korean ->English
Goldman Sachs Asset Management Distribution of property ordinance Korean->English Proofreading
Goldman Sachs Asset Management Asset portfolio data English ->Korean
Goldman Sachs Asset Management Global Financial pitchbook English ->Korean
Goldman Sachs Asset Management Global Equity pitchbook English ->Korean
Goldman Sachs Asset Management Global EM Leaders pitchbook English ->Korean
Goldman Sachs Asset Management Global BRICs pitchbook English ->Korean
Goldman Sachs Asset Management Korean Equity Fund Aug 2008 English ->Korean
Goldman Sachs Asset Management Financials Product Focus v3, GFS LEAFLET COPY English ->Korean
Goldman Sachs Asset Management 2Q 08 Offshore Inst.Value REVISED English ->Korean
Goldman Sachs Asset Management EDUCATION FORMATTED English ->Korean
Goldman Sachs Asset Management US Equity Strategy - SA offshore 2Q08 English ->Korean
Goldman Sachs Asset Management Disclaimer (GSAM) English ->Korean
Goldman Sachs Asset Management 4Q 08 GlS English ->Korean
Goldman Sachs Asset Management Market Pulse October 2008 English ->Korean
Goldman Sachs Asset Management Monthly Review (Sep08)) English ->Korean
Goldman Sachs Asset Management the Ministry of Information and Communication, postal service headquarters RFP English->Korean
Samsung Securities Co., Ltd.
Company Project Language
Samsung Securities Co., Ltd. Duke Street Capital - December 2012 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VIII Year End Letter - Korea Post Savings Bureau, 31,12,2012 English ->Korean
Samsung Securities Co., Ltd. PEF Proposal for KTCU ( MezzVest) & Partners Group Direct Mezzanine 2013, L.P. Inc.』Fund Documents - Partners Group Direct Mezzanine 2013, L.P. Inc. Fund Proposal, 23 January 2013 English ->Korean
Samsung Securities Co., Ltd. Korea Post RFP Final Draft English ->Korean
Samsung Securities Co., Ltd. Korea Post Questionnaire(2-1) English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2009 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Partners Group PPM/LPA English ->Korean
Samsung Securities Co., Ltd. Industry Outlook English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2009 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street No.5 PEF Performance Report (As of Dec. 31, 2008) Korean->English Proofreading
Samsung Securities Co., Ltd. Partners Group Secondary 2008 May 2008 English ->Korean
Samsung Securities Co., Ltd. Partners Group Private Equity and Private Debt General Information Q2 2008 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2008 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street No.5 PEF Performance Report (As of Dec. 31, 2008) Korean ->English
Samsung Securities Co., Ltd. articles of incorporation. Korean ->Chinese
Samsung Securities Co., Ltd. Duke December 2007 Quarterly report English ->Korean
Samsung Securities Co., Ltd. Korea Post, Ministry of Information and Communications, Republic of Korea - Savings - Duke Street Capital VI No. 1 Limited Partnership English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2008 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. DSC VI FUND SUMMARY, Unrealised Investment Review, Financial Statements , Notes to the Financial Statements, DSC VI Fund Cashflow History Schedule English ->Korean
Samsung Securities Co., Ltd. Brookfield Confidential Due Diligence Questionnaire - Brookfield Infrastructure Fund II Brookfield’s Flagship Private Infrastructure Fund English ->Korean
Samsung Securities Co., Ltd. Partners Group Direct Mezzanine 2013, L.P. Inc., Seoul l 25 January 2013 - Korea Post Proj. English ->Korean
Samsung Securities Co., Ltd. Duke Street Parabis Summary, 17.12.12 English ->Korean
Samsung Securities Co., Ltd. Meetings with Duke Street JV English ->Korean
Samsung Securities Co., Ltd. LGT RFP Summary Sheet - Final Version English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2008 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street VI qtrly report 31 December English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2009 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street No.6 PEF Annual Report As of Dec. 31 2009 English ->Korean
Samsung Securities Co., Ltd. ANNUAL REPORT 2009 - PARTNERS GROUP SECONDARY 2008, L.P. English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2010 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2010 English ->Korean
Samsung Securities Co., Ltd. Request for Proposal to Korea Post - Baillie Gifford Global Alpha & Baillie Gifford North American Equities English ->Korean
Samsung Securities Co., Ltd. American Equities GIPS June 2010 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2010 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Partners Group Secondary 2008 - PORTFOLIO OVERVIEW English ->Korean
Samsung Securities Co., Ltd. Korea Post Special Report_201006. English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2010 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Asia Pacific Equity Strategy (Citi) 18 November 2010 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2010 English ->Korean
Samsung Securities Co., Ltd. JONES LANG LASALLE IP, INC - Global Market Perspective November 2010, Real Estate Outlook for 2011 English ->Korean
Samsung Securities Co., Ltd. JONES LANG LASALLE IP, INC - Indian Real Estate An Outlook on industry trends English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2010 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2010 English ->Korean
Samsung Securities Co., Ltd. Duke Korea Post Special Reoprt-31 December 2010 & PG - Korea Post Special Report English ->Korean
Samsung Securities Co., Ltd. Korea Post RFP_9 May - Application Documents of Tunstall RCP II Fund, L.P. English ->Korean
Samsung Securities Co., Ltd. Korea Post Supplemental Information English ->Korean
Samsung Securities Co., Ltd. Distressed Investments Solution for Korea Post English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2011 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street VII, Portfolio Review May 2011 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2011 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Duke Street Private Equity Inspiring the ambitious English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Leveraged Buyouts How Do They Work? English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2011 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2011 English ->Korean
Samsung Securities Co., Ltd. AMP Capital Investors - Global REIT update : Week ending Friday, 23 September 2011 English ->Korean
Samsung Securities Co., Ltd. Korea Teachers Pension - QUESTIONNAIRE (1) FOR DUE DILIGENCE OF Dover Street VIII L.P. English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Korea Teachers Pension Dover Street VIII L.P. Due Diligence – Part 2 & Dover Street VIII L.P. Due Diligence – Part 3 English ->Korean
Samsung Securities Co., Ltd. LGT Capital Partners Crown Global Secondaries III (“CGS III”) A program focusing on global secondary transactions October 2011 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Partners Secondary Program Korea Post Savings – Request for Proposal OCTOBER 2011 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2011 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. LGT Capital Partners' secondary strategy & HARBOURVEST Korea Post Potential Impact of European Financial Crisis on Dover Street VIII English ->Korean
Samsung Securities Co., Ltd. LGT Capital Partners - Presentation to Korea Post Savings Crown Global Secondaries III (“CGS III”) A program focusing on global secondary transactions 12 December 2011 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2011 English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Korea Post– Implications of the Global Macroeconomic Environment on HarbourVest Partners Secondary Investment Strategy English ->Korean
Samsung Securities Co., Ltd. Dover Street VIII L.P. Summary of Major Terms and Conditions English ->Korean
Samsung Securities Co., Ltd. Duke Street VI Fund Investor Letter English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Korea Post– Answers to DDQ English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2011 English ->Korean
Samsung Securities Co., Ltd. Dover Street VIII L.P. Investment Program to Purchase Limited Partnership Interests on the Secondary Market, May 2011 & HarbourVest_Staff_2012_03(1) English ->Korean
Samsung Securities Co., Ltd. HarbourVest – Overview of Controls English ->Korean
Samsung Securities Co., Ltd. Duke Street Presentation to Korea Post 29 May 2012 & Additional request from Korea Post English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2012 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. - Portfolio update | as of 31 March 2012 English ->Korean
Samsung Securities Co., Ltd. MORGAN STANLEY Monthly Commentary June 2012 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2012 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Dover Street Investment Program Case Studies English ->Korean
Samsung Securities Co., Ltd. Duke Street Summary for Korea Post English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2012 English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Dover Street Investment Program, AUGUST 2012 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - DUKE STREET MAKES INVESTMENT IN LEADING PROVIDER OF LEGAL AND CLAIMS MANAGEMENT SERVICES English ->Korean
Samsung Securities Co., Ltd. Special Reporting for Korea Post (Insurance) Appendix, PG Secondary 2008, L.P. English ->Korean
Samsung Securities Co., Ltd. ADVISORY COMMITTEE NOTE OF MEETING OF 5 SEPTEMBER English ->Korean
Samsung Securities Co., Ltd. Duke Street Portfolio Review, September 2012 English ->Korean
Samsung Securities Co., Ltd. Brand name firm built over 20 years operating in Western European mid-market operation out of offices in London and Paris English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2012 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Partners Group Direct Mezzanine 2013 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2012 English ->Korean
Samsung Securities Co., Ltd. Partners Group Foreign Account Tax Compliance Act (FATCA) November 2012 English ->Korean
Samsung Securities Co., Ltd. DS VI Minutes of the Advisory Committee Meeting, 28 February 2013 at Nations House, 103 Wigmore Street, London W1U 1QS English ->Korean
Samsung Securities Co., Ltd. Brookfield Infrastructure Fund II Request for Information Public Officials Benefit Association (“POBA”), March 2013 English ->Korean
Samsung Securities Co., Ltd. HARBOURVEST Minutes of the Dover Street Advisory Committee Meeting, February 12, 2013 English ->Korean
Samsung Securities Co., Ltd. HarbourVest KTCU Due Diligence Check List - March 2013 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2012 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII Due Diligence Check List - Korea Post – April 2013 English ->Korean
Samsung Securities Co., Ltd. KKR North America Fund XI L.P. Executive Summary Prepared for and at the request of: Korea Post, April 2013 English ->Korean
Samsung Securities Co., Ltd. Korea Post Buyout RFP_(ENG) vF English ->Korean
Samsung Securities Co., Ltd. HarbourVest –2012 DIRECT - KP, APRIL 2013 English ->Korean
Samsung Securities Co., Ltd. Korea Post Buyout RFP_(ENG) v2 English ->Korean
Samsung Securities Co., Ltd. CANACCORD Genuity Project Spring Overview of portfolio companies, April 2013 English ->Korean
Samsung Securities Co., Ltd. KKR A Balanced Portfolio: The Case for Mega-Buyout Funds, 2013 English ->Korean
Samsung Securities Co., Ltd. KKR Details of probation English ->Korean
Samsung Securities Co., Ltd. HarbourVest Secondary Investment Types, KTP – June 2012 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2013 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2013 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VIII Quarterly Report Letter - Samsung Securities Co., Ltd., 31,03,2013 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII Update - Korea Post – JULY | 2013 English ->Korean
Samsung Securities Co., Ltd. Arkadin Transscirpt, Tuesday, 6 August 2013 English ->Korean
Samsung Securities Co., Ltd. KOREA POST: Notice on the follow-up action plan for the post management of POST deposit alternative investments Korean ->English
Samsung Securities Co., Ltd. KOREA POST: Notice on the follow-up action plan for the post management of POST deposit alternative investments Korean->English Proofreading
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2013 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2013 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - DUKE STREET OPPORTUNITIES FUND I, 20.11.13 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2013 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. CFA Level 2 Schweser Study Notes 2010 - Book 1 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2013 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - DUKE STREET OPPORTUNITIES FUND I £100M TARGET TO SUPPORT £500M INVESTMENT OVER 3 YEARS English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - FUND RETURNS & DEAL ATTRIBUTION - KIO Summary & Forecas, 20.01.14 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2013 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2013 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - 2013 Financial Statements - Duke Street VI No.1 Limited Partnership English ->Korean
Samsung Securities Co., Ltd. Duke Street VI Investor Update Call, 6 March 2014 English ->Korean
Samsung Securities Co., Ltd. KTP RFP PROPOSAL_vFINAL English ->Korean
Samsung Securities Co., Ltd. DS VI Minutes of the Advisory Committee Meeting, 5 March 2014 at Nations House, 103 Wigmore Street, London W1U 1QS English ->Korean
Samsung Securities Co., Ltd. GoldPoint Partners - GoldPoint Partners Co-Investment V, LP - Presentation to Teachers’ Pension, April 1, 2014 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII 2013 Annua Report and Audited Fiinancial Stattements - Korrea Post Saviings Bureau– May 2014 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2014 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2014 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Duke Street VI Fund Investor Update Call, Tuesday 20 May 2014 English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VIII Quarterly Report Letter - Korea Post Savings Bureau, 31.03.2014 English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VIII Quarterly Report Update Letter - Korea Post Savings Bureau, 30.06.2014 English ->Korean
Samsung Securities Co., Ltd. Viking Press Release: Partners Group and Duke Street/Tikehau to lead GBP 375 million acquisition of Voyage Care from HgCapital, 6 August 2014 English ->Korean
Samsung Securities Co., Ltd. TGP Capital - VII Disclaimer and Forward Looking Statements, August 2014 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2014 English ->Korean
Samsung Securities Co., Ltd. Brookfield Brookfield Infrastructure Fund II – Investor Update August 2014 English ->Korean
Samsung Securities Co., Ltd. MS GCM Grosvenor SEMA Multi Strategy Proposal Presentation - Client Composition by Hedge Fund Assets Under Management English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2014 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2014 English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II 2014 Third Quarter Report English ->Korean
Samsung Securities Co., Ltd. AMP Capital Investors - AMP Capital Global Infrastructure Fund (GIF) Prepared for Korea Post, JANUARY 2015 English ->Korean
Samsung Securities Co., Ltd. AMP Capital Global Infrastructure Fund RFP FINAL DRAFT, 15.01.2015 English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VII Dover VIII Year End Update Letter - Korea Post Savings Bureau, JANUARY 2015 English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover VIII Quarterly Report Letter - Korea Post Savings Bureau, DECEMBER 2014 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - wagamama maps out fresher way for noodle Peach Report, 23 February 2015 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2014 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2014 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Brookfield Infrastructure Fund II – Investor Update February 2015 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Duke Street realises its investment in Payzone Ireland with sale to Carlyle joint venture, 9 March 2015 English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II, 2014 Annual Report English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II, 2015 First Quarter Report English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2015 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q1 2015 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII L.P. A Semi-Annual Report 2015 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - DUKE STREET CO-INVESTMENT, 17 July 2015 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2015 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2015 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Brookfield Real Estate Finance Fund IV, 2015 Second Quarter Report, August 2015 English ->Korean
Samsung Securities Co., Ltd. Oaktree Capital Management, L.P. - It’s Not Easy English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII L.P. 2015 A Semi-Annual Report English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Annual Investor Meeting 2015 English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II, 2015 Third Quarter Report English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD Private Funds Annual Investor Conference, 17-18.November. 2015 - Brookfield Infrastructure Fund II (BIF II) English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover Street L.P. VIII Q3 2015 Querterly Report, December 2015 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q3 2015 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - December 2015 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q4 2015 English ->Korean
Samsung Securities Co., Ltd. Brookfield Infrastructure Fund II – Investor Update, Q4 2015 English ->Korean
Samsung Securities Co., Ltd. Brookfield Real Estate Finance Fund IV, 2015 Fourth Quarterly Report, 15.04.2015 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII L.P. 2015 Annual Report - EXECUTIVE SUMMARY English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II 2015 First Quarter Report English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - March 2016 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. InfraRed Capital Partners - InfraRed Active Real Estate Fund IV - Confidential Private Placement Memorandum English ->Korean
Samsung Securities Co., Ltd. InfraRed Capital Partners - European Real Estate Markets And value-add investing in Europe with InfraRed, May 2016 English ->Korean
Samsung Securities Co., Ltd. InfraRed Capital Partners - European Real Estate Markets And value-add investing in Europe with InfraRed, Appendix 1 Active Fund III – Case Studies English ->Korean
Samsung Securities Co., Ltd. DS VI Minutes of the Advisory Committee Meeting, 24 May 2016 at Nations House, 103 Wigmore Street, London W1U 1QS English ->Korean
Samsung Securities Co., Ltd. HarbourVest – Investor Update, Thursday, June 23, 2016 English ->Korean
Samsung Securities Co., Ltd. Brookfield Real Estate Finance Fund IV, 2016 First Quarter Report, 26.06.2015 English->Korean
Samsung Securities Co., Ltd. DS VI Minutes of the Advisory Committee Meeting, 24 May 2016 at Nations House, 103 Wigmore Street, London W1U 1QS English ->Korean
Samsung Securities Co., Ltd. Oaktree Capital Management, L.P. - EU Referendum, June 24, 2016 English ->Korean
Samsung Securities Co., Ltd. GEPS_Response v5 - Investment Performance of Private Debt Fund (Mezzanine and related strategy) English ->Korean
Samsung Securities Co., Ltd. Global Private Debt Fund Proposal for GEPS (Fund name : GoldPoint Mezzanine Partners IV, LP), 15.07.2016 English ->Korean
Samsung Securities Co., Ltd. Harbourvest Dover Street L.P. VIII Q1 2016 Querterly Report, July 2016 English ->Korean
Samsung Securities Co., Ltd. Brookfield Real Estate Finance Fund IV, 2016 Second Quarter Report, August 2016 English ->Korean
Samsung Securities Co., Ltd. AMP Capital Investors - Have you overlooked opportunities in Australia’s real estate and infrastructure?, SEMTEMBER 2016 English ->Korean
Samsung Securities Co., Ltd. AMP Capital Investors - AMP Capital Samsung Seminar_Draft 2, AUGUST 2016 English ->Korean
Samsung Securities Co., Ltd. InfraRed Capital Partners - The Property Environment post Brexit Global Alternative Investments Seminar, Samsung Securities, September 2016 English ->Korean
Samsung Securities Co., Ltd. Brookfield Infrastructure Fund II – Investor Update, Q2 2016 English ->Korean
Samsung Securities Co., Ltd. BROOKFIELD INFRASTRUCTURE FUND II 2016 SECOND QUARTER REPORT, AUGUST 23, 2016 English ->Korean
Samsung Securities Co., Ltd. PARTNERS GROUP SECONDARY 2008, L.P. QUARTERLY REPORT Q2 2016 English ->Korean
Samsung Securities Co., Ltd. HarbourVest – Investor Update, September 12, 2016 English ->Korean
Samsung Securities Co., Ltd. GoldPoint Partners - RESPONSES TO PUBLIC OFFICIALS BENEFIT ASSOCIATION, JULY 2016 English ->Korean
Samsung Securities Co., Ltd. GoldPoint Partners - MARKET ENVIRONMENT OVERVIEW FOR POBA, OCTOBER 2016 English ->Korean
Samsung Securities Co., Ltd. HarbourVest Dover Street VIII L.P. 2016 A Semi Annual Report EXECUTIVE SUMMARY, English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - June 2016 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - DS Re Investment Fund Term Sheet v3 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - September 2016 Quarterly Report English ->Korean
Samsung Securities Co., Ltd. DS VI Minutes of the Advisory Committee Meeting, 18 November @ 1.30pm (UK time) Via telephone conference English ->Korean
Samsung Securities Co., Ltd. HarbourVest – Investor Letter, 25 November 2016 - Korea Post Insurance English ->Korean
Samsung Securities Co., Ltd. Brookfield Infrastructure Fund II – Investor Update, Q3 2016 English ->Korean
Samsung Securities Co., Ltd. Duke Street Capital - Project Arrow Advisory Committee, 18 November 2016 English ->Korean
Samsung Securities Co., Ltd. GOLDPOINT MEZZANINE PARTNERS IV, LP - SECOND AMENDED AND RESTATED LIMITED PARTNERSHIP AGREEMENT, CONFORMED AS OF AUGUST 1, 2016 English ->Korean
Bayer Korea Ltd.
Company Project Language
Bayer Korea Ltd. Bayer Magazine, December 2016 Korean ->English
Bayer Korea Ltd. 10th Congress of the Asia-Pacific Vitreo-Retina Society (APVRS) 2016: One Year Results Demonstrate Effectiveness of EYLEA® as Monotherapy in Patients with Polypoidal Choroidal Vasculopathy English ->Korean
Bayer Korea Ltd. DIGITAL FARMING: MORE EFFICIENT AGRICULTURE, MORE RELIABLE HARVESTS - The networked farm, Bayer research 30 November 2016 English ->Korean
Bayer Korea Ltd. TRUST & COLLABORATION & EXPERIMENTATION & CUSTOMER FOCUS Korean->English Proofreading
Bayer Korea Ltd. Stivarga (regorafenib) Tablets 2.7.4 Summary of Clinical Safety, 20 October 2016 English ->Korean
Bayer Korea Ltd. The Future Has Just Begun" A book celebrating 100th anniversary of Asprin English ->Korean
Bayer Korea Ltd. The Dept. of Radiology at Seoul National University Hospital (SNUH) Intoduction data Korean ->English
Bayer Korea Ltd. CARTOON Collaboration script EN_680 English ->Korean
Bayer Korea Ltd. RA Newsletter Volume 5 │ Oct 2016 Korean ->English
Bayer Korea Ltd. Bayer Magazine, September 2016 Korean ->English
Bayer Korea Ltd. CARTOON Customer Focus script, CARTOON Experimentation script & Smart Cartoon TRUST script English ->Korean
Bayer Korea Ltd. Update: Global transfer of HR services - Relaunch of BayerNet | myServices English ->Korean
Bayer Korea Ltd. 30 to 40% stock-out revives only market sale Korean ->English
Bayer Korea Ltd. Bayer Increases Monsanto Offer and Provides Certainty on Financing and Regulatory Matters English ->Korean
Bayer Korea Ltd. RA News Letter Volume 4 │ July 2016 Korean ->English
Bayer Korea Ltd. Bayer Magazine, May 2016 Korean ->English
Bayer Korea Ltd. Mosquito-borne diseases prevention and control, Learning module English ->Korean
Bayer Korea Ltd. The right culture for the new structure - Video script translation English ->Korean video translation
Bayer Korea Ltd. Innovation Powerhouse to Deliver Integrated Solutions for the Next Generation of Farming: Bayer Offers to Acquire Monsanto to Create a Global Leader in Agriculture English ->Korean
Bayer Korea Ltd. Werner Baumann: Portrait and Interview Video: Interview with the New Bayer CEO English ->Korean video translation
Bayer Korea Ltd. Welcome to your seminar EPFC 2.0 – High Performance through Developmental Feedback English ->Korean
Bayer Korea Ltd. EPFC 2.0 – High Performance through Developmental Feedback Development Dialogue - Course of a development dialogue English ->Korean
Bayer Korea Ltd. EPFC 2.0 – High Performance through Developmental Feedback - Creating a climate of appreciation English ->Korean
Bayer Korea Ltd. EPFC 2.0 – High Performance through Developmental Feedback - Practice simulation English ->Korean
Bayer Korea Ltd. EPFC 2.0 – High Performance through Developmental Feedback - My Personal 6 Months Diary English ->Korean
Bayer Korea Ltd. Kyung Nong and Bayer seem to have a disagreement with regard to the contract term. Korean ->English
Bayer Korea Ltd. KVALIFIOINNIN RAPORTTI, KVALIFIOINNIN LOPPURAPORTTI, KVALIFIOINNIN YHTEENVETORAPORTTI, 9 cases Finnish ->Korean
Bayer Korea Ltd. Elevit Pronatal Tab - Appearance: Perform visual inspection. Korean ->English
Bayer Korea Ltd. [Hot Issue Diagnosed] Foreign companies supplying raw materials for agricultural chemicals in controversy over its gabjil (power harassment) Korean ->English
Bayer Korea Ltd. Shareholders of membership-based wholesale corporations or crop protection agent marketing cooperatives - Business letter Korean ->English
Bayer Korea Ltd. BAYER LOYALTY PROGRAM 2015 - Registeation Form - English ->Korean
Bayer Korea Ltd. Bayer Magazine, March 2016 Korean ->English
Bayer Korea Ltd. SBR Message proofreading Korean->English Proofreading
Bayer Korea Ltd. CLOSE OF THE SALE OF BAYER DIABETES CARE TO CREATE NEW STAND-ALONE COMPANY, ASCENSIA DIABETES CARE English ->Korean
Bayer Korea Ltd. CONCEPT SCLC study 14615 Investigator Letter final, Feb 2016 English ->Korean
Bayer Korea Ltd. Conglomerates begin to look at agriculture as a higher value-added business & "Working to strengthen the industry's competency, and to disseminate residual pesticide analysis technology" Korean ->English
Bayer Korea Ltd. Purchase & Delivery Agreement of Agricultural Chemicals Korean ->English
Bayer Korea Ltd. Outlook for the Non-Selective Herbicide Market in Korea - Is the heyday of Basta coming to an end? Suppliers engaged in a cutthroat battle due to excessive supply Korean ->English
Bayer Korea Ltd. Aflibercept in DME (Week 148) 2.5 Clinical Overview, 08 December 2015 English ->Korean
Bayer Korea Ltd. Amended Clinical Study Report No. PH-38460 Synopsis - amended English ->Korean
Bayer Korea Ltd. Clinical Study Report VGFT-OD-1009 (Year 3) CLINICAL STUDY REPORT SYNOPSIS English ->Korean
Bayer Korea Ltd. Bayer Magazine, December 2015 Korean ->English
Bayer Korea Ltd. DISTRIBUTION AGREEMENT English ->Korean
Bayer Korea Ltd. SBR message Q4 Proofreading Korean->English Proofreading
Bayer Korea Ltd. Left in the rain (5) English ->Korean
Bayer Korea Ltd. Fascinating Image: A Shoal of Fish with a Remarkable Story English ->Korean
Bayer Korea Ltd. A Vegetable Garden on the Roof, New and unconventional perspectives English ->Korean
Bayer Korea Ltd. Employer Branding Image - Researchers on the Arctic Circle English ->Korean
Bayer Korea Ltd. Image Motifs for Employer Branding - Food for a Hungry Planet English ->Korean
Bayer Korea Ltd. Employer Branding Images - Singapore’s Supertrees English ->Korean
Bayer Korea Ltd. Monitoringbericht - Reinigung der Frewitt-Granuliermaschinen German->Korean
Bayer Korea Ltd. GMP - Inspektionsbericht FIRMENNAME DES INSPIZIERTEN BETRIEBES German->Korean
Bayer Korea Ltd. Bayer Magazine, Oct 2015 Korean ->English
Bayer Korea Ltd. Bayer Schering Pharma AG: Batch Record (BR), Media Fill Vials 6 ml German->Korean
Bayer Korea Ltd. Bayer Schering Pharma AG: Batch Record (BR), Media Fill Ansatz German->Korean
Bayer Korea Ltd. Bayer Pharma AG: Batch Record (BR), Media Fill Vials 6 ml German->Korean
Bayer Korea Ltd. Bayer Pharma AG: Batch Record (BR), Media Fill Vials 6 ml (BK: GO/SW) German->Korean
Bayer Korea Ltd. Bayer Magazine, September 2015 Korean ->English
Bayer Korea Ltd. Disposal of Dongbu Farm Hannong and TERRAD'OR & Chemical industries look to agriculture and life science for their survival Korean ->English
Bayer Korea Ltd. Life first began four billion years ago when the Earth had finally cooled to a temperature of below 100 degrees Celsius. English ->Korean video translation
Bayer Korea Ltd. Bayer Healthcare: Anweisung Supply Center Berlin Version 12.0 - SOP Media Fill PL06 German->Korean
Bayer Korea Ltd. Abweichungsmeldung Production Supply Certer Berlin HL2_2011_94_2 German->Korean
Bayer Korea Ltd. Bayer Healthcare: Revalidierungsplan Nr. A10217D120 Streng vertraulich - Revalidierung der Reinigungsverfahren nach Herstellung von Hormonölampullen German->Korean
Bayer Korea Ltd. Pesticide Purchase and Supply Agreement (Draft) Korean ->English
Bayer Korea Ltd. SBR Q3 letter Korean ->English
Bayer Korea Ltd. This is Daniel. As a Bayer CropScience employee, he also wants to contribute to making his company the No. 1. But he doesn’t really know how he can support this major goal in practice. English ->Korean video translation
Bayer Korea Ltd. EYLEA Learning Resource: BRVOTRAINING Background and epidemiology of BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: Pathophysiology and natural history of BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: BRVOTRAINING Management approaches in BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: BRVOTRAINING Key clinical trials in BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: BRVOTRAINING EYLEA clinical trials in BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: BRVOTRAINING EYLEA’s Contribution to the Management of BRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING Background and epidemiology of CRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING EYLEA clinical trials in CRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING EYLEA’s contribution to the management of CRVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING Key clinical trials in RVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING Management approaches in RVO Training Manual English ->Korean
Bayer Korea Ltd. EYLEA Learning Resource: CRVOTRAINING Pathophysiology and natural history of CRVO Training Manual English ->Korean
Bayer Korea Ltd. Dongbu Farm Hannong engages in a sales offensive with pesticide and fertilizer & How can we set a supply of Glyposate by company? Korean ->English
Bayer Korea Ltd. Please Visit the Bayer Korea Live Webcast at 9:00 AM, Wednesday, on July 8, 2015. Korean ->English
Bayer Korea Ltd. CONTRATO DE DISTRIBUCIÓN , En Valencia, a ….. de …….. de 2014 Spanish->Korean
Bayer Korea Ltd. Bayer Healthcare Korea, Animal Health Division: Sterility Test English ->Korean
Bayer Korea Ltd. SBR Q2_YEK_490 Korean ->English
Bayer Korea Ltd. Bayer CropScience holds rice transplanting event to wish for a good harvest - - At Pyeongtaek lab with Bayer employees and foreign children Korean ->English
Bayer Korea Ltd. Late Breaking Clinical Trial Session at Heart Rhythm 2015: New Data on Bayer’s Xarelto® Versus Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation English ->Korean
Bayer Korea Ltd. A new kind of herbicide, Terrad’or, agreed on patent technology transfer Korean ->English
Bayer Korea Ltd. Dongbu Farm Hannong accomplishes the highest first quarter sales figures this year 250 billion won in sales and 46.3 billion won in operating profit Korean ->English
Bayer Korea Ltd. “Protecting pollinators in Korea through active support” Korean ->English
Bayer Korea Ltd. TOPPS-Training for Shift supervisors & Production technicians, craftsmen … - Rules and Regulations English ->Korean
Bayer Korea Ltd. TOPPS- Training for Cat. 2 - Process Hazard Analysis (PHA/HAZOP) English ->Korean
Bayer Korea Ltd. TOPPS- Training for Level 2 - Safety Relevant Utilities English ->Korean
Bayer Korea Ltd. TOPPS- Training for - Site Managers, HSE-Managers, - Production Supervisors and -Experts, Technicians, - Shift Supervisors, Production Operators and Craftsmen / Consequence Analysis English ->Korean
Bayer Korea Ltd. Dear Members of Sales Headquarters: April 2015 Korean ->English
Bayer Korea Ltd. Dongbu Group, puts forward an application for separating an affiliated company, Dongbu Farm Hannong … promoting its sale & Dongbu Farm Hannong to be sold to ORIX? Korean ->English
Bayer Korea Ltd. Dongbu Farm Hannong to Receive KRW60bn in Emergency Funds & One Week to Define Dongbu’s Destiny… Stopping the 100-to-1 Capital Reduction Korean ->English
Bayer Korea Ltd. Procedure Third Party Due Diligence Process Group Regulation No. 2083, Effective: February 1, 2015 English ->Korean
Bayer Korea Ltd. Dongbu CNI considers selling stake in Dongbu Farm Hannong & Dongbu Group to sell Dongbu Farm Hannong, making electronics its only manufacturing business Korean ->English
Bayer Korea Ltd. Negotiations for disposal of the chemicals unit of Dongbu Farm Hannong break down - Repayment crisis growing & [Issue & News] 'Agriculture in crisis' - Does corporate participation in agriculture do good or harm? Korean ->English
Bayer Korea Ltd. BASIC LEGAL PRINCIPLES FOR BUSINESS RELATIONSHIPS WITH RETAILERS AND AGENTS English ->Korean
Bayer Korea Ltd. Ingrid U. Drechsel Appointed as New SBR/CEO of Bayer Korea, Hosted Compliance Challenge Golden Bell Welcoming the Lunar New Year, Fruit-full Monday Korean ->English
Bayer Korea Ltd. Pyeongtaek Branch of Suwon District Court Table of Allowance Korean ->English
Bayer Korea Ltd. COMPLIANCE WITH INTERNATIONAL SANCTIONS AND EXPORT CONTROL & Compliance Letter English ->Korean
Bayer Korea Ltd. Sales Agreement Korean ->English
Bayer Korea Ltd. Employee Newsletter: New SBR Interview / Feb 26, 2015 Korean ->English
Bayer Korea Ltd. Dongbu Farm Hannong's new herbicide enters overseas markets through Japan Korean ->English
Bayer Korea Ltd. Bayer Healthcare:Integrated Clinical Study Protocol - A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) – CHRONOS-2 English ->Korean
Bayer Korea Ltd. BHC Anti-Corruption Compliance Manual - BHC Regulation No. 700 Module: Animal Health English ->Korean
Bayer Korea Ltd. Bayer Healthcare: Directive BHC Price Reporting Compliance BHC Regulation No. 1043 (Edition: 1), Effective: November 15, 2014 English ->Korean
Bayer Korea Ltd. Functional Processes Referenced document Price Reporting Compliance Corporate Price Database SOP Version 1.0 English ->Korean
Bayer Korea Ltd. Layoffs at Bayer Korea, the labor-management conflict continues Korean ->English
Bayer Korea Ltd. Email Tips Daily Note: Hold on for 2 seconds when e-mailing Korean ->English
Bayer Korea Ltd. Bayer Branding with Bayer04Leverkusen Category: Best Integrated Campaign Korean ->English
Bayer Korea Ltd. Bayer Healthcare: Directive Business and Private Use of Electronic Communication Systems Group Regulation No. 2080 (Edition: 1): Effective: December 1, 2014 English ->Korean
Bayer Korea Ltd. BNC Bayer Holds Bayer Health Day to Help Seniors Live a Better Life Korean ->English
Bayer Korea Ltd. Clinical Study Report: A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of on-demand and prophylactic treatment with BAY 94-9027 in Severe Hemophilia A English ->Korean
Bayer Korea Ltd. SBR Message Q4 2014 Korean ->English
Bayer Korea Ltd. Bayer Healthcare: Procedure BHC Anti-Corruption Compliance Manual BHC Regulation No. 700 (Edition: 1), Effective: May 15, 2014 English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Concept Development – Assessment Aid for Observers English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Concept Development – Instructions for participants English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Direct Report – Instruction for participants English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Direct Report – Instruction for role players English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Dialogue with a Peer – Instructions for role players English ->Korean
Bayer Korea Ltd. Future Leader Development Center: Dialogue with a Peer – Instructions for participants English ->Korean
Bayer Korea Ltd. Bayer Interview Manual - Competency Based Interview / Passion to Innovate, Power to Change English ->Korean
Bayer Korea Ltd. 1. Align Your Top Management, 2. Build Awareness and Skills for All Managers, 3. Empower All Talents, 4. Include Customers and Markets, 5. Review HR Systems & Processes, What YOU Say, English ->Korean
Bayer Korea Ltd. Step 2: Discover HCP Point of View - Purpose: To visually introduce Step 2: Discover HCP Point of View. English ->Korean
Bayer Korea Ltd. Supplementary Terms and Conditions of Bayer AG and its Affiliated Companies for the Award and Execution of Construction Services - Edition: 08/2008 English ->Korean
Bayer Korea Ltd. Bayer Korea Holds Welcome Reception to Celebrate Head Office Renovation: Renovated to Offer a More Open and Practical Space, the Integrated Head Office Now Accommodates BCS Staff As Well Korean ->English
Bayer Korea Ltd. Notification of Important Information for Radium Ra 223 Dichloride Study Patients English ->Korean
Bayer Korea Ltd. PS1 Content Translations: Breadcrumb title: Product Safety First - Website L10N English ->Korean
Bayer Korea Ltd. Sales Incentive Agreement for **** Korean ->English
Bayer Korea Ltd. BiK Authorization, Approval, Signature and Seal Directive, October 1, 2014 English ->Korean
Bayer Korea Ltd. BiK Contract Management Directive Preparation, Execution and Archiving of Contracts, October 1, 2014. English ->Korean
Bayer Korea Ltd. Vaccination of Piglets up to 1 Week of Age with a Single-Dose Mycoplasma hyopneumoniae Vaccine Induces Protective Immunity within 2 Weeks against Virulent Challenge in the Presence of Maternally Derived Antibodies English ->Korean
Bayer Korea Ltd. Investigator’s Brochure BAY 1187982 Version:1.0 Date: 11 SEP 2014 English ->Korean
Bayer Korea Ltd. POSITION STATEMENT Hormonal Contraception and Risk of Venous Thromboembolism (VTE), 19 February 2013 English ->Korean
Bayer Korea Ltd. INVESTIGATOR’S BROCHURE Oncology, 11 SEP 2014 English ->Korean
Bayer Korea Ltd. Clinical Study Protocol No. BAY 1187982 / 16897 , 01 Oct 2014 English ->Korean
Bayer Korea Ltd. Patient Information & Informed Consent Form - Study number: 16897 English ->Korean
Bayer Korea Ltd. Late-Breaking Presentation at European Society of Medical Oncology (ESMO) 2014 Congress: English ->Korean
Bayer Korea Ltd. Customer Complaints Handling QA-700-07 Rev.02 Korean ->English
Bayer Korea Ltd. Bayer MaterialScience AG - Dear (name of customer) English ->Korean
Bayer Korea Ltd. Integrated Clinical Study Protocol Roniciclib / 14615 Version 3.0, 03 SEP 2014 English ->Korean
Bayer Korea Ltd. PATIENT INFORMATION & INFORMED CONSENT FORM - RONICICLIB/14615 English ->Korean
Bayer Korea Ltd. Study No. 14615 roniciclib/placebo DOSING DIARY English ->Korean
Bayer Korea Ltd. Bayer Magazine, Semtember 2014 - Make a good use of refurbished Shindaebang-dong workplace of Bayer Korea when you know it well Korean ->English
Bayer Korea Ltd. Contract Template for the Conduct of an Observational Study - Observational Study Agreement English ->Korean
Bayer Korea Ltd. Bayer CEO Message - Dear colleagues, Korean ->English
Bayer Korea Ltd. Foreign firms pay over 80 percent of net profits as dividends with employment and investment going down Korean ->English
Bayer Korea Ltd. What is the impact of BCS’s “Commercial Excellence” project on distribution? Spanish->English
Bayer Korea Ltd. Purchase ERP Resource Data: IACR_C 20140818 English ->Korean
Bayer Korea Ltd. Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism, Draft: Aug 5, 2014 English ->Korean
Bayer Korea Ltd. Bayer Healthcare: Standard Operating Procedure - Archiving and Retrieval of Regulatory Affairs Documents English ->Korean
Bayer Korea Ltd. Bayer Healthcare: Procedure BHC Anti-Corruption Group Regulation No. 2041 (Edition: 1), Effective: January 1, 2012 English ->Korean
Bayer Korea Ltd. Bayer Healthcare: BHC Anti-Corruption Compliance Manual BHC Regulation No. 700, Effective: May 15, 2014 English ->Korean
Bayer Korea Ltd. Bayer Healthcare: ERP Resource Data 5 Cases English ->Korean
Bayer Korea Ltd. Charta: New Directions, Yulia Melikova, General Counsel Office English ->Korean
Bayer Korea Ltd. Bayer HealthCare Animal Health - Held the first LIVE Webinar in Korea aimed at clinical veterinarians Korean ->English
Bayer Korea Ltd. Bayer HealthCare Product Supply Ansung plant selected as Fire Safety Excellence Building Korean ->English
Bayer Korea Ltd. DuPont Moves from Chemicals and Textiles to Agriculture as a Future Growth Engine Korean ->English
Bayer Korea Ltd. The wholesalers will not win the margin war against multinational pharmaceuticals Korean ->English
Bayer Korea Ltd. Bayer Healthcare: ERP Resource Data 2 Cases English ->Korean
Bayer Korea Ltd. SkillCamp FOUNDATIONAL TRAINING Version 3.0 data 13 Cases English ->Korean
Bayer Korea Ltd. Bayer Magazine, July 2014 - Renovation work at headquarter offices starts from July. Korean ->English
Bayer Korea Ltd. PS1 KOREA page comments - MAIN PAGE We Help Customers Minimize Risk English ->Korean
Bayer Korea Ltd. UTT Leasing Agreement English ->Korean
Bayer Korea Ltd. TAEYOUNG CHEMICAL CO., LTD. - Agreement Korean ->English
Bayer Korea Ltd. Global First-Line Sales Manager Field Coaching Program Participant Workbook English ->Korean
Bayer Korea Ltd. Global First-Line Sales Manager Field Coaching Program Instructor’’s’ Guide English ->Korean
Bayer Korea Ltd. Print: Min Yun-gi/ Free Trade Agreement Division No. 3 (05-08-2014 10:29:12) Seoul Main Customs - Information on Voluntary Review of Korea-EU FTA Certified Exporter Number Korean ->English
Bayer Korea Ltd. Integrated Clinical Study Protocol No. BAY no. 88-8223 / 15397, 17 APR 2014 English ->Korean
Bayer Korea Ltd. Radimetrics 2.2 User Guide English ->Korean
Bayer Korea Ltd. PATIENT INFORMATION & INFORMED CONSENT FORM - RONICICLIB/14615 English ->Korean
Bayer Korea Ltd. Dong-A ST’s Submission of NDA to FDA for its Super Bacteria Antibiotics Korean ->English
Bayer Korea Ltd. STUDY 16349 – PART B PATIENT’S BLOOD GLUCOSE MONITORING DIARY NON- DIABETIC PATIENT English ->Korean
Bayer Korea Ltd. Clinical Study Protocol Roniciclib / 14615 English ->Korean
Bayer Korea Ltd. [Appendix 8] Guidelines to Establishment of Maximum Residue Limits of Pesticides in Food and Veterinary Pharmaceuticals Korean ->English
Bayer Korea Ltd. [Appendix] Toxicity Test Methods for Veterinary Pharmaceuticals, etc. (relating to Article 3) Korean ->English
Bayer Korea Ltd. [Appendix] Residue Test Methods for Veterinary Pharmaceuticals, etc. (relating to Article 3) Korean ->English
Bayer Korea Ltd. Regulations on the Review of Safety and Efficacy for Veterinary Pharmaceuticals, etc. - [Enforced 8 Jan. 2014] [Animal and Plant Quarantine Agency Notification No. 2014-2, 8 Jan. 2014, Partial Amendment] Korean ->English
Bayer Korea Ltd. Bayer Healthcare: Standard Operating Procedure - Management of Safety Relevant Local Studies, BAH-RD-SOP#0221 English ->Korean
Bayer Korea Ltd. Bayer Healthcare: Supplement- Flowchart "Management of safety relevant local studies", BAH-RD-SOP#0221 English ->Korean
Bayer Korea Ltd. Appendix 14.6 “study part B” to Integrated Clinical Study Protocol No. BAY 80-6946 / 16349, 28 Mar 2013 English ->Korean
Bayer Korea Ltd. Phase II PI3K inhibitor in relapsed, indolent or aggressive NHL (Part B) English ->Korean
Bayer Korea Ltd. PATIENT INFORMATION AND INFORMED CONSENT - Dose Modification 16349 English ->Korean
Bayer Korea Ltd. DECLARATION OF CONSENT - Active Assessment Follow-up period English ->Korean
Bayer Korea Ltd. Integrated Clinical Study Protocol No. BAY 80-6946 / 16349, 17 Feb 2014 English ->Korean
Bayer Korea Ltd. RFID/USN User Technology Consulting Result Report - Bayer CropScience: Feasibility analysis for developing advanced distribution system for RFID-based crop protection product, Jan. 2014 (NIPA) Korean ->English
Bayer Korea Ltd. CONFIDENTIALITY AGREEMENT - Nifco Korea Inc. English ->Korean
Bayer Korea Ltd. Patent Specification - LIGHT DIFFUSION PLATE - <0001> The invention relates to a light diffusion plate. Korean ->English
Bayer Korea Ltd. Integrated Clinical Study Protocol No. BAY 86-9766 / 16553, 27 Nov 2013 Korean ->English
Bayer Korea Ltd. Patient Information & Informed Consent Form, Study number: 16553 Korean ->English
Bayer Korea Ltd. The Journal of Obstetrics and Gynaecology Research, January 2014: Recurrence of ovarian endometrioma after laparoscopic excision: Risk factors and prevention English ->Korean
Bayer Korea Ltd. JMIG Original Article: Efficacy of Dienogest in Thinning the Endometrium Before Hysteroscopic Surgery English ->Korean
Bayer Korea Ltd. FAU Busan campus from Germany below expectations Korean ->English
Bayer Korea Ltd. PI / IC for Study Updates, Study number: 16728 English ->Korean
Bayer Korea Ltd. COOPERATION AGREEMENT, Ecoplastic Corp. English ->Korean
Bayer Korea Ltd. Bayer Healthcare: Best Practice IT Security for Users Group No. 1473 (Edition: 3), Effective: October 1, 2013 English ->Korean
Boehringer Ingelheim Korea
Company Project Language
Boehringer Ingelheim Korea Summary of the Memo from CD Purchasing - RE: Agency Holding Agreementsl Strategy for Selecting Agencies -> CD 구매부 메모 요약 - 답신: 에이전시 선정을 위한 에이전시 보유 계약/전략 English ->Korean
Boehringer Ingelheim Korea Vendor Management Policy - Effective Date: Jan. 2008 -> 벤더(공급업체) 관리 규정 - 효력발생일: 2008년 1월 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim - Checklist for Preparation of Local Contracts - September 2005 -> 베링거인겔하임 - 현지 계약 작성을 위한 체크리스트 - 2005년 8월 English ->Korean
Boehringer Ingelheim Korea CD Purchasing CORPORATE PROCEDURE - Title : Corporate Procedure Procurement of Agency Services -> CD 구매부 회사 절차 - 제목: 에이전시 서비스 조달을 위한 회사 절차 English ->Korean
Boehringer Ingelheim Korea CD Purchasing CORPORATE PROCEDURE - Title : Corporate Procedure for Contractual Liability Arrangements with Suppliers -> CD 구매부 회사 절차 - 제목: 공급업체와 계약상 책임 조정을 위한 회사 절차 English ->Korean
Boehringer Ingelheim Korea Adaptation of "BI Global Supply Regulation" (Version 2009) -> “BI 글로벌 공급 규정”의 개정 (2009 버전) English ->Korean
Boehringer Ingelheim Korea WUNSCH Preis German->Korean
Boehringer Ingelheim Korea TIA Lancet Neurology Press Release English ->Korean
Boehringer Ingelheim Korea Rocket AF toolkit & QA English ->Korean
Boehringer Ingelheim Korea Interview with Dr Jonas Oldgren Coverage Korean ->English
Boehringer Ingelheim Korea Subject Information - Single rising dose with BI 135585 XX in healthy Asian volunteers -> 피험자 정보 - 신체 건강한 아시아계 지원자에서의 BI 135585 XX 단 회 상승 투여 English ->Korean
Boehringer Ingelheim Korea Subject Information - Single rising dose with BI 135585 XX in healthy Asian volunteers -> 主题信息 - 单剂量BI 135585 XX在健康亚洲自愿者 English ->Chinese
Boehringer Ingelheim Korea Subject Information - Single rising dose with BI 135585 XX in healthy Asian volunteers -> 被験者情報シート - アジア人健常ボランティアにおけるBI 135585 XX用量漸増・単回投与 English->Japanese
Boehringer Ingelheim Korea Press Release - New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients likely to have EGFR mutations -> 보도자료 - LUX-Lung 1 시험의 새로운 부분군 분석을 통해, EGFR 변이가 있을 가능성이 높은 폐암 환자에서 아파티닙(afatinib)* 효용성이 확인되었다 English ->Korean
Boehringer Ingelheim Korea External Social Media Guidelines 2011 -> 2011년 사외 소셜 미디어 관련 지침 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Signature Policy (“four-eyes-principle") & Quality Policy December 2010 -> Boehringer Ingelheim 서명정책 ("2인 인증원칙") & 품질 정책 2010년 12월 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Vetmedica Korea - Plan for PRRS Area Regional Control in Jeju 2011. Jan. Korean ->English Proofreading
Boehringer Ingelheim Korea Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide - January 11, 2011 -> Boehringer Ingelheim과 Eli Lilly and Company, 전세계 당뇨병 환자들에게 새로운 치료제를 제공하기 위한 전략적 제휴 발표 2011년 1월 11일 English ->Korean
Boehringer Ingelheim Korea COMBINED VACCINES FOR PIGS - Are combined vaccines as suitable for pigs as individual vaccines? -> 돼지용 배합백신 - 혼합백신이 개별 백신만큼 돼지용으로 적합한가? English ->Korean
Boehringer Ingelheim Korea CLINICAL TRIAL PROTOCOL SYNOPSIS - Objectives: To investigate safety, tolerability, and pharmacokinetics of BI 207127 -> 임상시험 프로토콜 개요 - 목적: BI 207127의 안전성, 내약성 및 약동학을 연구 English ->Korean
Boehringer Ingelheim Korea Subject Informed Consent Form - Single rising dose with BI 207127 NA in healthy male Asian and Caucasian volunteers -> 피험자 동의서 - 건강한 남성 아시아인 및 백인 지원자에서의 BI 207127 NA 단회 상승 투여 English ->Korean
Boehringer Ingelheim Korea Subject Information - Single rising dose with BI 20712NA in healthy male Asian and Caucasian volunteers -> 피험자 정보 - 건강한 남성 아시아인 및 백인 지원자에서의 BI 20712NA 단회 상승 투여 English ->Korean
Boehringer Ingelheim Korea Subject Information sheet for pharmacogenetic testing - Single rising dose with BI 207127 NA in healthy male Asian and Caucasian volunteers -> 약물유전체검사에 관한 피험자 정보지 - 건강한 남성 아시아인 및 백인 지원자에서의 BI 207127 NA 단 회 상승 용량 English ->Korean
Boehringer Ingelheim Korea Patient Information and Consent Form - combination with pegylated interferon-α and ribavirin -> 환자 정보 및 사전 동의서 - 페그인터페론- α(pegylated interferon- α) 및 리바비린(ribavirin)과 병용 English ->Korean
Boehringer Ingelheim Korea A case of PRRS control in Korea Korean ->English Proofreading
Boehringer Ingelheim Korea Clinical Trial Protocol - Investigational Product(s): BI 207127 NA -> 임상시험 연구계획서 - 시험 제품(들): BI 207127 NA English ->Korean
Boehringer Ingelheim Korea ELSEVIER Virus Research - Review - Control and elimination of porcine reproductive and respiratory syndrome virus -> 바이러스 조사 - 검토 - 돼지 생식기 및 호흡기 증후군 바이러스의 관리 및 제거 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Key Messages 2011 - PR-KEY Messages on Brands -> 베링거인겔하임(Boehringer Ingelheim) 주요 내용(KEY Messages) 2011년 - 브랜드 홍보 – 주요 내용(KEY Messages) English ->Korean
Boehringer Ingelheim Korea Commentary - Peer reviewed - Terminology for classifying swine herds by porcine reproductive and respiratory syndrome virus status -> 해설 - 상호 검토문 - 돼지 생식기 및 호흡기 증후군 바이러스 상태에 의한 돈군 분류 용어 English ->Korean
Boehringer Ingelheim Korea Research Agreement - Research Project Name: Experiment on the Effect and Safety of Pimobendan <- 연구계약서 - 연구과제명: 피모벤단의 효능과 안전성 실험 Korean ->English
Boehringer Ingelheim Korea Jeju PRRS ARC TFT TC Minute Korean ->English
Boehringer Ingelheim Korea PRADAXA® (dabigatran etexilate) QUESTIONS & ANSWERS RESOURCE - Bayer/J&J ROCKET AF results -> PRADAXA® (다비가트란 이텍실레이트) 질문 & 답변 자료 - Bayer/J&J ROCKET AF 결과 English ->Korean
Boehringer Ingelheim Korea Chronic Obstructive Pulmonary Disease (COPD) Media backgrounder March 2011 -> 만성 폐쇄성 폐질환(COPD) 배경설명 자료 2011년 3월 English ->Korean
Boehringer Ingelheim Korea Early Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) Media backgrounder March 2011 -> 만성폐쇄성폐질환(COPD)의 조기진단 및 관리 배경설명 자료 2011년 3월 English ->Korean
Boehringer Ingelheim Korea COPD Exacerbations Media backgrounder March 2011 -> COPD의 악화 배경설명 자료 - 2011년 3월 English ->Korean
Boehringer Ingelheim Korea The POET-COPD® study (The Prevention Of Exacerbations with Tiotropium) Media backgrounder March 2011 -> POET-COPD® 시험 (The Prevention Of Exacerbations with Tiotropium) 배경설명 자료 2011년 3월 English ->Korean
Boehringer Ingelheim Korea The POET-COPD® Study (The Prevention Of Exacerbations with Tiotropium) Reactive Media Q&A 24 March, 2011 -> POET-COPD® 연구 (티오트로퓸(Tiotropium)으로 악화 예방) 반응 매체 Q&A 2011년 3월 24일 English ->Korean
Boehringer Ingelheim Korea SPIRIVA® (tiotropium)* Media backgrounder March 2011 -> 스피리바® (티오트로퓸)* 배경설명 자료 2011년 3월 English ->Korean
Boehringer Ingelheim Korea The Economic Burden of Chronic Obstructive Pulmonary Disease (COPD) Media backgrounder March 2011 -> 만성 폐쇄성 폐질환(COPD)의 경제적 부담 배경설명 자료 2011년 3월 English ->Korean
Boehringer Ingelheim Korea For medical media outside the USA and Canada -The POET-COPD® study results demonstrate superiority of Spiriva® (tiotropium) over long-acting beta agonist salmeterol in reducing the risk for COPD exacerbations -> Korean English ->Korean
Boehringer Ingelheim Korea 미국 및 캐나다 외 지역 의학 매체용 -POET-COPD® 연구 결과, COPD(만성폐쇄성폐질환) 악화 위험을 감소시키는 지속성 베타 작용제 살메테롤(salmeterol)에 대해 스피리바® (티오트로퓸)의 우수성을 증명 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - Sustained Viral response achieved in 83% of Hepatitis C infected patients with new HCV protease inhibitor from Boehringer Ingelheim -> 보도자료 - 베링거 인겔하임의 새로운 HCV 단백질분해효소 억제제로 치료 받은 C형 간염 감염 환자의 83%가 지속 바이러스 반응을 보였다. English ->Korean
Boehringer Ingelheim Korea Press Release - Dabigatran etexilate is cost-effective for stroke prevention in atrial fibrillation, particularly in real-world clinical practice-> 보도자료 -다비가트란 이텍실레이트는 특히 실제 임상 진료에서 비판막성 심방세동 환자의 뇌졸중 예방에 있어 비용효과적이다. English ->Korean
Boehringer Ingelheim Korea Press Release - New SPIRIVA® RESPIMAT® Soft MistTM Inhaler now available for the management of COPD - Patients to benefit from easy-to-use inhaler with enhanced drug delivery-> 보도자료 -COPD 관리를 위한 새로운 스피리바® (SPIRIVA®) 레스퍼매트® (RESPIMAT) ® Soft MistTM 흡입기- 환자 English ->Korean
Boehringer Ingelheim Korea Press Release - Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups-> 보도자료 - 획기적인 치료인 다비가트란은 모든 심방세동 유형 및 뇌졸중 위험군에 걸쳐 일관된 효용을 제공한다 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within the BI HCV portfolio -> 보도자료 - Boehringer Ingelheim이 C형 간염 화합물의 III 단계를 향한 움직임을 선도 - BI HCV 최초 English ->Korean
Boehringer Ingelheim Korea JEJU PRRS ARC Meeting Apr. 1, 2011 (Friday) <- 제주 PRRS ARC 간담회 2011년 4월 1일(금요일) Korean ->English
Boehringer Ingelheim Korea Boehringer Ingelheim Korea Supply Agreement <- 한국베링거인겔하임㈜ 공급계약서 Korean ->English
Boehringer Ingelheim Korea Cosmetic Product Data Sheet, ANTISTAX Leg Cooling Spray -> 화장품 데이터시트 ANTISTAX Leg Cooling Spray English ->Korean
Boehringer Ingelheim Korea Clinical Trial Report for Cosmetics - Test Substance: Antistax® Spray -> 화장품 임상시험 보고서 - 검사성분: Antistax® Spray English ->Korean
Boehringer Ingelheim Korea ANTISTAX Leg Cooling Spray Homepage Contents translation English ->Korean
Boehringer Ingelheim Korea Birthday thank-you letter - Hello, everyone. I'm La In Gang. <- 생일 감사 편지 - 안녕하세요, 라인강입니다. Korean ->English
Boehringer Ingelheim Korea Corporate Procedure for Handling Technical Complaints of Veterinary Products - Effective Date: 02-Feb-2004 -> 수의학 제품 관련 기술적 불만 처리 절차 - 발효일자: 2004년 2월 2일 English ->Korean
Boehringer Ingelheim Korea Press Release - Dabigatran etexilate now approved in eight Asia Pacific countries for stroke prevention in atrial fibrillation-> 보도자료 - 다비가트란 이텍실레이트(Dabigatran etexilate), 심방세동 환자의 뇌졸중 예방 목적으로 아시아 태평양 8개국에서 허가 English ->Korean
Boehringer Ingelheim Korea Origin of the UK Foot and Mouth Disease epidemic in 2001 - Department for Environment, Food and Rural Affairs June 2002 -> 2001년 영국 구제역 유행의 원인 - 영국 환경농식품부 2002년 6월 English ->Korean
Boehringer Ingelheim Korea The Regulations on New Accounts and the Termination of Contract - Date of Execution: April 1, 2011 <- 거래처 신규 및 계약종료에 관한 규정 - 실시일 : 2011.04.01 Korean ->English
Boehringer Ingelheim Korea Control of foot and mouth disease: lessons from the experience of Ireland - Rev. sci. tech. Off. int. Epiz., 2002, 21 (3), 739-750 -> 구제역(foot and mouth disease) 관리: 아일랜드 경험으로부터의 교훈 English ->Korean
Boehringer Ingelheim Korea Control of foot and mouth disease: lessons from the experience of the outbreak in Great Britain in 2001 - Rev. sci. tech. Off. int. Epiz., 2002, 21 (3), 699-710 -> 구제역 관리: 2001년 영국(Great Britain)에서의 구제역 발생으로부터의 교훈 - 영국 SW1P 4PQ, 런던 1A Page가, 주 수의학 서비스, 환경 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim/Pfizer position regarding the recent publication by Singh et. al., in British Medical Journal, June 15, 2011 -> 보도자료 - 2011년 6월 15일 British Medical Journal의 Singh 등 최근 발표 관련 베링거 인겔하임/화이자 측 입장 English ->Korean
Boehringer Ingelheim Korea Press Release - New data confirm superior blood pressure reductions in diabetic patients treated with TWYNSTA® compared to amlodipine alone -> 보도자료 - 암로디핀(amlodipine) 단독 투여 대비 TWYNSTA®투여 당뇨환자에서 우월한 혈압 강하 효능 확인 English ->Korean
Boehringer Ingelheim Korea Press Release - New data for linagliptin* show clinically meaningful efficacy similar to glimepiride but with fewer cardiovascular events -> 보도자료 - 리나글립틴*, 글리메피리드 대비 유효성은 유사하나 심혈관 사건 발생률은 더 낮아 English ->Korean
Boehringer Ingelheim Korea Case report: Effect of mass vaccination with Ingelvac® PRRS MLV on sow performance <- Korean Korean ->English
Boehringer Ingelheim Korea Press Release - Breakthrough therapy PRADAXA® (dabigatran etexilate) first drug in 50 years to gain approval for stroke prevention in atrial fibrillation in Europe -> 보도자료 - PRADAXA® (dabigatran etexilate), 50년 만에 최초로 심방세동환자의 뇌졸중 예방을 위한 혁신적 치료법으로 유럽에서 승인 English ->Korean
Boehringer Ingelheim Korea 1st Conference of MAF for the 29 March (Tue) 2011, Technology Planning, IPET <- 제1차 농식품부 (구제역 R&D 기획단) 회의자료 2011.3.29(화) 농기평 기술기획실 Korean ->English
Boehringer Ingelheim Korea FMD Planning RFP - Project Name Development of technology for the production of a recombinant FMD vaccine <- 구제역 기획과제 제안요구서 RFP - 과제명: 유전자 재조합 구제역 백신 생산 기술개발 Korean ->English
Boehringer Ingelheim Korea 2nd Conference of the FMD Planning Group at the Ministry for Food, Agriculture, Forestry and Fisheries (MAF) for [2011.4.26] <- 제2차 농림수산식품 구제역 기획단 회의자료 [2011.4.26] Korean ->English
Boehringer Ingelheim Korea Overall Project Milestone Plan - G. Considerations related to technology development - 5. Research Period and Research Budget <- 전체 추진 마일스톤 - 사. 기술개발과 관련된 검토사항 - 5. 연구기관 및 연구 예산 규모 Korean ->English
Boehringer Ingelheim Korea PROJECT ②: Development of Production Technology for a Recombinant Vaccine for Foot-and-Mouth Disease (FMD) <- 기획과제 ② : 유전자 재조합 구제역 백신 생산 기술개발 Korean ->English
Boehringer Ingelheim Korea Mortality associated with tiotropium mist inhaler? A critical appraisal of the authors' selection and use of previously communicated tiotropium Respimat data -> 티오트로피움 분무흡입기 관련 사망: 이전에 알려진 티오트로피움 Respimat 자료의 저자 선정 및 사용 비평 English ->Korean
Boehringer Ingelheim Korea World Hepatitis Day 2011 and our commitment to hepatitis C patients worldwide English ->Korean
Boehringer Ingelheim Korea Press Release - Dabigatran etexilate protects against recurrent venous thromboembolic (VTE) events 92% reduction in risk of VTE with dabigatran etexilate compared to placebo (RE-SONATE trial)-> 보도자료 -다비가트란 이텍실레이트는 재발성 정맥 혈전색전증(VTE)을 방지한다 다비가트란 이텍실레이트는 VTE English ->Korean
Boehringer Ingelheim Korea Press Release - Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe -> 보도자료 - 트라젠타® (리나글립틴), 유럽에서 제 2형 당뇨병 치료약으로 승인 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa® (dabigatran etexilate, 150mg bid) shows significant reduction in the risk of stroke over warfarin in patients with atrial fibrillation taking antiplatelet or other concomitant therapies -> 보도자료 - 프라닥사® (다비가트란 에텍실레이트) 150mg 1일 2회 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa® (dabigatran etexilate) revolutionizes stroke prevention in atrial fibrillation -> 보도자료 - 프라닥사®(다비가트란 에텍실레이트) 심방세동환자 뇌졸중 예방의 혁신을 이루다 English ->Korean
Boehringer Ingelheim Korea Press Release - New data for once-daily linagliptin show durable efficacy over two years -> 보도자료 - 리나글립틴 1일 1회 투여 시 유효성이 2년 동안 지속된다는 새로운 자료 발표돼 English ->Korean
Boehringer Ingelheim Korea Bericht zur Leistungsqualifizierung (PQ) - TZL 18, PQ-Überprüfungslauf nach Umzug der Linie ins LogiPack Center -> 적격 검사(PQ) 보고서 - 가열성형라인 18, LogiPack Center로의 라인 이동에 따른 PQ-심사과정 German->Korean
Boehringer Ingelheim Korea Bericht zur Leistungsqualifizierung (PQ) - TZL 19, PQ-Überprüfungslauf nach Umzug der Linie ins LogiPack Center-> 적격 검사(PQ) 보고서 - 가열성형라인 19, LogiPack Center로의 라인 이동에 따른 PQ-심사과정 German->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa® (dabigatran etexilate) in Europe -> 보도자료 - 베링거인겔하임, 프라닥사®(다비가트란 이텍실레이트)의 적절한 사용을 위한 추가지침 시행 English ->Korean
Boehringer Ingelheim Korea Bericht zur Leistungsqualifizierung (PQ) - TZL23 - Kombilinie- Format: Micardis Mono 10er Blister- ínit Perforation -> 적격 검사(PQ) 보고서 - 가열성형라인 23-조합라인-유형: 절취선이 있는 미카르디스 10정용 블리스터 German->Korean
Boehringer Ingelheim Korea Bericht zur Leistungsqualifizierung (PQ) - Tiefziehli nie 26 I Qualifizierung 10er-Blisterformate (Micardis Plus I Twynsta und Micardis Mono)-> 적격 검사(PQ) 보고서 -가열성형라인 26/10정용 블리스터의 제품 유형에 대한 적격 검사 German->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim gains approval of the extended 4.5 hour time-window for Actilyse® (Alteplase) in acute ischaemic stroke for majority of EU countries* -> 보도자료 - Boehringer Ingelheim, 대다수의EU 국가에서 급성 허혈성 뇌졸중에 대해 Actilyse® (Alteplase)의 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim enrols first patient in Phase III program for new once-daily fixed-dose combination of tiotropium plus olodaterol in COPD -> 보도자료 - Boehringer Ingelheim, 만성폐쇄성 폐질환(COPD)에서의 새로운 하루 1회 고정용량 티오트로피움 및 올로다테롤 조합에 대한 제3상 프로그 English ->Korean
Boehringer Ingelheim Korea Applying PRRS Risk Assessment v2.3 to Jeju PRRS Area Regional Control and Analysis of Results <- PRRS Risk Assessment v2.3의 제주 PRRS Area Regional Control에의 적용 및 결과 분석 Korean ->English
Boehringer Ingelheim Korea Application of PRRS Area Regional Control in Jeju <- 대한민국 제주도에서의 PRRS 지역 관리(Area Regional Control)의 적용 Korean ->English
Boehringer Ingelheim Korea Meeting Report of the Jeju PRRS ARC TFT Meeting, dated 27 Sep, 2011 Place: Jeju Grand Hotel <- 2011년 9월 27일 제주 PRRS ARC TFT 미팅 결과 보고 - 장소: 제주 그랜드호텔 Korean ->English
Boehringer Ingelheim Korea Press Release - New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis -> 보도자료 - 뉴잉글랜드 저널 오브 메디슨 지(New England Journal of Medicine English ->Korean
Boehringer Ingelheim Korea Cases of Using Ileitis Vaccine in the Korean Field: Increasing Productivity through the Ileitis Vaccine <- 회장염 백신의 국내 필드 사용 사례: 회장염 백신을 통한 농장 생산성 증가 Korean ->English
Boehringer Ingelheim Korea The Efficacy and Safety Evaluation of 3FLEX in Jeju Island <- Korean Korean ->English
Boehringer Ingelheim Korea The labor cost saving after using mixed PCV2 and Mycoplasma hyopneumonia vaccine in Korea <- Korean Korean ->English
Boehringer Ingelheim Korea SECTION 8 VACCINATION Article 49 Use, manufacture, sales and controls of foot-and-mouth Article 50 Decision on introducing emergency vaccination Article 51 Conditions for emergency vaccination -> SECTION 8 백신 접종 제49조 구제역 백신의 사용, 제조, 판매 및 관리 제50조 긴급 백신 접종 English ->Korean
Boehringer Ingelheim Korea Manuscript checklist (space for manuscript ID) - 원고(Manuscript) 체크리스트 (원고 ID 기입 공백) English ->Korean
Boehringer Ingelheim Korea Analysis of Correlations between PRRS Monitoring Results Using the Risk Factors of the Risk Assessment and Blood on Korean Farms <- 대한민국 농장에서의 Risk Assessment의 Risk Factor와 혈액을 이용한 PRRS 모니터링 결과간의 상관관계 분석 Korean ->English
Boehringer Ingelheim Korea Final Report of PRRS Research Group Field Trial - Analysis Result of PRRS Risk Assessment <- Korean Korean ->English
Boehringer Ingelheim Korea PHOENYX is effective for respiratory organ diseases caused by PRRS viruses by activating innate immunity (IFN – α, β, TNF – α). Find the effectiveness yourself by injecting PHOENYX on atrophic pigs or infected pigs! <- Korean Korean ->English
Boehringer Ingelheim Korea PRADAXA® (dabigatran etexilate) - QUESTIONS & ANSWERS RESOURCE Direct Healthcare Professional Communication on the importance of assessing renal function in patients treated with Pradaxa® (dabigatran etexilate) in Europe-> 프라닥사® (다비가트란 이텍실레이트) - 질문 & 답변 , English ->Korean
Boehringer Ingelheim Korea Pharmaton Web Translation Document - 1.1.1.A.d. FAQ 1. What are the main advantages of taking Pharmaton® Vitality? -> 1.1.1.A.d. 자주 묻는 질문 1. Pharmaton® Vitality 복용의 주요 장점은 무엇인가요? English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH ABCD Consumer Health Care Basic Medical Information - Product: Standardised Panax ginseng G115® extract, vitamins and minerals -Pharmaton ® Core (Soft gelatine capsules, effervescents, and caplets) English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH COMPANY CORE DATA SHEET GERIATRIC PHARMATON * (Pharmaton capsules, Geriavit Pharmaton, Gericomplex, Pharmaton Caplets) * -> 게리아트릭 파마톤 (GERIATRIC PHARMATON) * (Pharmaton capsules, Geriavit Pharmaton, Gericomplex, Pharmaton Caplets English ->Korean
Boehringer Ingelheim Korea Fachinformation des Arzneimittel-Kompendium der Schweiz® - Pharmaton® Vital Tabletten -> 파마톤® 바이탈 정 German->Korean
Boehringer Ingelheim Korea Press Release - BI 201335 demonstrates potential to shorten HCV treatment duration while achieving high sustained virological response rates in difficult to treat patients -> 보도자료 - BI 201335, 치료가 어려운 환자들에서 HCV치료 기간 단축과 높은 지속적 바이러스 반응 비율 입증1,2 English ->Korean
Boehringer Ingelheim Korea Press Release - Hepatitis C: Interferon-free combination of BI 201335 plus BI 207127 and ribavirin shows up to 76% of patients achieve a virological response at week 12, and 63% achieve SVR12 with 16 weeks treatment 1-> 보도자료 - C형 간염: 인터페론이 포함되지 않는 BI 2013 English ->Korean
Boehringer Ingelheim Korea Press Release - Patients with atrial fibrillation should continue to protect themselves against the risk of stroke -> 보도자료 - 심방세동 환자는 뇌졸중 위험으로부터 지속적으로 스스로를 지켜야 한다 English ->Korean
Boehringer Ingelheim Korea ABCD Patient Information and Consent Form - Inje University Busan Paik Hospital -> ABCD Өвчтөний Мэдээлэл ба Зөвшөөрлийн Маягт - Инже Их Сургуулийн дэргэдэх Бусан Пайк Эмнэлэг English ->Mongolian
Boehringer Ingelheim Korea PATIENT IDENTIFICATIOM CARD CLINICAL TRIAL: 1220.47 - Front: Trial Identification Card For EMERGENCY Back: Visit 8 and 9 are only for patients in 48 weeks -> ӨВЧТӨНИЙ ТАНИХ КАРТ КЛИНИКИЙН ТУРШИЛТ: 1220.47 Урд: ЯАРАЛТАЙ ТҮРГЭН ТУСЛАМЖ-д зориулсан Судалгаан English ->Mongolian
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim completes patient entry for Phase III trial programme in Hepatitis C -> 보도자료 - 베링거인겔하임, C형 간염 제 3상 임상프로그램을 위한 환자 모집 완료해 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* -> 보도자료 - 베링거인겔하임, 아파티닙에 대한 제 3상 두경부암 임상시험프로그램 시작해 English ->Korean
Boehringer Ingelheim Korea First of all, I would like to congratulations on your promotion to the Head of Global Swine Marketing. <- 먼저 Head of Global Swine Marketing으로의 영전을 축하 드립니다. Korean ->English
Boehringer Ingelheim Korea Ministry of Health and Welfare [Attached Table 20 Form] Genetic TestㆍInformed Consent Form Inje University Busan Baik Hospital- <- 보건복지부 [별지 제20호서식] <개정 2009.12.31> 유전자 검사ㆍ연구 동의서 - 인제대학교 부산백병원 Korean ->English
Boehringer Ingelheim Korea Ministry of Health and Welfare [Attached Table 20 Form] Genetic TestㆍInformed Consent Form <- [Хүснэгт 20-ийн маягтыг хавсаргав.] <2009 оны 12 дугаар сарын 31-нд нэмэлт өөрчлөлт оруулав.> Генийн шинжилгээ - Өгсөн зөвшөөрлийн English ->Mongolian
Boehringer Ingelheim Korea Boehringer Ingelheim Korea Consumer Health Care (CHC) Greeting Letter <- 한국베링거인겔하임 일반의약품 CHC(Consumer Health Care) 인사 서신 Korean ->English
Boehringer Ingelheim Korea Reactive Global Media Q&A SPIRIVA® AND THE REVISED GOLD GUIDELINES SUMMARY Date Issued: xx January 2012 -> Reactive Global Media Q&A SPIRIVA®와 개정된 GOLD 가이드라인 요약 발행 일자: 2012년 1월 xx English ->Korean
Boehringer Ingelheim Korea 1-1-02-05 The standard for screening inactivated vaccine for staphylococcus aureus mastitis of dairy cows <- 1- 1- 02- 05 젖소 황섹포도상구균 유방염 불활화백신 검정기준 Korean ->English
Boehringer Ingelheim Korea XI. General Screening Standard for Veterinary Biological Medicines 1-11-20-01 Characteristic test 1-11-20-02 Vacuum test 1-11-20-03 Hydrogen ion concentration test <- X I. 동물용 생물학적제제 일반검정기준 1- 11- 20-01 특성 시 험 1-11- 20- 02 진공도 시험 1-11-20- 03 수소 이온 농도 시험 Korean ->English
Boehringer Ingelheim Korea XI. General Screening Standard for Veterinary Biological Medicines 1-11-20-04 Moisture content test 1-11-20-05 Purity test 1-11-20-06 Sterility test 1-11-20-07 Mycoplasma test 1-11-20-08 Bacteria test 1-11-20-09 Preservative quantity test <- Korean Korean ->English
Boehringer Ingelheim Korea X I. 동물용 생물학적제제 일반검정기준1- 11-20 - 04 함습도 시험 1- 11-20- 05 순수 시험 1- 11-20- 06 무균 시험 1-11-20-07 마이코플라즈마 부정시험 1- 11- 20-08 세균 시험 1- 11-20-09 방부제 정량시험 -> English Korean ->English
Boehringer Ingelheim Korea Press Release - Revised GOLD Guidelines highlight - Long-acting anticholinergics supported by new guidelines as the only therapeutic class recommended for every patient requiring maintenance therapy -> 보도자료 - 개정 GOLD 가이드라인, 악화 위험성과 COPD 증상 강조 - 새로운 가이드라 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim/Pfizer’s Spiriva Has Earned Decision Resources’ Proprietary Clinical Gold Standard Status for the Treatment of Chronic Obstructive Pulmonary Disease-> 보도자료 - 베링거인겔하임/화이자의 스피리바, Decision Resources로부터 만성 폐쇄성 폐질환의 치료에 대한 English ->Korean
Boehringer Ingelheim Korea Boehringer lngelheim Corporate Policy on Purchαsing at Boehringer lngelheim Group of Companies -> 베링거인겔하임 그룹에서 그룹 차원의 구매에 관한 회사 정책 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH Corporate Division Purchasing Procedure - Ident.-No PCP-001 Version No: 03 -> 베링거인겔하임 회사 구매 절차 - 식별번호 PCP-001 버전 번호: 03 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Combination Therapy with Insulin -> 트라드젠타 (리나글립틴) 정제 인슐린과의 병용 요법 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Add-on Combination Therapy with Metformin -> 트라드젠타 (리나그립틴) 정제 메트포르민과의 추가적 병용 요법 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Combination with Pioglitazone -> 트라드젠타 (리나그립틴) 정제 피오글리타존(Pioglitazone)과의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Combination with Alpha Glucosidase Inhibitors -> 트라드젠타 (리나그립틴) 정제 알파 글루코시데이스 억제제와의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Combination with Sulfonylurea & Sulfonylurea/Metformin -> 트라드젠타 (리나글립틴) 정제 술포닐우레아 및 술포닐우레아/메트포르민과의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Drug Interactions -> 트라드젠타 (리나글립틴) 정제 약물상호작용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Drug-Drug Interactions with Bile Acid Sequestrants (Welchol®) -> 트라드젠타 (리나그립틴) 정제 담즙산 결합수지(Welchol®)와의 약물-약물 상호작용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Drug-Drug Interactions with Transplant Drugs (CellCept®, Sandimmune® and Prograf®) -> 트라드젠타 (리나글립틴) 정제 이식 거부반응 예방약과의 약물-약물 상호작용 (CellCept®, Sandimmune® and Prograf®) English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use with Glucagon-like Peptide 1 (GLP-1) Agonist Therapy -> 트라드젠타 (리나글립틴) 정제 글루카곤-유사 펩티드 1(GLP-1) 작용제 요법과의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use with Meglitinides -> 트라드젠타 (리나글립틴) 정제 메글리티나이드계와의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use with Pramlintide -> 트라드젠타 (리나글립틴) 정제 프람린티드와의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use with SGLT-2 Inhibitors -> 트라드젠타 (리나그립틴) 정제 SGLT-2 억제제와의 병용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Alternative dosing -> 트라드젠타 (리나글립틴) 정제 대체 용법 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Dosage and Administration -> 트라드젠타 (리나글립틴) 정제 용량 및 투여법 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Switching from another DPP-4 Inhibitor to TRADJENTA -> 트라드젠타 (리나글립틴) 정제 다른 DPP-4 억제제에서 트라드젠타로의 전환 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Switching from Glucagon Like Peptide -1 (GLP-1) Agonist Therapy to TRADJENTA -> 트라드젠타 (리나글립틴) 정제 글루카곤-유사 펩티드-1 (GLP-1) 작용제 요법에서 트라드젠타로의 전환 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Comparison to Alpha Glucosidase Inhibitors -> 트라드젠타 (리나그립틴) 정제 알파 글루코시데이즈 억제제와의 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Comparison to Glucagon-like Peptide-1 (GLP-1) Agonist Therapy -> 트라드젠타 (리나글립틴) 정제 글루카곤-유사 펩티드 1(GLP-1) 작용제 요법과의 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Comparison with Januvia® -> 트라드젠타 (리나그립틴) 정제 Januvia®와의 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Comparison with ONGLYZATM (saxagliptin) -> 트라드젠타 (리나글립틴) 정제 ONGLYZATM (삭사글립틴)와의 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Comparison with Sulfonylureas -> 트라드젠타 (리나글립틴) 정제 술포닐우레아계와의 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Effect on Indicators of β-cell function -> 트라드젠타 (리나글립틴) 정제 β-세포 기능 지표에 대한 효과 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Summary of Efficacy and Safety -> 트라드젠타 (리나글립틴) 정제 유효성 및 안전성 요약 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Monotherapy -> 트라드젠타 (리나글립틴) 정제 단독요법 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Glycemic Endpoints across 6 TRADJENTA Pivotal Trials -> 트라드젠타 (리나글립틴) 정제 6건의 트라드젠타 중추적 시험에서의 혈당 평가변수들 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Elimination Half-Life -> 트라드젠타 (리나그립틴) 정제 제거 반감기 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Mechanism of Action and Pharmacodynamics -> 트라드젠타 (리나글립틴) 정제 작용기전과 약역학 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Onset of Action -> 트라드젠타 (리나글립틴) 정제 작용발현 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Pharmacokinetics -> 트라드젠타 (리나그립틴) 정제 약동학 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Cardiovascular Safety -> 트라드젠타 (리나글립틴) 정제 심혈관 안전성 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Effect on Body Weight -> 트라드젠타 (리나글립틴) 정제 체중에 대한 효과 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Effect on Laboratory Tests -> 트라드젠타 (리나글립틴) 정제 실험실 검사에 대한 효과 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Hyperlipidemia/Effect on Triglycerides -> 트라드젠타 (리나글립틴) 정제 고지질혈증/중성지방에 대한 효과 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Hyperuricemia, Nephrolithiasis (Kidney Stones), and Gout -> 트라드젠타 (리나글립틴) 정제 고요산혈증, 신장결석증(신장결석), 통풍 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Hypoglycemia -> 트라드젠타 (리나글립틴) 정제 저혈당증 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Incidence of Malignancy -> 트라드젠타 (리나글립틴) 정제 암 발생률 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Nasopharyngitis -> 트라드젠타 (리나글립틴) 정제 비인두염 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Overdosage / Removal by Dialysis -> 트라드젠타 (리나글립틴) 정제 과량투여/투석에 의한 제거 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Incidence of Pancreatitis -> 트라드젠타 (리나글립틴) 정제 이자염 발생률 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Rash, Hypersensitivity and Skin Lesions -> 트라드젠타 (리나글립틴) 정제 발진, 과민 및 피부 병터 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Geriatric Patients -> 트라드젠타 (리나글립틴) 정제 노인 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Pediatric Use -> 트라드젠타 (리나글립틴) 정제 소아 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Pregnancy and Lactation -> 트라드젠타 (리나글립틴) 정제 임신 및 수유중 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Alcoholic Patients -> 트라드젠타 (리나글립틴) 정제 알코올중독 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in American Indian Patients -> 트라드젠타 (리나글립틴) 정제 아메리카 인디언 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Asian Patients -> 트라드젠타 (리나글립틴) 정제 아시아 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Black/African American Patients -> 트라드젠타 (리나글립틴) 정제 흑인/아프라카계 미국인 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Hepatic Impairment -> 트라드젠타 (리나글립틴) 정제 간 장애에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Hispanic / Latino Patients -> 트라드젠타 (리나글립틴) 정제 히스패닉계/라틴계 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Males versus Females -> 트라드젠타 (리나그립틴) 정제 남성과 여성에서의 사용 비교 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Obese Patients -> 트라드젠타 (리나그립틴) 정제 비만 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Use in Renally Impaired Patients -> 트라드젠타 (리나글립틴) 정제 신장 장애가 있는 환자들에서의 사용 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Bibliography -> 트라드젠타 (리나글립틴) 정제 참고문헌 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Measuring GLP-1 Levels in the Clinical Trials -> 트라드젠타 (리나글립틴) 정제 임상 시험들에서 GLP-1 수준의 측정 English ->Korean
Boehringer Ingelheim Korea TRADJENTA (linagliptin) tablets Storage and Stability -> 트라드젠타 (리나글립틴) 정제 보관 및 안정성 English ->Korean
Boehringer Ingelheim Korea ABCD 피험자 설명문 건강한 아시아 남성 자원자에서 BI 1021958 단회 증량 (BI) 임상시험 번호: 1310.3 -> ABCD 试验对象说明书 以健康的亚洲男性志愿者为对象进行的BI1021958单次递增剂量给药试验 (BI) 临床试验编号: 1310.3 Korean ->Chinese
Boehringer Ingelheim Korea ABCD 피험자 설명문 건강한 아시아 남성 자원자에서 BI 1021958 단회 증량 (BI) 임상시험 번호: 1310.3 -> ABCD 受试者说明书 以健康的亚洲男性志愿者为对象进行的BI1021958单次递增剂量给药试验 (BI) 临床试验编号: 1310.3 Korean ->Chinese
Boehringer Ingelheim Korea ABCD 피험자 설명문 건강한 아시아 남성 자원자에서 BI 1021958 단회 증량 (BI) 임상시험 번호: 1310.3 -> ABCD 被験者説明文書 健康なアジア人男性志願者における BI 1021958の単回増量 (BI) 治験番号: 1310.3 Korean->Japanese
Boehringer Ingelheim Korea ABCD 피험자 설명문 건강한 아시아 남성 자원자에서 BI 1021958 단회 증량 (BI) 임상시험 번호: 1310.3 -> ABCD 被験者説明文書 健康なアジア人男性ボランティアを対象とする BI 1021958の単回増量 (BI) 治験番号: 1310.3 Korean->Japanese
Boehringer Ingelheim Korea Subsequently, Korea’s first PRRS ARC project, J-PAP, was promoted to 18 piggeries in the eastern Jeju-do, although there are 60% to 70% of concentrated piggeries in the west. <- 제주도는 양돈장이 서쪽에 60~70% 집중되어 있지만 분석 결과 동쪽지역 18농장을 대상으로 J-PAP이라는 프로젝트명으로 한국 최초의 P Korean ->English
Boehringer Ingelheim Korea ABCD Patient Information BI Trial No: 1220.47 Inje University Busan Paik Hospital -> ABCD Өвчтөний Мэдээлэл BI Туршилтын No: 1220.47 Инже Их Сургуулийн дэргэдэх Бусан Пайк Эмнэлэг English ->Mongolian
Boehringer Ingelheim Korea Clinical Trial Protocol Final Protocol Date: 09 February 2012 CLINICAL TRIAL PROTOCOL SYNOPSIS Name of finished product: Tiotropium Inhalation Solution - Respimat® Inhaler -> 임상시험 계획서 최종 임상시험계획서 날짜: 2012년 2월 9일 임상시험계획서 개요 완제품명: 티오트로피움 흡입액- Respimat® 흡입기 English ->Korean
Boehringer Ingelheim Korea Subject Information and Consent Form - Tiotropium in children with moderate persistent asthma - INFORMATION FOR PATIENTS -> 피험자 정보 및 동의서 - 중등도 지속 천식이 있는 아동들에서 티오트로피움 - 환자를 위한 정보 English ->Korean
Boehringer Ingelheim Korea Purchasing Script - 1. Scope of work 2. Process and Regulation & We will support purchasing with better quality based on our purchasing missions, purchasing ethics, profits, and efficiency. <- 구매 스크립트 - 1. 업무 범위 2. 프로세스와 규정 & 우리는 구매 미션인 구매윤리, 이익, 효율을 바탕으로 Korean ->English
Boehringer Ingelheim Korea Press Release - First ever data investigating interferon-free treatment in cirrhotic hepatitis C patients shows high viral cure rate -> 보도자료 - 간경변이 있는 C형 간염 환자들에게 인터페론(interferon)이 없는 치료를 임상시험한 데이터에서 높은 바이러스 치유율이 나타나 English ->Korean
Boehringer Ingelheim Korea Press Release - Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*) -> 보도자료 - C형 간염 환자의 82%에서 인터페론 없이 달성된 바이러스 치유 (GT-1a & -1b*) English ->Korean
Boehringer Ingelheim Korea Niemals Geht Man So Ganz -> No one is gone forever German->English
Boehringer Ingelheim Korea Niemals Geht Man So Ganz -> 영원히 떠나는 이는 없네 German->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim HCV Clinical Trials Overview -> 보도자료 - 베링거인겔하임 HCV 임상시험 개요 English ->Korean
Boehringer Ingelheim Korea Press Release - Research & Development in Hepatitis C -> 보도자료 - C형 간염 분야의 연구개발 English ->Korean
Boehringer Ingelheim Korea Press Release - Hepatitis C Virus (HCV) What is Hepatitis C? -> 보도자료 - C형 간염 바이러스 (HCV) , C형 간염이란? English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Vetmetrica Korea Inc. Special Contract 2012 <- 베링거인겔하임동물약품㈜ 2012년 특약사항 Korean ->English
Boehringer Ingelheim Korea 1-2-02-07 Guideline for Validation of Inactivated Vaccines for Porcine Pleuropneumonia <- 1- 2- 02-07 돼지 흉막 폐렴 불활화벡신 검정기준 Korean ->English
Boehringer Ingelheim Korea 1-2-01-03 Guideline for the Validation of Dried Live Vaccines for Porcine Proliferative Ileitis <- 1-2-01 - 03 돼지 증식성 회장염 생건조백신 검정기준 Korean ->English
Boehringer Ingelheim Korea 1-2-02-03 Guideline for the Validation of Porcine Mycoplasma Pneumonia Inactivated Vaccines <- 1-2- 02- 03 돼지 마이코플라즈마성 폐렴 불활화벡신 검정기준 Korean ->English
Boehringer Ingelheim Korea 1-2-02-21 Guideline for the Validation of Inactivated Mixing Vaccines of Porcine Atrophic Rhinitis, Atrophic Rhinitis Toxoid and Pasteurella Toxoid <- 1-2- 02- 21 돼지 위축성비염,위축성비염 톡소이드,파스튜렐라 톡소이드 불활화혼합백신 검정기준 Korean ->English
Boehringer Ingelheim Korea 1-2-04-03 Guideline for the Validation of Porcine Circovirus Type 2 Genetic Recombination Inactivated Vaccines <- 1- 2- 04-03 돼지 써코바이러스 type 2 유전자제 조합 불활 화백신 검정기준 Korean ->English
Boehringer Ingelheim Korea 14P5.20 PO - OUTLINE OF PRODUCTION CANINE CORONA VIRUS V ACCINE, KILLED VIRUS - U.S. Veterinary License No. 124 VS Code No. 14P5.20 January 20, 2011 -> 14P5.20 PO - 바이러스 치료제 개 코로나바이러스에 대한 제품 개요 - 미국 수의사법 124조 VS Code No. 14P5.20 2011년 1월 20일 English ->Korean
Boehringer Ingelheim Korea Press Release - Pivotal study on afatinib may challenge current standard first line treatment for lung cancer patients with EGFR mutations -> 보도자료 - EGFR-활성변이가 있는 진전된 폐샘암종 환자의 일차 치료로서의 페메트렉시드/시스플라틴과 아파티닙을 비교하기 위한 무작위배정, 공개라벨 제3상 시험) English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim announces positive phase II results for once-daily -> 보도자료 - 베링거인겔하임, 천식 대상 1일 1회 티오트로피움(tiotropium)의 제2상 임상시험에서 긍정적인 결과를 얻었다고 발표 English ->Korean
Boehringer Ingelheim Korea Press Release - Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial -> 보도자료 - 아파티닙*, EGFR 변이 양성 폐암 등록 시험에서 1차 요법으로서의 유효성 시사 English ->Korean
Boehringer Ingelheim Korea Core target consumer for MUCOPECT in Korea - Presentation data <- Korean Korean ->English
Boehringer Ingelheim Korea Mucoangin® lozenges for relieving the pain of sore throat The active ingredient ambroxol and its local anaesthetic properties By Horst Wunderer -> 인후염의 통증 완화를 위한 뮤코안진® 로젠지(Mucoangin® lozenges) 주성분 암브록솔과 국소마취 속성 Horst Wunderer 저 English ->Korean
Boehringer Ingelheim Korea PRESCRIPCIÓN DE ANÁLISIS (PA) lNGELV AC APP X Especificaciones de p roducto terminado Bac!erina con!ra Ac!inobacillus pleuroneumoniae Sinonimo: Ingelvac HI APPI APPx -> 분석 처방(PA) lNGELV AC APP X 완제품 사양 -흉막폐렴균 퇴치균 동의어: Ingelvac H/ APP/APPx Spanish->Korean
Boehringer Ingelheim Korea AGENCY EVALUATION -> 에이전시 평가 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III results: Tiotropium Respimat® significantly reduces exacerbations in asthma patients still symptomatic despite ICS/LABA treatment -> 보도자료 - 티오트로피움 레스피맷® 3상 임상시험 결과, ICS/LABA 치료 요법으로도 증상이 지속되는 천식 환자들의 증상 악화를 크게 감소시킴 English ->Korean
Boehringer Ingelheim Korea Asthma Media Backgrounder - What is asthma? -> 천식 언론매체용 배경설명 - 천식이란? English ->Korean
Boehringer Ingelheim Korea Are Pharmaceutical Companies in Korea becoming Multinational Wholesalers? Written: 2012-07-26 17:46 Revised: 2012-07-26 17:50 <- 국내제약사, 다국적 도매상 전락? 기사 입력 2012-07-26 17:46 기사 수정 2012-07-26 17:50 Korean ->English
Boehringer Ingelheim Korea Mucosolvan Triple effect/Three way action 1. Loosens and thins - SECRETOLYTIC Effect 2. Frees/Clears - SECRETOMOTORIC Effect 3. Protects - PROTECTIVE Effect -> 3중 효과 /3가지 작용 1. 느슨하고 얇게 – 점액용해작용 2. 떨어지고 배설되게 - 분비촉진작용 3. 보호- 보호 작용 English ->Korean
Boehringer Ingelheim Korea ABCD Mucosolvan® (ambroxol) Standard Presentation -> ABCD 뮤코솔반®(암브록솔) 표준 프리젠테이션 English ->Korean
Boehringer Ingelheim Korea Mucosolvan® Medico-Marketing package Key messages / claims May 2012 -> 뮤코솔반® 의약시판 포장 주요 메세지/ 주장 2012년 5월 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Mucosolvan® (ambroxol), CHC, Basic Medical Information December 17, 2008-> 베링거인겔하임 뮤코솔반(암브록솔) CHC, 기본 의학 정보 2008년 12월 17일 English ->Korean
Boehringer Ingelheim Korea Korean Academy of Medical Sciences - Wunsch Medical Award Introduction - Enactment of the Wunsch Medical Award <- 대한의학회 - 분쉬의학상 소개 자료 - 분쉬의학상 제정 Korean ->English
Boehringer Ingelheim Korea Understanding COPD - MEDIA BACKGROUNDER -> COPD의 이해 - 언론매체용 배경설명 English ->Korean
Boehringer Ingelheim Korea SPIRIVA® (tiotropium) Milestone Trials - MEDIA BACKGROUNDER -> 스피리바® (티오트로피움) 중요시험 - 언론매체용 배경설명 English ->Korean
Boehringer Ingelheim Korea Press Release - SPIRIVA celebrates 10 years of ongoing commitment to patients and advancing clinical innovation in COPD -> 보도자료 - 환자 치료제로 사용되어 왔고 COPD 치료 혁신을 촉진한 스피리바, 10주년을 맞아 English ->Korean
Boehringer Ingelheim Korea SPIRIVA (tiotropium) - MEDIA BACKGROUNDER -> 스피리바 (티오트로피움) - 언론매체용 배경설명 English ->Korean
Boehringer Ingelheim Korea Ministry of Health and Welfare - Revision of Standards for Decision and Adjustment for Drugs (Draft) <- 보건복지부 - 약제의 결정 및 조정 기준 중 개정(안) Korean ->English
Boehringer Ingelheim Korea Press Release - Cost effectiveness and clinical efficacy of Pradaxa® (dabigatran etexilate) versus rivaroxaban analysed. -> 보도자료 - 리바록사반 대비 프라닥사® 의 (다비가트란 에텍실레이트)의 비용 효과 및 임상효용 분석. English ->Korean
Boehringer Ingelheim Korea Press Release - New data show significant improvements in lung function using combination of tiotropium and olodaterol in COPD patients -> 보도자료 - 티오트로피움과 올로다테롤 의 조합으로 COPD 환자의 폐 기능 크게 향상 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim in Respiratory - Media Backgrounder -> 호흡기 질환 분야의 베링거인겔하임 - 언론매체용 배경설명 English ->Korean
Boehringer Ingelheim Korea Press Release - Key results from new tiotropium studies in COPD and asthma to be presented at ERS 2012 -> 보도자료 - ERS 2012에서 COPD와 천식에 대한 신규 티오트로피움 연구의 주요 결과 발표 English ->Korean
Boehringer Ingelheim Korea Chronic Obstructive Pulmonary Disease (COPD) Media backgrounder August 2012 -> 만성 폐쇄성 폐질환(COPD) 배경설명 자료 2012년 8월 English ->Korean
Boehringer Ingelheim Korea Press Release - Worldwide, one in ten patients presenting in the emergency department with atrial fibrillation will die within one year-> 보도자료 - 전세계적으로, 응급실 내 심방세동 환자 10명 중 1명이 1년 이내에 사망하는 것으로 알려져 English ->Korean
Boehringer Ingelheim Korea Press Release - Clinical experience with Pradaxa® crosses one million patient-years of treatment -> 보도자료 - 프라닥사® 임상경험이 100만 환자-치료년수를 넘어 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim submits first oncology compound, afatinib* for European approval -> 보도자료 - 베링거인겔하임, 최초 항암제인 아파티닙* 유럽 허가를 위한 신청서 제출 English ->Korean
Boehringer Ingelheim Korea Press Release - Analyses presented at EASD support Trajenta™ (linagliptin) as effective and well-tolerated for patients with type 2 diabetes with different background therapies -> 보도자료 - EASD, 상이한 기본요법을 받는 제 2형 당뇨병 환자에게 Trajenta™ (linagliptin)의 유효성과 내약성을 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Corp. Div. Internal Auditing / Audit Report No. 2012-15 -> 베링거인겔하임 기업 부서 내부 감사 / 감사 보고 No. 2012-15 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim BeNeLux Purchasing Policy - Effective date: 1st July 2012-> 베링거인겔하임 BeNeLux 구매정책 - 유효일자: 2012년 7월 1일 English ->Korean
Boehringer Ingelheim Korea External/Internal Social Media Guidelines for All Boehringer Ingelheim Employees -> 베링거 인겔하임 전 직원용 사내/사외 소셜 미디어에 대한 지침 English ->Korean
Boehringer Ingelheim Korea Press Release - Asian populations with atrial fibrillation (AF) benefit from better stroke prevention with Pradaxa® (dabigatran etexilate) compared to warfarin-> 보도자료 - 아시아인 심방세동 환자에서 와파린 대비 프라닥사®(성분명: 다비가트란 에텍실레이트)의 뇌졸중 예방 효과가 더 우수한 것으로 나타나 English ->Korean
Boehringer Ingelheim Korea Press Release - Recruitment complete for two pivotal Phase III studies of nintedanib* in patients with idiopathic pulmonary fibrosis -> 보도자료 - 특발성 폐섬유증 환자에서 닌테다닙*의 핵심 제 3상 시험 2건에 대한 환자 모집이 완료돼 English ->Korean
Boehringer Ingelheim Korea 2by 2020 internal calendar comment <- Korean Korean ->English
Boehringer Ingelheim Korea Press Release - Unprecedented progression-free survival benefit with afatinib* associated with clinically meaningful improvements in life-limiting lung cancer symptoms and better quality of life -> 아파티닙*의 전례없는 무진행 생존률 효용으로 임상적으로 유의한 생활을 제한하는 폐암 증상 및 삶의 질 English ->Korean
Boehringer Ingelheim Korea Medico-Marketing Package, Version 03, February 01, 2008 Antistax®, Clinical Trials -> 안티스탁스(Antistax)-임상시험 English ->Korean
Boehringer Ingelheim Korea Efficacy of Orally Administered Extract of Red Vine Leaf AS 195 (folia vitis viniferae) in Chronic Venous Insufficiency (Stages I-II) A randomized, double-blind, placebo-controlled trial -> Korean English ->Korean
Boehringer Ingelheim Korea Improvement of Cutaneous Microcirculation and Oxygen Supply in Patients with Chronic Venous Insufficiency by Orally Administered Extract of Red Vine Leaves of AS 195 - A randomized, Double-Blind, Placebo-Controlled, Crossover Study -> Korean English ->Korean
Boehringer Ingelheim Korea 만성정맥부전(I-II 단계)에서 Red Vine Leaf AS 195(folia vitis viniferae)의 경구용 추출물 효능 -무작위배정, 이중맹검, 위약대조 시험 <- English English ->Korean
Boehringer Ingelheim Korea 경구용 레드바인잎 AS 195 추출물에 의한 만성정맥부전 혼자에서의 피부 미세순환과 산소공급 개선 - 무작위배정, 이중맹검, 위약대조, 교차시험 <- English English ->Korean
Boehringer Ingelheim Korea Zusammenfassung -> 요약 - 적색 포도 잎 추출물인 경구용 AS195(folia vitis viniferae)의 만성 정맥 부전(1~2기)에 대한 효능/ 무작위 더블 블라인드 위약 대조 연구. German->Korean
Boehringer Ingelheim Korea Press Release - NICE recommends treatment with alteplase is started as early as possible, within 4.5 hours of onset of ischaemic stroke symptoms-> 보도자료 - NICE, 허혈성 뇌졸중 증상 개시 후 최대 4.5시간 이내에 조속히 알테플라제 투여를 시작하도록 권고해 English ->Korean
Boehringer Ingelheim Korea The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD) -> Korean English ->Korean
Boehringer Ingelheim Korea LUCK 시험: 영국 일반집단 및 임산부 중 GP가 진단한 변비 환자에 완하제 사용. 일반진료연구데이터베이스(GPRD)를 이용한 역학 연구. <- English English ->Korean
Boehringer Ingelheim Korea Wunsch speech Andreas Barner 2012 -> 분쉬의학상 연설문 - 2012년 안드레아스 바너 English ->Korean
Boehringer Ingelheim Korea Press Release - The Respimat® success story: Boehringer Ingelheim doubles its production capacity -> 보도자료 - 레스피맷® 성공 스토리: 베링거인겔하임의 생산 능력 배가 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D -> 보도자료 - 베링거인겔하임, 호흡기 R&D를 중심으로 한 탄탄한 파이프라인 발표 English ->Korean
Boehringer Ingelheim Korea Press Release - RELY-ABLE®: Unprecedented long-term data confirm favourable safety profile and sustained efficacy of Pradaxa® for stroke prevention in AF -> 보도자료 - RELY-ABLE®: 전례 없는 장기간 자료를 통해 심방세동환자의 뇌졸중 예방에 대한 프라닥사®(Pradaxa®)의 양호한 안전성 프로파일과 지속적인 효능 확인 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s interferon-free all-oral hepatitis C treatment+ shows up to 85% viral cure in Phase IIb study including patients with advanced liver disease-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 진행성 간질환 환자가 포함된 제 2b상 시험에서 베링거인겔하임의 무 인터페론, 경구용 C형 간염치료제+의 바이러스 치료율이 최대 85%인 것으로 나타나 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC -> 보도자료 - 미국 FDA, EGFR 변이 양성 진행성 NSCLC를 위한 베링거인겔하임 아파티닙(Afatinib)* 의 NDA에 우선심사권 부여 English ->Korean
Boehringer Ingelheim Korea Local Service Agreement Template -> 로컬 서비스 계약 템플릿 English ->Korean
Boehringer Ingelheim Korea Master Agreement for Media Service MINDSHARE / BI - Master Agreement for Planning and Buying Media Services -> 미디어 서비스 MINDSHARE/BI 를 위한 마스터계약 - 미디어 서비스 기획 및 구매를 위한 마스터계약 English ->Korean
Boehringer Ingelheim Korea Press Release - New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism -> 보도자료 - 두 연구를 통해 심부정맥 혈전증 및 폐색전증 재발 예방을 위한 프라닥사®의 상당한 효과가 새로이 드러나 English ->Korean
Boehringer Ingelheim Korea Enforcement Regulations for the Act on Bioethics and Safety [Annex Form No. 34] - Informed Consent for Human Derivatives Research <- 생명윤리 및 안전에 관한 법률 시행규칙 [별지 제34호서식] - 인체유래물 연구 동의서 Korean ->English
Boehringer Ingelheim Korea ABCD I. TITULO DEL PROTOCOLO (PROTOCOL TITLE): Determinación del punto protectivo para Actinobacillus pleuropneumoniae serotipos 1,2,3,4,5 y 7, en Ingelvac H -> ABCD I. 실험계획서 제목 (PROTOCOL TITLE): Ingelvac H에서의 흉막폐렴균 혈청형 1,2,3,4,5,7의 방어 정도 확인 English ->Korean
Boehringer Ingelheim Korea Harvard Business School - 9-393-012 September 8, 1992 - ACCOR (A) Introduction -> 하버드 비지니스 스쿨 - 9-393-012 1992년 9월 8일 - 아코르그룹(ACCOR) 소개 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III results: tiotropium Respimat® is effective in symptomatic asthma patients irrespective of their allergic status -> 보도자료 - 제 3상 시험결과: 티오트로피움 레스피맷®은 알레르기 상태와 무관하게 증상이 지속되는 천식환자에 효과적 English ->Korean
Boehringer Ingelheim Korea Press Release - Preventing disease: One billion pigs vaccinated with Ingelvac CircoFLEX® -> 보도자료 - 질병 예방: 10억 마리 돼지, 인겔백 써코플렉스®로 접종 English ->Korean
Boehringer Ingelheim Korea Press Release - Rare disease day: Boehringer Ingelheim announces initiation of pivotal trial investigating volasertib* in patients with acute myeloid leukaemia -> 보도자료 - 희귀질환의 날: 베링거 인겔하임, 급성 골수성 백혈병 환자 대상 volasertib* 연구를 위한 핵심 임상시험 시작 발표 English ->Korean
Boehringer Ingelheim Korea The new england journal of medicine - Extended Use of Dabigatran, or Placebo in Venous Thromboembolism -> 영국 최신 의학 저널 - 정맥 혈전색전증에서 다비가트란, 와파린, 위약의 연장 사용 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim announces interim results from a Phase III trial in HIV patients co-infected with chronic hepatitis C -> 보도자료 - 베링거인겔하임, 만성 C형 간염과 HIV의 중복감염 환자를 대상으로 한 제3상 임상연구의 중간 결과 발표 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim and Lilly initiate MARLINA™ clinical trial to evaluate use of Trajenta® (linagliptin) in patients with type 2 diabetes and albuminuria-> 보도자료 - 베링거인겔하임과 릴리, 제 2형 당뇨병 및 알부민뇨증 환자에서의 Trajenta® (linagliptin) 사용 평가를 위한MARLI English ->Korean
Boehringer Ingelheim Korea 2013 CHC Brand Convention for Wholesalers Welcome Speech President <- Korean Korean ->English
Boehringer Ingelheim Korea Press Release - FDA perspective published in the New England Journal of Medicine reinforces safety of Pradaxa® (dabigatran etexilate) -> 보도자료 - FDA, NEJM에서 프라닥사® (다비가트란 에텍실레이트)의 안전성에 대한 견해 재확인 English ->Korean
Boehringer Ingelheim Korea Press Release - Investigational compound faldaprevir+ shows high viral cure and early treatment success in treatment-naïve patients with genotype-1 hepatitis C -> 보도자료 - 임상연구용 의약품 팔다프레비어+, 치료 경험이 없는 유전자 1형 C형 간염 환자에서 바이러스 치유 및 조기 치료 성공 English ->Korean
Boehringer Ingelheim Korea CHRISTOPHER A . BARTLETT ANDREW N . McLEAN - GE's Talent Machine: The Making of a CEO -> CHRISTOPHER A . BARTLETT ANDREW N . McLEAN - GE의 인재 육성 기계(Talent Machine): CEO 양성하기 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III results: tiotropium Respimat® effective in symptomatic asthma patients irrespective of their age, allergic status, smoking status and bronchodilator response -> 보도자료 - 제3상 결과: 티오트로피움 레스피맷®, 나이, 알레르기와 흡연 여부 및 기관지확장제 반응에 상관없이 증상이 English ->Korean
Boehringer Ingelheim Korea Press Release - New European survey highlights ischaemic stroke protection as treatment priority for patients with atrial fibrillation-> 보도자료 - 유럽의 새로운 연구, 심방세동 환자의 우선적 치료로 허혈성 뇌졸중 예방 강조 English ->Korean
Boehringer Ingelheim Korea Trial identification card Korea V1.0 English 14 May 2013 -> Korean English ->Korean
Boehringer Ingelheim Korea Trial identification card Korea V1.0 English 14 May 2013 -> Chinese / 研究编号. 1293.8 试验应急识别证 English ->Chinese
Boehringer Ingelheim Korea Press Release - New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF -> 보도자료 - 심방세동 환자의 뇌졸중 예방에 대한 프라닥사®의 안전성을 보강하는 새로운 장기간의 자료 English ->Korean
Boehringer Ingelheim Korea American Journal of Gastroenterology - Myths and misconceptions about chronic constipation_muller lissner -> 만성 변비에 대한 미신과 오해 English ->Korean
Boehringer Ingelheim Korea Studies assessing bisacodyl and sodium picosulfate in chronic patients can be used to support their use in chronic and acute constipation -> 만성 환자에서의 비사코딜과 소듐 피코설페이트를 평가한 연구 결과는 만성 및 급성 변비에 대한 이들의 사용을 뒷받침한다 English ->Korean
Boehringer Ingelheim Korea Stimulant laxatives do not impair normal colonic function or increase the risk of habituation, tolerance and dependency -> 자극성 완하제는 정상적인 대장기능을 손상시키거나 습관화, 내성 및 의존성 위험을 증가시키지 않는다. English ->Korean
Boehringer Ingelheim Korea Use of laxatives in recommended doses does not cause electrolyte or metabolic disturbances or renal impairment -> 권장 용량의 완하제 사용은 전해질 장애, 대사 장애 또는 신장 손상을 유발하지 않는다. English ->Korean
Boehringer Ingelheim Korea Press Release - Application submitted to the European Medicines Agency (EMA) for use of Pradaxa® in treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE-> 심부정맥 혈전증(DVT) 및 폐색전증(PE) 치료와 재발성 심부정맥 혈전증 및 폐색 English ->Korean
Boehringer Ingelheim Korea Press Release - U.S. FDA approves Gilotrif™ (afatinib) as first-line treatment for lung cancer patients with EGFR mutations-> 보도자료 - 지오트립™(Afatinib; 항암제(비소세포폐암)) , 미국 FDA로부터 EGFR 변이 폐암 환자의 우선 치료제로 승인 English ->Korean
Boehringer Ingelheim Korea Press Release - Benefits of Pradaxa maintained in difficult to treat patients with atrial fibrillation and symptomatic heart failure-> 보도자료 - 프라닥사, 치료가 어려운 심방세동 및 증후성 심부전 환자에서도 혜택 유지 English ->Korean
Boehringer Ingelheim Korea Press Release - Volasertib* receives FDA Breakthrough Therapy designation for treatment of patients with acute myeloid leukaemia-> 보도자료 - FDA, 급성 골수성 백혈병 환자를 위한 획기적인 치료법으로 볼라설팁(Volasertib*) 지정 English ->Korean
Boehringer Ingelheim Korea Press Release - First patient enrolled in new cardiovascular and renal outcomes trial for linagliptin in Type 2 Diabetes -> 보도자료 - 제2형 당뇨병 환자 대상 새로운 심혈관계 및 신장 결과에 관한 리나글립틴 임상 연구에 첫 환자 등록 English ->Korean
Boehringer Ingelheim Korea Press Release - Afatinib* shows benefits for EGFR mutation positive non-small cell lung cancer patients across various efficacy endpoints-> 보도자료 - 아파티닙*, 다양한 유효성 종점에서 EGFR 변이 양성 비소세포폐암 환자에게 효과 증명 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Korea Human Resources - Guideline for Overseas Business Trip -> 한국베링거인겔하임 HR - 해외 비지니스 여행 가이드라인 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III safety and efficacy data of Trajenta® (linagliptin) in elderly people with Type 2 Diabetes published in The Lancet -> 보도자료 - 의학저널 란셋(The Lancet)에 제2형 노인 당뇨병 환자에서 트라젠타®(성분명: 리나글립틴)의 안전성과 유효성에 관한 3상 임상 연구 결과 게재 English ->Korean
Boehringer Ingelheim Korea Press Release - New Phase III data presented for first time demonstrate: tiotropium Respimat® significantly improves lung function and provides sustained bronchodilation in asthma patients who remain symptomatic despite ICS treatment1-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 티오트로피움 레스피맷® 새로운 3상 임상 연구 결과, 유의한 폐기능 개선과 ICS 치료1에도 증상이 지속되는 천식 환자에게 지속적인 기관지 확장 효과 최초 입증 <- English English ->Korean
Boehringer Ingelheim Korea Advertisement - Winter-time is cough time - Get rid of your cold-related cough – fast -> 광고 - 겨울은 기침의 계절 - 추위와 관련된 기침에서 빨리 벗어나세요 English ->Korean
Boehringer Ingelheim Korea Reactive Global Media Q&A for TIOSPIRTM trial - Date: 30 August 2013 -> TIOSPIRTM 시험에 대한 전세계 매체 대응용 Q&A - 날짜: 2013년 8월 30일 English ->Korean
Boehringer Ingelheim Korea Security Abroad - Guidance for Business Travelers -> 해외 여행에서의 보안 - 비지니스 여행자용 가이드라인 English ->Korean
Boehringer Ingelheim Korea Security Risk Avoidance - Emergency for Guide Business Trips abroad -> 보안 위험 방지 - 해외 출장 중 비상 상황 안내 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa® (dabigatran etexilate) drives Boehringer Ingelheim’s innovation promise in cardiovascular diseases-> 보도자료 - 베링거인겔하임, 프라닥사® (다비가트란 에텍실레이트)로 심혈관계 질환에 대한 혁신 약속 실현 English ->Korean
Boehringer Ingelheim Korea Press Release - Landmark TIOSPIRTM trial reinforces importance of SPIRIVA in both available formulations as the world’s leading maintenance therapy for chronic obstructive pulmonary disease (COPD) -> 보도자료 -획기적 임상시험 TIOSPIRTM으로 만성폐쇄성폐질환 (COPD)의 세계적인 주요 유지 English ->Korean
Boehringer Ingelheim Korea 100-PCP-00011_1.0_Corporate Procedure for Contractual Liability Arrangements with Suppliers -> 공급사와의 계약상의 배상책임 협정에 대한 회사 절차 English ->Korean
Boehringer Ingelheim Korea Exceptional Bidding Items, Out of scope of Purchasing & Standard Operating Procedure - Purchasing Standard Operating Procedure for BIK <- 입찰 예외 항목들, 구매 예외 범위, 표준 운영 절차서 - 한국베링거인겔하임용 표준 구매 운영 절차 Korean ->English
Boehringer Ingelheim Korea Press Release - GIOTRIF® (afatinib) approved in Europe for patients with EGFR mutation positive lung cancer -> 보도자료 - 지오트립® (아파티닙) , EGFR 변이 양성 폐암 환자 치료제로 유럽에서 승인 English ->Korean
Boehringer Ingelheim Korea Press Release - Data presented at EASD support safety profile of Trajenta® (linagliptin) in broad range of adults with Type 2 Diabetes -> 보도자료 - EASD에서 발표된 결과, 광범위한 제2형 당뇨병 성인 환자에서 트라젠타®(리나글립틴)의 안전성 프로파일 뒷받침 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim Animal Health achieves milestone: 500 million pigs benefit from Mycoplasma vaccination -> 보도자료 - 베링거인겔하임, 동물 건강의 중요 단계 달성: 5억 마리의 돼지, 마이코플라즈마 백신 혜택 받아 English ->Korean
Boehringer Ingelheim Korea THE COMPOUND AFATINIB BACKGROUNDER Date: September 2013 -> 화합물 아파티닙 배경 설명 날짜:2013년 9월 English ->Korean
Boehringer Ingelheim Korea LUNG CANCER BACKGROUNDER Date: September 2013 -> 폐암 배경설명 날짜: 2013년 9월 English ->Korean
Boehringer Ingelheim Korea Targeted Therapies for Lung Cancer Backgrounder Date: September 2013 -> 폐암을 위한 표적치료 배경설명 날짜: 2013년 9월 English ->Korean
Boehringer Ingelheim Korea EGFR Mutation Testing Backgrounder Date: September 2013 -> ErbB FAMILY 배경설명 - 진행성 NSCLC와 ErbB FAMILY와의 관련성 - 날짜: 2013년 9월 English ->Korean
Boehringer Ingelheim Korea AFATINIB* – THE FIRST APPROVED IRREVERSIBLE ERBB FAMILY BLOCKER -> 아파티닙*-최초 허가된 비가역적 ErbB Family 차단제 English ->Korean
Boehringer Ingelheim Korea LUX-Lung Clinical Trial Programme: Afatinib* is being studied in a comprehensive lung cancer clinical trial programme -> LUX-Lung 임상시험 프로그램: 아파티닙*은 포괄적인 폐암 임상시험 프로그램에서 연구 중이다. English ->Korean
Boehringer Ingelheim Korea Press Release - Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa® compared to warfarin -> 보도자료 - 항응고제 프라닥사® 치료군, 와파린 치료군에 비해 대출혈 발생 후 더 나은 결과 보여 English ->Korean
Boehringer Ingelheim Korea SGLT2 Inhibition Media Fact Sheet - 1. Type 2 Diabetes (T2D) 2. Sodium glucose cotransporter 2 (SGLT2) 3. What is SGLT2 inhibition? 4. Why is SGLT2 inhibition important? -> SGLT2 억제제 미디어 자료 - 1. 제2형 당뇨병 (T2D) 2. 나트륨 포도당 공동수송체 2 (SGLT2) 3. SGLT2 억제제란 무엇인가? English ->Korean
Boehringer Ingelheim Korea Press Release - New efficacy and safety data adds to evidence supporting treatment with afatinib*(GIOTRIF®) in Asian and non-Asian lung cancer patients-> 보도자료 - 아시아 및 비 아시아인 폐암 환자 대상, 아파티닙* (지오트립®) 치료 효과를 입증하는 새로운 유효성 및 안전성 결과 추가 English ->Korean
Boehringer Ingelheim Korea Press Release - New data presented at AASD further demonstrate benefits of Trajenta® (linagliptin) efficacy and safety in specific patient populations -> 보도자료 - AASD에서 발표된 새로운 결과, 특정 환자군에서 트라젠타® (리나글립틴)의 유효성과 안전성 추가 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - Micardis crosses 50 million patient-years of experience on 15th anniversary -> 보도자료 - 미카르디스 15주년 기념일에 5천만 환자 년 수 경험 달성 English ->Korean
Boehringer Ingelheim Korea Press Release - New survey in four major Asian countries reveals complexity of managing Type 2 Diabetes is currently underestimated1-> 보도자료 - 새로운 아시아 주요 4개국 연구 결과, 제2형 당뇨병 관리의 복잡성이 현재 과소평가되고 있다고 밝혀1 English ->Korean
Boehringer Ingelheim Korea Press Release - Global Lung Cancer Coalition to identify patient challenges and improve support strategies in partnership with Boehringer Ingelheim -> 보도자료 - 국제폐암연맹, 베링거인겔하임과 협력을 통한 환자의 어려움 파악, 지원전략 개선 English ->Korean
Boehringer Ingelheim Korea Press Release - New long-term treatment data confirms consistent benefit and safety profile of Pradaxa® beyond 6 years -> 보도자료 - 새로운 장기 치료 결과, 6년 이상 프라닥사®의 일관적인 효과와 안전성 프로파일 확인 English ->Korean
Boehringer Ingelheim Korea Press Release - Largest global survey investigating early Type 2 Diabetes conversations launched by Boehringer Ingelheim and Eli Lilly and Company in partnership with the International Diabetes Federation -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 베링거인겔하임과 일라이릴리, 국제당뇨병연맹과 협력을 통해 초기 제2형 당뇨병 환자와의 대화를 조사하는 세계 최대 규모의 설문 착수 <- English English ->Korean
Boehringer Ingelheim Korea AUSTRALIA - PET HEALTHCARE RECORD (Passport) - > 호주- 애완동물 건강관리 기록 (패스포트) English ->Korean
Boehringer Ingelheim Korea Canine Parvovirus (CPV) Vaccination: Comparison of Neutralizing Antibody Responses in Pups after Inoculation with CPV2 or CPV2b Modified Live Virus Vaccine -> 개 파보바이러스(CPV) 백신: CPV2 또는 CPV2b 변형 생바이러스 백신으로 접종한 후 새끼 강아지들의 중화항체반응 비교 English ->Korean
Boehringer Ingelheim Korea Adverse events diagnosed within three days of vaccine administration in dogs -> 개에게 백신 투여 3일 내 진단된 이상 반응 English ->Korean
Boehringer Ingelheim Korea Evolution of canine parvovirus—A need for new vaccines? -> 개 파보바이러스(canine parvovirus)의 진화 – 새로운 백신이 필요한가? English ->Korean
Boehringer Ingelheim Korea Lung Cancer in Asia Infographic -> 아시아에서의 폐암 인포메이션 그래픽 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa® (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY® – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban English ->Korean
Boehringer Ingelheim Korea Press Release - 프라닥사®(다비가트란 에텍실레이트) 150mg 1일 2회 투여 요법, 중추적 연구 RE-LY® 에서 계속하여 와파린 대비 허혈성뇌졸중을 월등하게 감소시키는 유일한 경구용 항응고제로 남아 - 와파린 대비 에독사반을 연구한 ENGAGE AF-TIMI 48 임상 결과에도 프라닥사®의 입지에는 변화 없어<- English English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Animal Health - Received award for the excellent voluntary inspection company from the Animal and Plant Quarantine Agency in 2013! <- 베링거인겔하임동물약품㈜ - 2013년 농림축산검역본부 자율점검 우수업체 우수상 수상! Korean ->English
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim planning two new Global Clinical Trials for Pradaxa® (dabigatran etexilate) in expanded patient populations -> 보도자료 - 베링거인겔하임, 환자군을 확대하여 프라닥사®(다비가트란 에텍실레이트) 대상 2개의 새로운 글로벌 임상 연구 계획 English ->Korean
Boehringer Ingelheim Korea External Statement re. decision to terminate development programme for Boehringer Ingelheim’s investigational interferon free hepatitis C regimen containing deleobuvir. -> 베링거인겔하임의 델레오부비르를 함유한, 인터페론이 포함되지 않은 C형 간염 치료 요법 연구 개발 프로그램의 종료 결정에 대한 외부 성명 English ->Korean
Boehringer Ingelheim Korea Trial data in Hepatitis C below expectations - Based on Phase III trial data for combination of deleobuvir and faldaprevir the difficult decision was taken to halt all further development efforts and investment into our interferon free Hepatits C combinat English ->Korean
Boehringer Ingelheim Korea 기대 이하의 C형 간염 대상 임상시험 데이터 - 델레오부비르와 팔다프레비어의 병용 요법을 연구한 제3상 임상시험 데이터를 기반으로 인터페론이 포함되지 않은 C형 간염 병용 요법에 대해 추가적인 모든 개발 노력과 투자를 중단한다는 어려운 결정을 내렸습니다. <- English English ->Korean
Boehringer Ingelheim Korea VTI Award Recommendation - How to recommend? <- VTI 상 권장사항 - 추천방법 Korean ->English
Boehringer Ingelheim Korea Press Release - New data on safety and efficacy of Pradaxa® in treatment of acute deep vein thrombosis and pulmonary embolism -> 보도자료 - 급성 심부정맥혈전증과 폐색전증 치료에서 프라닥사®의 안전성 및 효능에 관한 새로운 결과 English ->Korean
Boehringer Ingelheim Korea Corporate Quality Manual of the Pharmaceutical Quality System -> 의약품 품질관리 시스템 기업 품질 매뉴얼 English ->Korean
Boehringer Ingelheim Korea Quality Management Review -> 품질관리 평가 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Quality & Environmental Health and Safety CORPORATE PROCEDURE -> 품질 및 환경 보건 및 안전 기업 절차서 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Corporate Division Quality MANDATORY REFERENCE DOCUMENT-> 기업 부문 품질 - 의무 관련 문서 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Quality & Environmental Health and Safety - MANDATORY REFERENCE DOCUMENT -> 품질 및 환경 보건과 안전 - 의무 관련 문서 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Preparing for Audits and dealing with Audit Findings -> 감사준비 및 감사결과 처리 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - BI Material Service Supplier Qualification -> BI 재료/서비스 공급자 적격성 평가 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Certification by a Qualified Person and Batch Release -> 배치 인증 및 출하 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Product Quality Review -> 제품 품질 검토 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Management of Contracts with Quality relevant content -> 품질 관련 계약 관리 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - BI Material _ Service supplier selection -> BI 재료/서비스 공급자 선정 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - BI Material _ Service Supplier Performance Evaluation -> BI 재료/서비스 공급자 성과 평가 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - BI system for Quality- and EHS-audits -> 품질 및 EHS 감사를 위한 BI 시스템 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - BI Material_Service Supplier Audits (Quality and EHS) -> BI 재료/서비스 공급자 감사(품질 및 EHS) English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Management of Contracts with Quality relevant content -> 품질관련 계약 관리 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Storage of Chemical Pharmaceutical, Biopharmaceutical and Veterinary Products -> 화학제품, 의약품, 생물의약품, 동물제품 보관 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Working document_ Annex 9 to WHO Technical Support Series, No 908, 2003, Guide to Good Storage Practices for pharmaceuticals -> 의약품의 모범 보관 관행을 위한 지침 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Hazardous and Pharmaceutical Waste -> 위험 폐기물 및 약제 폐기물 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Warehouse Performance Standard - Safety and GMP in Warehouse -> 창고운영 표준 EHS 측면 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - Handling of Market Returns -> 시장 반품 제품 취급 English ->Korean
Boehringer Ingelheim Korea Internal update and reactive statement in relation to documents unsealed as part of litigation process and New York Times article -> 소송과정에서 공개된 문서들과 뉴욕타임즈 기사에 관련한 최신 내부 대응 진술문 English ->Korean
Boehringer Ingelheim Korea Press Release - AAAAI 2014 ASTHMA: New Phase III data show tiotropium Respimat® effective across asthma severities-> 보도자료 - AAAAI 2014 천식: 새로운 제3상 결과, 천식 중증도 전반에서 티오트로피움 레스피맷®의 효과 입증 English ->Korean
Boehringer Ingelheim Korea Pradaxa® litigation in the U.S. - RESPONSIVE STATEMENT FOR BLOOMBERG ARTICLE ON SELECTION OF DATA FOR FDA -> 보도자료 - 미국 내 프라닥사® 소송 - FDA용 데이터 선정 관련 블룸버그 기사에 대한 대응 진술문 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation-> 보도자료 - 프라닥사®(다비가트란 에텍실레이트), 현재 심방세동 환자의 뇌졸중 예방에 대해 100개국 이상에서 승인 English ->Korean
Boehringer Ingelheim Korea Unilateral cancellation of the planned Boehringer Ingelheim seminar scheduled on Mar. 12 in Gangwon-do <- 12일에 있을 예정이었던 베링거 강원도 세미나 일방적인 취소 Korean ->English
Boehringer Ingelheim Korea Press Release - 10,000 patients with atrial fibrillation now enrolled in innovative GLORIA™-AF Registry-> 보도자료 - 10,000명의 심방세동 환자, 혁신적 GLORIA™-AF 등록 임상 프로그램에 등록 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - 028-OCP-00109-RD01-Appendix-017E (3.0) QAA for Warehouses, 028-OCP-00109-RD01-Appendix-019E (1.0) Analytical Service QAA-Template English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - 028-OCP-00109-RD01-Appendix-033E (1.0) Packaging Material QAA-Template, 028-OCP-00109-RD01-Appendix-034E (1.0) Template QAA for Repackaging English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - 028-OCP-00109-RD01-Appendix-035E (2.0) QAA for Freight Forwarders English ->Korean
Boehringer Ingelheim Korea Interview Briefing Document - Mr. David B. Gocken, BIVK Sales & Marketing President <- 축산 경제 D.Gocken 사장님 인터뷰 답변서 Korean ->English
Boehringer Ingelheim Korea Opening remark_Focus SPAF_2014_1 Korean ->English
Boehringer Ingelheim Korea Temperature MonitoringTest Protocole – During Delivery Service <- 배송시 온도 모니터링 절차 Korean ->English
Boehringer Ingelheim Korea Temperature Mapping Test Procedure in Warehouse <- 창고 온도 Mapping 절차 Korean ->English
Boehringer Ingelheim Korea Boehringer Ingelheim VETMEDICA - Procedure for Training - For Warehouse <- 교육 규정 - 창고용 Korean ->English
Boehringer Ingelheim Korea Boehringer Ingelheim VETMEDICA - Procedure for re-packaging in ware house - For Warehouse <- 재포장 작업규정- 창고용 Korean ->English
Boehringer Ingelheim Korea Boehringer Ingelheim VETMEDICA - Warehouse Control for Product and Other materials - For Warehouse <- 제품 및 자재 보관관리 기준 - 창고용 Korean ->English
Boehringer Ingelheim Korea Press Release - American Diabetes Association Announces Research Collaboration with Boehringer Ingelheim Awards will focus on chronic kidney disease and renal insufficiency in diabetes-> 미국당뇨병협회, 베링거인겔하임과의 연구 협력 발표 -상은 당뇨병에서의 만성 신장 질환과 신부전에 초점을 둘 것이다 English ->Korean
Boehringer Ingelheim Korea 4 eLearning - Seven Steps to Effective Customer Engagement - Video script translation English ->Korean video script translation
Boehringer Ingelheim Korea Agenda FLM – Workshop, 7 Steps to Excellence in Customer Engagement - Roadmap FLM Workshop, FLM 3 Workshop Presentation, FLM 4 Seven Steps Poster English ->Korean
Boehringer Ingelheim Korea 5 Video - Sales Call Trajenta - Video script translation English ->Korean video script translation
Boehringer Ingelheim Korea FLM 5_1 Handout 1 Facilitator_Review Game, FLM 5_2 Handout 2 Facilitator_Video Guide, FLM 6_1 Handout 3 Participant_Observer Form, FLM 6_2 Handout 4 Participant_Proficiency Rating Scale English ->Korean
Boehringer Ingelheim Korea FLM 6_3 Handout 5 Participant_Round 1 Coach, FLM 6_4 Handout 6 Participant_Round 1 Sales Rep, FLM 6_5 Handout 7 Participant_Round 2 Coach, FLM 6_6 Handout 8 Participant_ Round 2_Sales Rep English ->Korean
Boehringer Ingelheim Korea FLM 6_7 Handout 9 Participant_Roleplay SPAF_A, FLM 6_8 Handout 10 Participant_Roleplay SPAF_B, FLM 6_9 Handout 11 Participant_Roleplay SPAF_C, FLM 6_10 Handout 12 Participant_Insight & Action English ->Korean
Boehringer Ingelheim Korea FLM 6_11 Handout 13 Participant_Own Role Play, FLM 6_12 Handout 14 Participant_Preparation Practice Session, FLM 7_1 Printer Spread - Seven Steps Quick Reference Guide English ->Korean
Boehringer Ingelheim Korea FLM 7_2 Printer Cover - Seven Steps Quick Reference Guide English ->Korean
Boehringer Ingelheim Korea FLM 7_2 Printer Cover - Seven Steps Quick Reference Guide - Video script translaion English ->Korean video script translation
Boehringer Ingelheim Korea SR 1_Agenda Sales Rep, SR 2 Roadmap new, SR 3 Workshop Presentation, SR 4 Seven Steps Poster, SR 5_1 Handout 1 - Roleplay SPAF_A, SR 5_2 Handout 2 - Roleplay SPAF_B English ->Korean
Boehringer Ingelheim Korea SR 5_3 Handout 3 - Roleplay SPAF_C, SR 5_4 Handout 4 - Insight & Action, SR 5_5 Handout 5 - TriFold, SR 6_1 Printer Spread - Seven Steps Quick Reference Guide English ->Korean
Boehringer Ingelheim Korea SR 6_2 Printer Cover - Seven Steps Quick Reference Guide, SR 7 Certificate English ->Korean
Boehringer Ingelheim Korea 3 Seven Steps Quick Reference Guide English ->Korean
Boehringer Ingelheim Korea CfE 1 Coaching for Excellence Presentation, CfE 2 Coaching for Excellence User Guide & CfE 3 Coaching for Excellence Quick Reference Card English ->Korean
Boehringer Ingelheim Korea 1 CEE Toolkit Contents, 2 CEE Trainer Tips English ->Korean
Boehringer Ingelheim Korea Security Crisis Manual -> 보안 위기 대응 매뉴얼 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim GmbH - 028-OCP-00109-RD01-Appendix-017E (3.0) QAA for Warehouses & 028-OCP-00109-RD01-Appendix-019E (1.0) Analytical Service QAA-Template English ->Korean
Boehringer Ingelheim Korea Title : Quality Assurance Regulation ID No: SOP-Vet-04-001-General Provisions <- ID No : SOP-Vet-04-001총칙 Korean ->English
Boehringer Ingelheim Korea Boehringer Ingelheim Korea Title of the SOP/Guideline Korean ->English
Boehringer Ingelheim Korea Press Release - FDA approves Pradaxa® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) -> 보도자료 - FDA, 심부정맥혈전증(DVT)과 폐색전증(PE)의 치료 및 재발 위험 감소에 대하여 프라닥사® 승인 English ->Korean
Boehringer Ingelheim Korea NINTEDANIB CONSUMER MEDIA MESSAGES -> 닌테다닙 소비자 미디어 메시지 English ->Korean
Boehringer Ingelheim Korea NINTEDANIB MEDICAL MEDIA MESSAGES -> 닌테다닙 의료 미디어 메시지 English ->Korean
Boehringer Ingelheim Korea BMC Family Practice - Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis & BI internal review - Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis by Chenot JF, Weber P, Friede T English ->Korean
Boehringer Ingelheim Korea Recall of Voren® Suspension for Injection - Date: April 11, 2014 -> 주사용 보렌® 현탁액 리콜 - 날짜: 2014년 4월 11일 English ->Korean
Boehringer Ingelheim Korea Press Release - Volasertib, Boehringer Ingelheim´s investigational treatment of acute myeloid leukaemia, is granted ‘orphan drug designation’ in the EU and the US-> 보도자료 - 베링거인겔하임의 급성 골수성 백혈병 연구 치료제인 볼라설팁, EU와 미국에서 '희귀의약품 지정' 승인받아 English ->Korean
Boehringer Ingelheim Korea PRADAXA® LITIGATION COMMUNICATIONS - TOOLKIT FOR OPU IMPLEMENTATION -> 프라닥사® 소송 커뮤니케이션 - OPU 이행에 관한 툴키트 English ->Korean
Boehringer Ingelheim Korea Tiotropium Respimat® in asthma* Media backgrounder -> 천식에서의 티오트로피움 레스피맷®* 미디어 배경 설명 English ->Korean
Boehringer Ingelheim Korea Innovative SOLUTIONS TO HELP MILLIONS BREATHE EASIER - About asthma -> 수많은 사람이 편하게 숨쉴 수 있도록 돕는 혁신적인 솔루션 - 천식에 관하여 English ->Korean
Boehringer Ingelheim Korea Press Release - Positive CHMP opinion for Pradaxa® in treatment of deep vein thrombosis and pulmonary embolism and prevention of repeat blood clots-> 보도자료 - 심부정맥혈전증(DVT)과 폐색전증(PE) 치료 및 반복성 혈전 예방 관련 프라닥사®에 대한 CHMP의 긍정적인 견해 English ->Korean
Boehringer Ingelheim Korea New analysis shows Boehringer Ingelheim’s Giotrif® (afatinib) is the first treatment to demonstrate significant overall survival benefit for patients with a specific type of lung cancer -> 새로운 분석 결과는 베링거인겔하임의 지오트립®(아파티닙)이 특정 유형의 폐암 환자에게 전체 생존율에 유의미한 혜택을 주 English ->Korean
Boehringer Ingelheim Korea Press Release - New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients-> 보도자료 - 고위험 환자의 재발성 뇌졸중 예방을 위한 새로운 다비가트란 에텍실레이트 연구 English ->Korean
Boehringer Ingelheim Korea Press Release - New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat-> 보도자료 - 새로운 등록 임상 결과, 불규칙한 심장박동 환자의 뇌졸중 예방에서 상당한 세계적 차이 강조 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim will make detailed clinical trial data available to the scientific community-> 보도자료 - 베링거인겔하임, 과학계가 상세한 임상시험 데이터를 이용할 수 있도록 할 예정 English ->Korean
Boehringer Ingelheim Korea Press Release - IPF Phase III results published in NEJM show nintedanib* slows disease progression-> 보도자료 - NEJM에서 발표된 IPF 제3상 임상 결과, 닌테다닙*, 질병 진행을 늦추는 것으로 나타나 English ->Korean
Boehringer Ingelheim Korea Press Release - ATS 2014 COPD: First Phase III data show lung function benefits of tiotropium + olodaterol fixed-dose combination go beyond tiotropium (Spiriva®) alone-> 보도자료 - COPD: 최초 3상 임상 결과, 폐기능에서 티오트로피움+올로다테롤 병용 고정 용량이 티오트로피움(스피리바®) 단독 용량 이상의 효과 보여 English ->Korean
Boehringer Ingelheim Korea Social Media General Mgmt Guide Jan 2013 Final -> 소셜 미디어 관리 안내 English ->Korean
Boehringer Ingelheim Korea Press Release - Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients-> 보도자료 - 프라닥사®(다비가트란 에텍실레이트)의 빠른 역전 해독제, 환자 대상 임상 연구의 다음 단계로 나아가 English ->Korean
Boehringer Ingelheim Korea Press Release - EMA accepts marketing authorisation application for nintedanib* in IPF -> 보도자료 - EMA, 특발성 폐섬유화증(IPF)에 대한 닌테다닙*의 시판허가 신청 승인 English ->Korean
Boehringer Ingelheim Korea Press Release - Type 2 Diabetes: Physicians worldwide agree early conversations are crucial in the management of condition -> 보도자료 - 제2형 당뇨병: 전 세계 의료진, 초기 대화가 질병 관리에 매우 중요하다는 점에 동의 English ->Korean
Boehringer Ingelheim Korea 5 Video - Sales Call Trajenta & 6 Video - Seven Steps Pradaxa - Video Subtitling English ->Korean Video Subtitling
Boehringer Ingelheim Korea Press Release - Pradaxa® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism -> 보도자료 - 프라닥사®, 심부정맥혈전증(DVT) 및 폐색전증(PE) 치료와 재발 예방에 대한 EU 승인 획득 English ->Korean
Boehringer Ingelheim Korea Mucopect® prospect <- 뮤코펙트 전망 Korean ->English
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s volasertib showed in a Phase II study an improvement in overall survival in older AML patients-> 보도자료 - 베링거인겔하임의 볼라설팁, 제2상 임상연구에서 고령의 급성골수성백혈병 환자의 전체 생존율 개선 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - New survey in five European countries reveals urgent need to improve education about Acute Myeloid Leukaemia -> 보도자료 - 유럽 5개국에서의 새로운 설문, 급성골수성백혈병에 대한 교육 개선이 시급히 필요함을 밝혀 English ->Korean
Boehringer Ingelheim Korea Press Release - New Pradaxa® clinical study to explore practical management of patients with atrial fibrillation undergoing ablation-> 보도자료 - 프라닥사®에 대한 새로운 임상 연구, 절제술을 받은 심방세동 환자의 실용적 관리 탐구 English ->Korean
Boehringer Ingelheim Korea Press Release - U.S. FDA grants Breakthrough Therapy Designation to Pradaxa® (dabigatran etexilate) specific investigational antidote-> 보도자료 - 미 FDA, 프라닥사® (다비가트란 에텍실레이트) 전용 연구용 해독제, 획기적인 치료법으로 지정(BTD) 승인 English ->Korean
Boehringer Ingelheim Korea A fresh look at asthma - Media resource -The 3 facts you need to know about asthma -> 천식에 대하여 알아야 할 세 가지 사실 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s investigational therapy nintedanib* receives the first FDA breakthrough therapy designation in IPF -> 보도자료 - 베링거인겔하임의 연구용 치료제 닌테다닙*, 특발성 폐섬유화증(IPF)에서 최초로 FDA의 획기적 치료법으로 지정받아 English ->Korean
Boehringer Ingelheim Korea Position statement concerning recently published clinical data on extended-release (ER) guaifenesin (Mucinex®) English ->Korean
Boehringer Ingelheim Korea Inquiries about the blood test at Gasi farm on Jeju Island <- 제주도 소재 가시농장 채혈검사에 대한 의문사항 문의 Korean ->English
Boehringer Ingelheim Korea Monopoly Regulation and Fair Trade Act <- 독점규제 및 공정거래에 관한 법률 Korean ->English
Boehringer Ingelheim Korea [1]Interview Transcript Barner-Baum July 29 2014 EN & [2]Interview transcript Barner-Baum July 1 2014 ENG English ->Korean
Boehringer Ingelheim Korea Press Release - First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting-> 보도자료 - 베링거인겔하임, 더 넓은 환자군의 뇌졸중 예방 치료에서 프라닥사® 임상적 혜택을 평가하는 두 가지 대규모 글로벌 임상 연구 계획 발표 English ->Korean
Boehringer Ingelheim Korea Press Release - Asthma: new indication for Spiriva® (tiotropium) Respimat® in the EU may offer millions of adults a significant advance in asthma care -> 보도자료 - 천식: 유럽 연합 내에서 스피리바* 레스피맷® (티오트로피움)에 대한 새로운 적응증, 수백만의 성인 환자에게 천식 치료의 상당한 진전 제공 전망 English ->Korean
Boehringer Ingelheim Korea Press Release - ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa® on kidney function over time compared to warfarin-> 보도자료 - 2014 ESC 학회 핫라인 세션: 프라닥사®, 시간에 따른 신장 기능에서 와파린 대비 유리한 효과 보여 English ->Korean
Boehringer Ingelheim Korea Press Release - Extensive experience in clinical practice and expanding research programme support use of Pradaxa® for clot prevention -> 보도자료 - 광범위한 임상 실습 경험과 연구 프로그램 확대, 혈전 예방을 위한 프라닥사® 사용 뒷받침 English ->Korean
Boehringer Ingelheim Korea BIK_Working Instruction on Handling and distribution of promotional material <- Korean Korean ->English
Boehringer Ingelheim Korea Press Release - ERS INTERNATIONAL CONGRESS 2014 TONADO™ - further lung function and quality of life benefits with tiotropium + olodaterol Respimat® FDC in COPD-> 보도자료 - 2014 유럽 호흡기학회 국제회의: TONADO™ - 만성폐쇄성폐질환(COPD) 환자에서 티오트로피움+올로다테롤 레스피맷® FDC 를 통한 폐 기능과 삶 English ->Korean
Boehringer Ingelheim Korea Press Release - Nintedanib* slowed disease progression in IPF independent of patients’ lung function impairment at baseline -> 보도자료 - 닌테다닙*, 기저선에서 환자의 폐 기능 장애와 관계없이 질병 진행 지연 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s afatinib achieves primary endpoint in global Phase III study in recurrent/metastatic head and neck squamous cell cancer-> 보도자료 - 베링거인겔하임 아파티닙, 재발성/전이성 두경부 편평세포암 대상 글로벌 제3상 시험에서 일차 평가변수 달성 English ->Korean
Boehringer Ingelheim Korea Press Release - Head-to-head Phase III trial results demonstrate superior progression-free survival for afatinib compared to erlotinib in patients with advanced squamous cell carcinoma of the lung -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 제3상 직접 비교 임상시험 결과, 아파티닙, 진행성 폐 편평세포암 환자 대상 엘로티닙과 비교하여 우수한 무진행 생존기간 보여 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy-> 보도자료 - 베링거인겔하임과 큐어백(CureVac), 차세대 폐암 면역 요법 개발 협력 발표 English ->Korean
Boehringer Ingelheim Korea The understanding and application of the Personal Information Protection Act <- 개인정보 보호법의 이해 및 적용 Korean ->English
Boehringer Ingelheim Korea Media Factsheet - How are symptoms and lung function evaluated? -> 증상과 폐 기능은 어떻게 평가되는가? English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim’s OFEV® (nintedanib*) is approved by the FDA for the treatment of idiopathic pulmonary fibrosis-> 보도자료 - 베링거인겔하임의 OFEV® (닌테다닙*), 특발성 폐섬유화증(IPF) 치료제로 FDA 승인 받아 English ->Korean
Boehringer Ingelheim Korea BOEHRINGER INGELHEIM Animal Health GmbH - STANDARD OPERATING PROCEDURES SOP No. 00-05-01 - “Stndy numbering" -> 베링거인겔하임동물약품(BOEHRINGER INGELHEIM Animal Health GmbH) - 표준 운영 절차 SOP No. 00-05-01 - “연구 번호 붙이기” English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Korea - Working Instruction on Event Management - Effective date: 5 Jan. 2015 Korean ->English
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries-> 보도자료 - 베링거인겔하임과 일라이 릴리, 특정 국가 내 당뇨병 제휴의 운영 구조 수정 English ->Korean
Boehringer Ingelheim Korea Issue: Restructuring of Lilly-BI Diabetes Alliance Agreement -> 주제: 릴리-베링거인겔하임 당뇨병 합의 개편 English ->Korean
Boehringer Ingelheim Korea Press Release - New subgroup analysis shows Asian non-small cell lung cancer patients with most common EGFR mutation (del19) lived significantly longer with first line GIOTRIF® (afatinib) compared to chemotherapy -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 새로운 하위그룹 분석, 화학요법과 비교한 일차 치료법으로 지오트립®(아파티닙) 치료를 받은 가장 흔한 EGFR 변이(del19) 양성 아시아 비소세포폐암 환자의 생존 기간이 유의하게 연장되었음을 입증 <- English English ->Korean
Boehringer Ingelheim Korea Healthcare compliance_v1.1, Anti-Corruption_v2.0, Anti-Discrimination _v2.0_1104, Anti-Trust_v1.0_1030_FB, nsider Trading_v1.1_1028, Trade Compliance_v1.0_1107, Case Study Korean ->English
Boehringer Ingelheim Korea Press Release - Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin-> 보도자료 - 두 개의 새로운 대규모 실제 분석 결과, 와파린 대비 프라닥사® 치료의 대출혈 및 뇌졸중 발생 감소 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - Vargatef® (nintedanib*) approved in the EU for lung cancer patients with advanced adenocarcinoma after first-line chemotherapy -> 보도자료 - Vargatef® (닌테다닙*), EU에서 일차 화학요법 후 진행성 폐선암 환자 대상 승인 English ->Korean
Boehringer Ingelheim Korea Dulcolax® Brand Marketing data Korean ->English
Boehringer Ingelheim Korea Press Release - New data show specific antidote idarucizumab reverses dabigatran-induced anticoagulation also in elderly and renally impaired volunteers-> 보도자료 - 특이적 해독제 이다루시주맙 , 새로운 데이터를 통해 노인과 신장 장애를 가진 지원자에서도 다비가트란 유도 항응고제의 역전 효과 입증해 English ->Korean
Boehringer Ingelheim Korea My Honorary Public Official ID Card - Became a One-day Public Official <- 명예공무원증을 받으며... - 일일공무원이 되다 Korean ->English
Boehringer Ingelheim Korea Press Release - The Lancet Oncology publishes Phase III data showing Giotrif® (afatinib*) significantly extended overall survival of lung cancer patients with the most common EGFR mutation over chemotherapy -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 란셋 온콜로지(The Lancet Oncology), 지오트립® (아파니팁*)이 화학요법과 비교하여 가장 흔한 EGFR 변이 폐암 환자의 전체 생존기간을 유의하게 연장했음을 입증하는 제3상 임상 결과 발표 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - OFEV® (nintedanib*) approved in the EU for the treatment of IPF-> 보도자료 - OFEV® (닌테다닙*), EU 내 특발성 폐섬유화증(IPF) 치료제로 승인받아 English ->Korean
Boehringer Ingelheim Korea Mucopect Digital Viral Film script translation <- Korean Korean ->English Video translaion
Boehringer Ingelheim Korea Press Release - New large-scale study to investigate effect of tiotropium + olodaterol Respimat® on exacerbations in COPD -> 보도자료 - COPD 환자 악화에 대한 티오트로피움+올로다테롤 레스피맷® 효과 연구를 위한 새로운 대규모 임상 English ->Korean
Boehringer Ingelheim Korea Antistax - ‘Transformation' MOA Video script translation -> 안티스탁스 - ‘변형' MOA 비디오 스크립트 번역 English ->Korean video script translation
Boehringer Ingelheim Korea Press Release -Boehringer Ingelheim and Sanofi enter into a strategic contract manufacturing alliance to produce biopharmaceuticals-> 보도자료 - 베링거인겔하임ㆍ사노피, 생물의약품 생산 제휴 전략적 계약 체결 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Korea (CEO: Dirk Van Niekerk) announced that, since February 1st, 2015, the patients’ share for the thrombolytic treatment, Actilyse® (Ingredients: Alteplase, rt-PA), has been reduced from previous 20 percent to 5 percent. <- Korean Korean ->English
Boehringer Ingelheim Korea Press Release - First trial of a novel oral anticoagulant starts in prevention of recurrent stroke due to a blood clot of undetermined source -> 보도자료 - 새로운 글로벌 프라닥사® 연구, 급성 심부정맥혈전증(DVT) 및 폐색전증(PE) 관리에 대한 실질적 증거 추가 제공 English ->Korean
Boehringer Ingelheim Korea Press Release - New global Pradaxa® study to provide additional real-world evidence on the management of acute Deep Vein Thrombosis and Pulmonary Embolism -> 보도자료 - 베링거인겔하임, EMA, FDA, 캐나다 보건부에 다비가트란 에텍실레이트(프라닥사®)에 특이적인 역전제인 이다루시주맙* 승인 신청 제출 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim submits applications for approval of idarucizumab, specific reversal agent to dabigatran etexilate (Pradaxa®), to EMA, FDA and Health Canada ->베링거인겔하임, EMA, FDA, 캐나다 보건부에 다비가트란 에텍실레이트(프라닥사®)에 특이적인 역전제인 이다루시주맙 승인 신청 제출 English ->Korean
Boehringer Ingelheim Korea Mucosolvan GP DA_v12 & Mucosolvan Pharmacist DA_v15 English ->Korean
Boehringer Ingelheim Korea Press Release - Many Atrial Fibrillation patients at high risk of stroke fail to receive guideline-recommended oral anticoagulant treatment-> 보도자료 -뇌졸중 위험이 높은 심방세동 환자 다수가 가이드라인에서 권고되는 경구용 항응고제로 치료받지 못해 English ->Korean
Boehringer Ingelheim Korea Press Release - New international survey of lung cancer oncologists highlights underutilization of personalized treatments -> 보도자료 - 폐암 종양학자가 발표한 새로운 국제적 설문조사, 개인 맞춤형 치료법의 불충분한 사용 강조 English ->Korean
Boehringer Ingelheim Korea AN INTERNATIONAL SURVEY ASSESSED EGFR MUTATION TESTING RATES AND TREATMENT PRACTICES IN A SPECIFIC TYPE OF LUNG CANCER -> 국제적 설문조사는 폐암의 특이적 유형에서 EGFR 변이 검사 비율과 진료를 평가했다. English ->Korean
Boehringer Ingelheim Korea Buscopan HCP Detailing app screengrabs 11.03.15_REV_5000 English ->Korean
Boehringer Ingelheim Korea 2015_Dulcolax training ToolKit (CHC portal) - 2015 듈코락스 교육 툴킷 (CHC 포털) English ->Korean
Boehringer Ingelheim Korea Dulcolax claim compendium, Stimulant laxatives are effective in chronic constipation: multi-center, 4-week, double-blind, randomized, placebo-controlled trial of bisacodyl -> 듈코락스 주장 개요서, 자극성 완화제 만성변비에 효과적: 다기간, 4주, 이중눈가림, 무작위배정, 위약대조 비사코딜 시험 & English ->Korean
Boehringer Ingelheim Korea Stimulant laxatives do not impair normal colonic function or increase the risk of habituation, tolerance and dependency -> 자극성 완하제는 정상적인 대장 기능을 손상시키거나 습관화, 내성, 의존성 위험을 증가시키지 않는다. English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol - BI Trial No.: 1311.16 -> 임상시험계획서 - BI Trial No.: 1311.16 English ->Korean
Boehringer Ingelheim Korea Press Release - ASCO 2015: Superior overall survival for afatinib compared to erlotinib demonstrated in head-to-head trial in patients with previously treated advanced squamous cell carcinoma of the lung -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - ASCO 2015: 폐의 진행성 편평상피암(SCC)으로 이전에 치료받은 환자를 대상으로 한 직접 대면 시험, 에를로티닙과 비교하여 아파티닙의 우수한 전체 생존 기간 입증 <- English English ->Korean
Boehringer Ingelheim Korea Lung Cancer Backgrounder_1.0 & GIOTRIF backgrounder_1.0 English ->Korean
Boehringer Ingelheim Korea LUX-Lung 8 infographic_FINAL, LUX-Lung3&6 infographic_1.0 & Lung Cancer Infographic English ->Korean
Boehringer Ingelheim Korea Press Release - New data and analyses confirm the efficacy and safety of OFEV® (nintedanib*) for the treatment of IPF beyond 52 weeks and for distinct subgroups-> 보도자료 - 새로운 연구 결과와 분석, 52주간의 특발성 폐섬유화증(IPF) 치료와 별개 하위 그룹에서 OFEV® (닌테다닙*)의 효능과 안전성 확인 English ->Korean
Boehringer Ingelheim Korea 2011 AAHA Canine Vaccination Guidelines -> 2011년 AAHA 개 예방접종 가이드라인 English ->Korean
Boehringer Ingelheim Korea BI In Oncology Backgrounder_1.0 English ->Korean
Boehringer Ingelheim Korea Press Release - New data show benefit of tiotropium/ olodaterol Respimat® from the start of COPD maintenance therapy -> 보도자료 - 새로운 연구 결과, 만성폐쇄성폐질환(COPD) 유지요법 시작부터 티오트로퓸/올로다테롤 레스피맷®의 효과 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - First patient enrolled in dabigatran study comparing anticoagulation strategies during AF ablation-> 보도자료 - 심방세동(AF) 절제술 중 항응고 전략을 비교하는 다비가트란 연구에 첫 번째 환자 등록 English ->Korean
Boehringer Ingelheim Korea Press Release - FDA approves Boehringer Ingelheim’s Stiolto® Respimat® as once-daily maintenance treatment for COPD-> 보도자료 - 미국식품의약국(FDA), 만성폐쇄성폐질환(COPD)을 위한 1일 1회 유지요법으로서 베링거인겔하임의 Stiolto® 레스피맷® 승인 English ->Korean
Boehringer Ingelheim Korea Core Trial Subject Information -> 핵심 임상시험대상자 동의설명서 English ->Korean
Boehringer Ingelheim Korea Trial identification Card For EMERGENCY -> 응급용 임상시험 ID카드 English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol - BI Trial No.: 1311.16 updated data-> 임상시험계획서 - BI Trial No.: 1311.16 업데이트 자료 English ->Korean
Boehringer Ingelheim Korea Press Release - Respimat® success story: Boehringer Ingelheim invests EUR 72 million in production capacity in Ingelheim-> 보도자료 - 레스피맷®의 성공 스토리: 베링거인겔하임, 인겔하임의 생산 시설에 7천 2백만 유로 투자 English ->Korean
Boehringer Ingelheim Korea Spiolto® Respimat® fact sheet -> Spiolto® 레스피맷® 팩트 시트 English ->Korean
Boehringer Ingelheim Korea Press Release - New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries -> 보도자료 -COPD 유지요법의 새로운 진전, Spiolto® 레스피맷, 유럽 국가에서 최초 승인 English ->Korean
Boehringer Ingelheim Korea Press Release -New publication in The Lancet describes effective reversal of Pradaxa® in healthy volunteers-> 보도자료 - 란셋(The Lancet) 의 새로운 연구 논문, 건강한 지원자에서 프라닥사®의 효과적인 역전 효과 설명 English ->Korean
Boehringer Ingelheim Korea Press Release - Idarucizumab* reverses the anticoagulant effect of dabigatran within minutes in patient study -> 보도자료 - 이다루시주맙*, 환자 대상 연구에서 몇 분 만에 다비가트란의 항응고 효과 역전 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Korea Dirk van Niekerk Business letter - MERS crisis Korean ->English
Boehringer Ingelheim Korea Respimat® fact sheet - Respimat® is the propellant free platform inhaler for Boehringer Ingelheim’s COPD and Asthma product family. -> 레스피맷® Fact Sheet - 레스피맷®은 베링거인겔하임의 COPD와 천식 제품군을 위한 압축가스가 함유되지 않은 플랫폼 흡입기이다. English ->Korean
Boehringer Ingelheim Korea TOviTO® infographic - Spiolto® Respimat® TOviTO® Phase III Clinical Trial Programme -> TOviTO® 인포그래픽 - 스피올토® 레스피맷® TOviTO® 3상 임상시험 프로그램 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim Welcomes the Inclusion of OFEV® (nintedanib*) in the Updated International Treatment Guidelines for Idiopathic Pulmonary Fibrosis (IPF)-> 베링거인겔하임, 특발성 폐섬유화증(IPF)의 최신 국제 치료 가이드라인에 오페브® (닌테다닙*) 포함 환영 English ->Korean
Boehringer Ingelheim Korea Transcript: David Wright Video on Winning English ->Korean video script translation
Boehringer Ingelheim Korea Bi Interview (Mr. Marc Doetze) Video Dictation & Translation English ->Korean video dictation & translation
Boehringer Ingelheim Korea Press Release - Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamous cell carcinoma of the lung -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 란셋 온콜로지에 게재된 3상 임상 결과, 이전에 치료 경험이 있는 진행성 편평세포 폐암 환자에서 타쎄바®(엘로티닙) 대비 지오트립®(아파티닙)의 우수한 전체 생존 효과 보여 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - New data show Spiolto® Respimat® provides meaningful quality of life improvements in COPD-> 보도자료 - 새로운 연구 결과, 만성폐쇄성폐질환(COPD) 환자 대상 스피올토® 레스피맷®의 유의한 삶의 질 개선 효과 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - CHMP recommends label update for Giotrif® with addition of data demonstrating overall survival benefit for patients with EGFR mutation-positive lung cancer-> 보도자료 - CHMP, EGFR 변이 양성 폐암 환자에서 전체 생존 기간 연장 혜택을 입증한 연구 결과를 추가하여 지오트립®의 라벨 업데이트 권고 English ->Korean
Boehringer Ingelheim Korea Press Release - COPD: New data support role of Spiolto® Respimat® as 1st-line maintenance therapy and show superiority over LABA/ICS -> 보도자료 - 만성폐쇄성폐질환(COPD): 새로운 연구 결과, 일차 유지 요법으로서 스피올토® 레스피맷®의 역할과 LABA/ICS 대비 우수성 입증 English ->Korean
Boehringer Ingelheim Korea UNDERSTANDING COPD - MEDIA BACKGROUNDER -> 만성폐쇄성폐질환(COPD) - 미디어 참고자료(MEDIA BACKGROUNDER) English ->Korean
Boehringer Ingelheim Korea Pivotal phase III studies for tiotropium + olodaterol Respimat® FDC -> 티오트로퓸+올로다테롤 레스피맷® FDC에 관한 중추적 3상 임상 연구 English ->Korean
Boehringer Ingelheim Korea Press Release - Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events -> 보도자료 - 자디앙®, 심혈관계 질환 발생 위험이 높은 2형 당뇨병 환자의 심혈관 위험 감소 입증 English ->Korean
Boehringer Ingelheim Korea Cardiovascular disease in type 2 diabetes backgrounder -> 제2형 당뇨병 환자의 심혈관계 질환에 관한 배경 자료 English ->Korean
Boehringer Ingelheim Korea Cardiovascular Disease in Type 2 Diabetes -> 제2형 당뇨병에서 심혈관계 질환 English ->Korean
Boehringer Ingelheim Korea EMPA-REG OUTCOME® trial design backgrounder -> EMPA-REG OUTCOME® 임상 설계 배경 자료 English ->Korean
Boehringer Ingelheim Korea EMPA-REG OUTCOME® trial design -> EMPA-REG OUTCOME® 임상 설계 English ->Korean
Boehringer Ingelheim Korea Press Release - ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim-> 보도자료 - ESC, 베링거인겔하임의 특별 지원으로 심혈관계 연구의 혁신을 이끄는 새로운 연구 지원 사업 시작 English ->Korean
Boehringer Ingelheim Korea SPIOLTO® guide to addressing Questions and Perceptions -> 스피올토®에 관한 질문 및 인식 해결에 대한 가이드 English ->Korean
Boehringer Ingelheim Korea Buscopan-Country_template_language-file - Buscopan Website L10N Project English ->Korean
Boehringer Ingelheim Korea Basic Service Agreement -> 기본 서비스 계약 English ->Korean
Boehringer Ingelheim Korea Press Release - ECC 2015: GIOTRIF® (afatinib) demonstrates superior survival compared to Tarceva® (erlotinib) for patients with previously treated advanced squamous cell carcinoma of the lung, independent of EGFR mutation status-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - ECC 2015: 지오트립® (아파티닙), EGFR 변이 상태와는 상관없이 이전에 치료받은 진행성 편평세포 폐암 환자에서 타쎄바® (엘로티닙) 대비 우수한 생존 기간 입증 <- English English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Vetmedica Korea - Agreement - Ingelvac CircoFLEX -> 베링거인겔하임동물약품 주식회사 - 합의서 - 인겔백 써코플렉스 English ->Korean
Boehringer Ingelheim Korea Press Release - New analysis shows idarucizumab enables rapid initiation of emergency surgery in dabigatran-treated patients -> 보도자료 - 새로운 분석 결과, 다비가트란 치료 환자에 대한 이다루시주맙의 빠른 응급 수술 개시 가능성 보여 English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol - BI Trial No.: 1320.23 -> 임상시험 계획서 - BI Trial No.: 1320.23 English ->Korean
Boehringer Ingelheim Korea Press Release - FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate)-> 보도자료 - FDA, 프라닥사®(다비가트란 에텍실레이트)의 특이적 역전제, Praxbind® (이다루시주맙) 승인 English ->Korean
Boehringer Ingelheim Korea INFORMATION AND CONSENT FORM FOR TRIAL PARTICIPANTS - TRIAL PARTICIPANT No.: 1320.23 -> 시험 참가자에 대한 정보 및 사전 동의서 - 시험 참가자 번호: 1320.23 English ->Korean
Boehringer Ingelheim Korea Informed Consent Form for Clinical Trial Subjects - Trial No. : 1320.23 -> 임상시험대상자 설명문 및 동의서 - 시험 번호 : 1320.23 English ->Korean
Boehringer Ingelheim Korea Press Release - Real-World Analysis of more than 44,000 Patients Reinforces Safety and Effectiveness of Pradaxa® in Routine Clinical Care-> 보도자료 - 44.000명 이상의 환자를 대상으로 한 실제 분석 결과, 일상적인 진료에서 프라닥사®의 안전성과 효과 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - CHEST: New Sub-Analyses Show Improvement in Patient-Reported Outcomes with Spiolto® Respimat® -> 보도자료 - CHEST: 새로운 하위 분석, 스피올토® 레스피맷®에 대한 환자 보고 결과 개선 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim partners withleading scientific institutions in inflammatory bowel disease research -> 보도자료 - 베링거인겔하임, 염증성 장 질환 연구의 유수 과학 기관과 제휴 English ->Korean
Boehringer Ingelheim Korea Press Release - New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline -> 보도자료 - 새로운 자디앙®(엠파글리플로진) 연구, 베이스라인에서의 심부전 상태와 관계없이 심혈관 연구결과 개선 보여 English ->Korean
Boehringer Ingelheim Korea US FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors to include warnings about risk of ketoacidosis and serious urinary tract infections ->미국 FDA 의약품 안전성 공고 : FDA, SGLT-2 억제제의 라벨을 개정하여 케토산증 및 중대한 요로감염 위험에 대한 경고를 포함시키다. English ->Korean
Boehringer Ingelheim Korea Press Release - LUX-Lung 7 trial reveals that the second-generation EGFR tyrosine kinase inhibitor significantly improved PFS in naive patients with advanced mutated lung cancer compared to gefitinib-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 베링거인겔하임의 지오트립®/질로트립®(아파티닙), 이레사®(제피티닙) 대비 EGFR 변이 양성 진행성 비소세포폐암(NSCLC) 환자의 일차 치료제로써 우수한 무진행 생존기간(PFS) 및 치료 실패까지의 시간 입증 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with Type 2 Diabetes-> 제III상 데이터 분석 결과, 제2형 당뇨병 환자에게 단일요법으로 활용되는 임상시험용 화합물인 엠파글리플로진이 혈당을 유의하게 낮춰 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III data show investigational compound empagliflozin reduced blood glucose in adults with Type 2 Diabetes treated with basal insulin-> 보도자료 - 제III상 데이터 분석 결과, 임상시험용 화합물인 엠파글리플로진이 기저 인슐린 치료를 받은 제2형 당뇨병 환자의 혈당을 낮춰 English ->Korean
Boehringer Ingelheim Korea Press Release - Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulphonylurea in adults with Type 2 Diabetes-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 제 III상 데이터 분석 결과, 제 2형 당뇨병 성인 환자에서 메트포르민 또는 메트포르민+설포닐우레아에 추가한 임상시험용 화합물인 엠파글리플로진이 혈당을 유의하게 낮춰 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations -> 보도자료 - OFEV® (닌테다닙), 특발성 폐섬유화증(IPF) 질병 진행 지연과 급성 악화 위험을 감소시켜 English ->Korean
Boehringer Ingelheim Korea Cushman & Wakefield (Korea) Limited - AGREEMENT -> 쿠시먼웨이크필드코리아 - 합의서 English ->Korean
Boehringer Ingelheim Korea LUX-Lung 7: providing guidance for the treatment of lung cancer patients by comparing two important current treatments -Boehringer Ingelheim - Ongoing Commitment to Oncology->LUX-Lung 7: 2가지 최신 주요 치료제의 비교를 통해 폐암 환자의 치료에 대한 지침 제공 -베링거인겔하임 –종양학에 대한 지속적 헌신 English ->Korean
Boehringer Ingelheim Korea The treatment landscape for patients with EGFR mutation-positive NSCLC -> EGFR 변이 양성 비소세포폐암(NSCLC) 환자의 치료 배경 English ->Korean
Boehringer Ingelheim Korea LUX-Lung 7: providing guidance for the treatment of lung cancer patients by comparing two important current treatments - Unveiling LUX-Lung 7 -> LUX-Lung 7: 2가지 최신 주요 치료제의 비교를 통해, 폐암 환자의 치료에 대한 지침 제공 - LUX-Lung 7 공개 English ->Korean
Boehringer Ingelheim Korea PRAXBIND® (IDARUCIZUMAB) – KEY MESSAGE DOCUMENT -> 프락스바인드® (이다루시주맙) 핵심 메시지 문서 English ->Korean
Boehringer Ingelheim Korea PRAXBIND® – THE SPECIFIC REVERSAL AGENT TO DABIGATRAN -> 프락스바인드® – 다비가트란에 특이적인 역전제 English ->Korean
Boehringer Ingelheim Korea REVERSING THE ANTICOAGULANT EFFECTS OF DABIGATRAN ETEXILATE (PRADAXA®) - EXECUTIVE SUMMARY -> 다비가트란 에텍실레이트(프라닥사®)의 항응고 효과 역전 - 핵심 요약 English ->Korean
Boehringer Ingelheim Korea Press Release - New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype -> 보도자료 - 새로운 분석: 스피리바® 레스피맷®, 알레르기 하위 유형과 관계없이 통제되지 않는 천식에 효과 보여 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Internal Q&A, Version 2.0, March 2016 - FINAL -> 베링거인겔하임 내부용 Q&A, 버전 2.0, 2016년 3월 - 최종 English ->Korean
Boehringer Ingelheim Korea Press Release - Landmark head to head study demonstrating Giotrif® (afatinib) significantly improved clinical outcomes compared to Iressa® (gefitinib) in EGFR mutation-positive advanced non-small cell lung cancer published in The Lancet Oncology-> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - EGFR 변이 양성 진행성 비소세포폐암에서 이레사®(게피티닙) 대비 임상 결과의 유의한 개선을 입증한 지오트립®(아파티닙)에 관하여 직접 비교한 랜드마크 연구, 란셋 온콜로지(The Lancet Oncology)에 게재 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - Boehringer Ingelheim launches RE-COVERY DVT/PE™: global observational study on management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate) -> Korean English ->Korean
Boehringer Ingelheim Korea Press Release - 베링거인겔하임, 심재성정맥혈전증(DVT)과 폐색전증(PE) 관리에 있어 프라닥사®(다비가트란 에텍실레이트)의 효과를 연구한 글로벌 관찰 연구, RE-COVERY DVT/PE™ 착수 <- English English ->Korean
Boehringer Ingelheim Korea Press Release - Interim Phase III Data Show Praxbind® (idarucizumab) Reverses Dabigatran (Pradaxa®) in Emergency Situations-> 보도자료 - 3상 연구의 중간 결과, 응급 상황에서 프락스바인드®(이다루시주맙)의 다비가트란(프라닥사®) 역전 효과 입증 English ->Korean
Boehringer Ingelheim Korea Press Release - Type 2 Diabetes: Jardiance® (empagliflozin) as an add-on therapy significantly reduced blood glucose and body weight in two newly presented Phase III trials-> 제2형 당뇨병: 추가 치료제로서 자디앙® (엠파글리플로진), 새로 발표된 두 개의 3상 임상 연구에서 유의한 혈당 강하와 체중 감소 확인 English ->Korean
Boehringer Ingelheim Korea Press Release -New analysis demonstrates only minority of COPD patients may benefit from adding ICS to Spiriva®+LABA-> 보도자료 - 새로운 분석 결과, 소수의 만성폐쇄성폐질환(COPD) 환자만이 스피리바®+LABA 에 흡입 코르티코스테로이드(ICS) 추가한 치료법의 효과 얻을 수 있어 English ->Korean
Boehringer Ingelheim Korea Assignability & Termination clauses -> 양도가능성 및 해지 조항 English ->Korean
Boehringer Ingelheim Korea 50 years of bisacodyl - How to "invent" a laxative? -> 50년 역사의 비사코딜 - 완하제의 “발명” 과정 - 비사코딜(bisacodyl) “발명가”인 Ernst Seeger 박사를 PTAheute가 만나봅니다. English ->Korean
Boehringer Ingelheim Korea Contractual Matters – Contracts -> 계약 사항 – 계약서 English ->Korean
Boehringer Ingelheim Korea Press Release - Pradaxa®: First NOAC to be assessed in prospective study in patients with blood clots in the veins or venous sinuses of the brain-> 보도자료 - 프라닥사® - 최초의 신규 경구용 항응고제(NOAC), 뇌정맥 또는 정맥동 내 혈전 발생 환자를 대상으로 전향적 연구에서 평가 English ->Korean
Boehringer Ingelheim Korea Press Release - New Presentations at ATS 2016 Reinforce OFEV® (nintedanib) Efficacy, Safety and Tolerability Across Broad Range of Patients with IPF-> 보도자료 - ATS 2016에서 발표된 새로운 연구 결과, 광범위한 특발성폐섬유화증(IPF) 환자를 대상으로 OFEV® (닌테다닙)의 유효성, 안전성, 내약성 재확인 English ->Korean
Boehringer Ingelheim Korea Press Release - 3 out of 4 people with asthma report reduced productivity at work -> 보도자료 - 천식 환자 4명 중 3명, 업무 생산성 감소 보고 English ->Korean
Boehringer Ingelheim Korea Press Release - Study results support potential new asthma treatment for children and adolescents who still have symptoms despite taking treatment-> 보도자료 - 연구 결과, 치료에도 불구하고 여전히 증상이 지속되는 어린이 및 청소년 천식 환자를 위한 새로운 천식 치료제의 가능성 뒷받침해 English ->Korean
Boehringer Ingelheim Korea Press Release - Jardiance® (empagliflozin) significantly reduced the risk of progressive kidney disease in adults with type 2 diabetes with established cardiovascular disease -> 자디앙®(엠파글리플로진), 확립된 심혈관계 질환을 가진 제2형 당뇨병 성인 환자에서 진행성 신장 질환 위험의 유의한 감소 확인 English ->Korean
Boehringer Ingelheim Korea Rosso D, Felice R. Clinico-Pharmacological Review on antispasmodic drugs. Boehringer Ingelheim in-house files 2003 English ->Korean
Boehringer Ingelheim Korea Pulmonary Pharmacology & Therapeutics 17 (2004) 27–34 - Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial) English ->Korean
Boehringer Ingelheim Korea IDIOPATHIC PULMONARY FIBROSIS (IPF) MEDIA BACKGROUNDER -> 특발성폐섬유화증 (IDIOPATHIC PULMONARY FIBROSIS, IPF) 미디어 배경 자료 English ->Korean
Boehringer Ingelheim Korea IDIOPATHIC PULMONARY FIBROSIS (IPF) branded infographic -> 특발성폐섬유화증 (IDIOPATHIC PULMONARY FIBROSIS, IPF) 브랜드 인포그래픽 English ->Korean
Boehringer Ingelheim Korea Press Release - New study results show Trajenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment-> 보도자료 - 트라젠타® (성분명: 리나글립틴)의 새로운 연구 결과, 신장 장애의 위험이 있는 제2형 당뇨병 성인 환자들의 혈당 강하 효과를 드러내 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance American Diabetes Association (ADA) 76th Scientific Sessions® MARLINA-T2DTM Trial Talking Points-> 베링거인겔하임-일라이 릴리 당뇨병 연합 미국 당뇨병 학회(ADA) 제 76회 과학 세션® MARLINA-T2DTM 임상 요점사항 English ->Korean
Boehringer Ingelheim Korea Press Release - New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes-> 자디앙®(엠파글리플로진)에 대한 새로운 연구 결과, 제2형 당뇨병 성인 환자의 모든 연령 그룹에서 심혈관계(CV) 사망 위험 감소 입증해 English ->Korean
Boehringer Ingelheim Korea Press Release - New analysis of INPULSIS® trials demonstrates efficacy of OFEV® (nintedanib) across a range of IPF patients using broader diagnostic criteria -> INPULSIS® 임상의 새로운 분석 결과, 광범위한 진단 기준을 사용한 다양한 특발성폐섬유화증(IPF) 환자에서 오페브® (닌테다닙) 유효성 입증 English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol - Multi-centre, open-label, single arm, phase I study to investigate safety, tolerability, pharmacokinetics, pharmacogenomics and efficacy of a single intravenous dose of BI 655130 in patients with active generalized pustular psori English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol (임상시험계획서) - 활동성 전신 농포성 건선 환자들에서 BI 655130의 단회 정맥 투여의 안전성, 내약성, 약동학, 약리유전체학, 유효성을 조사하기 위한 다기관, 공개, 단일군, 제I상 시험 English ->Korean
Boehringer Ingelheim Korea Clinical Trial Protocol - BI Trial No.: 1368.11 Updated data -> 임상시험계획서- BI Trial No.: 1368.11 업데이트 자료 English ->Korean
Boehringer Ingelheim Korea 270716 Trainer Kit TTT BI AH, 280716 QRC BI_Data Change Request, Trainer notes for EUT- AH_V3_RL, 270716 BI Reference Guide AH V3.5_with comments_RL English ->Korean
Boehringer Ingelheim Korea Data Steward Ref Guide_V3.3_with comments, DS-Trainer Kit TTT BI AH_DS_V1.2pptx, AH DS Training Exercises_V1.0 English ->Korean
Boehringer Ingelheim Korea INFORMATION AND CONSENT FORM FOR TRIAL PARTICIPANTS - TRIAL PARTICIPANT No.: 1368.11 & Trial Participant Information and Consent Form (DNA Banking) Version No: 1.0 Version Date: 30 Aug 2016 English ->Korean
Boehringer Ingelheim Korea BOEHRINGER INGELHEIM GmbH - Clinergize – Corporate Template for Data Protection Information Statement title: USER INFORMED CONSENT (CONSENT TO COLLECTION, PROCESSING AND USE OF PERSONAL DATA FOR ) -> Korean English ->Korean
Boehringer Ingelheim Korea BOEHRINGER INGELHEIM GmbH - Clinergize – 데이터 보호 정보에 관한 기업 서식 - 진술 제목: 사용자 사전동의(개인 데이터 수집, 처리, 사용에 대한 동의 <한국>용) <- English English ->Korean
Boehringer Ingelheim Korea Assignment clauses for contracts: Contract Manufacturing Agreements: -> 계약 양도 조항: 위탁 생산 계약: English ->Korean
Boehringer Ingelheim Korea BI Transfer Contract Express Consent -approved by SAN English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Supplier Code of Conduct -> 베링거인겔하임 공급자 행동강령 English ->Korean
Boehringer Ingelheim Korea Boehringer Ingelheim Supplier Code of Conduct (SuCoC ) communication -> 베링거인겔하임 공급자 행동강령(SuCoC) 공지 레터 English ->Korean
Boehringer Ingelheim Korea Antistax CA Language Template -> 안티스탁스™ 소개 자료 English ->Korean
Boehringer Ingelheim Korea INFORMATION AND CONSENT FORM FOR TRIAL PARTICIPANTS - PROTOCOL No.: 1346.9 <- 시험 참가자에 대한 정보 및 사전 동의서 - 변경사항 업데이트 번역 및 역번역 English ->Korean & Back-Translaton
Boehringer Ingelheim Korea Let’s continue driving collaboration and teamwork within our ROPU Team. -> 앞으로도 ROPU 팀 내의 협력과 팀워크 발전이 지속되길 바랍니다. English ->Korean
Boehringer Ingelheim Korea We ask for your support of the CHC Carve-out and the transfer of a viable business to Sanofi. -> CHC 카브아웃(Carve-out) 및 Sanofi로의 실현 가능성 있는 비즈니스 이전과 관련하여 귀사의 협조를 당부 드립니다. English ->Korean
Boehringer Ingelheim Korea Strategic Sourcing - Asia RoundTable Meeting Notes 22 September 2016 at the Excelsior Hotel, Hong Kong -> 전략적 소싱 - 2016년 9월 22일 홍콩 엑셀시어 호텔 English ->Korean
Boehringer Ingelheim Korea Third party notification of assignment -> 제3자 양도 공지 English ->Korean
Boehringer Ingelheim Korea 1368 11 clinical-trial-protocol-revision-01-FINAL TrackChange_2016-11-09 & 1368.11_Main PISICF_Core V2.0_Korea_English_version 1.0_11Nov2016_Track changes English ->Korean
Boehringer Ingelheim Korea B_Communication_Supplier_POs-10-24_Final_contract_SAN English ->Korean
Boehringer Ingelheim Korea Move to Sanofi Guide -> 사노피 이전 가이드 English ->Korean
Boehringer Ingelheim Korea Evaluation of porcine reproductive and respiratory syndrome virus (PRRSV) challenge dose in vaccinated pigs -> 백신접종 돼지에서의 돼지생식호흡기증후군바이러스(PRRSV) 공격접종 평가 English ->Korean
Boehringer Ingelheim Korea Transition of Purchase Orders -> 발주서 인계 English ->Korean
Eisai Korea
Company Project Language
Eisai Korea Eisai Medical Research Inc. Clinical Study Report - Phase II Clinical Study of E7389 Locally Advanced or Metastatic Breast Cancer English ->Korean
Eisai Korea Eisai Medical Research Inc. Clinical Study Report - Phase I Clinical Study of E7389 for Solid Tumors - A stepwise dose-ascending, single-center, non-randomized, open-label study English ->Korean
Eisai Korea Eisai Medical Research Inc. Clinical Study Report - A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) Administered Once Every Three Weeks in Patients with Advanced Solid Tumors English ->Korean
Eisai Korea Eisai Medical Research Inc. Clinical Study Report - A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) in Patients with Advanced Solid Tumors English ->Korean
Eisai Korea Eisai Medical Research Inc. Clinical Study Report - E7389-G000-305 English ->Korean
Eisai Korea E7389 CLINICAL STUDY PROGRESS REPORT - A Phase Ib Open-Label, Two-Arm, Dose-Finding Study of E7389 in Combination with Carboplatin in Patients with Solid Tumors English ->Korean
Eisai Korea Eisai Medical Research Inc. E7389 (eribulin mesylate) Amended CSR E7389-A001-201- Amended Clinical Study Report English ->Korean
Eisai Korea Eisai Medical Research Inc. E7389 (eribulin mesylate) Amended CSR - STUDY SYNOPSIS English ->Korean
Eisai Korea Eisai Medical Research Inc. E7389 (eribulin mesylate) Amended CSR E7389-A001-202 - Amended Clinical Study Report English ->Korean
Eisai Korea Eribulin mesylate Solution for Injection 0.5mg/mL 2.6 Nonclinical Written and Tabulated Summaries 2.6.2 Pharmacology Written Summary English ->Korean
Eisai Korea Study Report - TIME COURSE OF CELL CYCLE EFFECTS GENERATED BY E7389 IN U937 HUMAN HISTIOCYTIC LYMPHOMA CELLS REPORT NUMBER: PPC2005-02 English ->Korean
Eisai Korea Study Report - ANTIPROLIFERATIVE EFFECTS OF E7389, PACLITAXEL AND VINBLASTINE IN HUMAN CANCER CELLS REPORT NUMBER: PPC2005-03 English ->Korean
Eisai Korea Study Report - ANTIPROLIFERATIVE EFFECTS OF E7389 AGAINST PACLITAXEL-RESISTANT HUMAN CANCER CELLS IN VITRO REPORT NUMBER: PPC2005-04 English ->Korean
Eisai Korea Study Report - E7389: EFFECTS OF E7389 ON TUBULIN POLYMERIZATION IN VITRO REPORT NUMBER: PPC2005-05 English ->Korean
Eisai Korea Study Report - ANTIPROLIFERATIVE EFFECTS OF E7389 AGAINST PGLYCOPROTEIN-OVEREXPRESSING MULTIDRUG RESISTANT HUMAN CANCER CELLS IN VITRO REPORT NUMBER: PPC2006-06 English ->Korean
Eisai Korea Study Report - ANTIPROLIFERATIVE EFFECTS OF E7389, PACLITAXEL AND VINBLASTINE AGAINST HUMAN SMALL CELL LUNG CANCER AND HEAD AND NECK CANCER CELLS IN VITRO REPORT NUMBER: PPC2006-07 English ->Korean
Eisai Korea STUDY REPORT & AMENDMENT NO. 1 - RESPONSE OF SC MDA-MB-435 MAMMARY TUMOR TO TREATMENT WITH E7389 REPORT NUMBER: PPC2003-03A English ->Korean
Eisai Korea STUDY REPORT & AMENDMENT NO. 1 - RESPONSE OF SC NCI-H522 LUNG TUMOR TO COMBINATION TREATMENT WITH E7389 AND GEMZAR REPORT NUMBER: PPC2003-04A English ->Korean
Eisai Korea Study Report - Response of SC MDA-MB-435 Mammary Tumor to Combination Treatment with E7389 and Doxorubicin REPORT NUMBER: PPC2003-05A English ->Korean
Eisai Korea Study Report - Response of SC PANC-l Pancreatic Tumor to Treatment with E7389 REPORT NUMBER: PPC2003-02A English ->Korean
Eisai Korea FINAL REPORT - RESPONSE OF SC NCI-H82 LUNG TUMOR XENOGRAFTS TO TREATMENT WITH E7389 Study No. ERI-74 English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED U251 HUMAN GLIOBLASTOMA CELLS TO TREATMENT WITH E7389 (Study No.ERI-89A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF SC U251 GLIOBLASTOMA XENOGRAFTS TO TREATMENT WITH E7389 (Study No. ERI-90A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED U251 HUMAN GLIOBLASTOMA CELLS TO TREATMENT WITH E7389 (Study No. ERI-95A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED U251 HUMAN GLIOBLASTOMA CELLS TO TREATMENT WITH E7389 (Study No. ERI-97A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED U251 HUMAN GLIOBLASTOMA CELLS TO TREATMENT WITH E7389 (Study No. ERI-98A) English ->Korean
Eisai Korea FINAL REPORT - RESPONSE OF SC SR475 HEAD AND NECK TUMOR XENOGRAFTS TO TREATMENT WITH E7389 Study No. ERI-99A English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED U251 HUMAN GLIOBLASTOMA CELLS TO TREATMENT WITH E7389 (Study No. ERI-I00A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED SF-295 HUMAN GLIOBLASTOMA TO TREATMENT WITH E7389 (Study No. ERI-I06A) English ->Korean
Eisai Korea Final Report To Eisai Research Institute On RESPONSE OF INTRACRANIALLY IMPLANTED SF-295 HUMAN GLIOBLASTOMA TO TREATMENT WITH E7389 (Study No. ERI-ll1A) English ->Korean
Eisai Korea FINAL REPORT - EVALUATION OF THE ANTITUMOR EFFICACY OF E7389 WHEN ADMINISTERED IN COMBINATION WITH XELODA AGAINST S.C. MX-1 HUMAN MAMMARY TUMOR XENOGRAFTS IN FEMALE ATHYMIC NCR-NU/NU MICE Study No. ERI-118 English ->Korean
Eisai Korea STUDY REPORT & AMENDMENT NO. 1 - Evaluation of the antitumor efficacy of E7389 when administered in combination with XELODA against S.C. UISO-BCA-1 Human Mammary Tumor Xenografts in female Athymic NCR-NU/NU MICE Study Number: ERI 119 English ->Korean
Eisai Korea STUDY REPORT & AMENDMENT NO. 1 - Evaluation of the antitumor efficacy of E7389 when administered in combination with TARCEVA or ARIMITA against S.C. NCI-H322M Human Lung Tumor Xenografts in female Athymic NCR-NU/NU MICE Study Number: ERI 120 English ->Korean
Eisai Korea FINAL REPORT - EVALUATION OF THE ANTITUMOR EFFICACY OF ERLOTINIB, PEMETREXED, AND E7389 AGAINST S.C. NCI-H522 HUMAN LUNG TUMOR XENOGRAFTS IN FEMALE ATHYMIC NCR-NU/NU MICE Study No. ERI-121 English ->Korean
Eisai Korea FINAL REPORT- EVALUATION OF THE ANTITUMOR EFFICACY OF E7389 WHEN ADMINISTERED IN COMBINATION WITH PEMETREXED AND ERLOTINIB AGAINST S.C. NCI-H322M HUMAN LUNG TUMOR XENOGRAFTS IN FEMALE ATHYMIC NCR-NU/NU MICE Study No. ERI-122 English ->Korean
Eisai Korea The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth - Mary Ann Jordan,1 Kathryn Kamath,1 Tapas Manna,1 Tatiana Okouneva,1 Herbert P. Miller,1 Celia Davis,1 Bruce A. Littlefield,2 and Leslie English ->Korean
Eisai Korea Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389 - Galina Kuznetsov,1 Murray J. Towle,2 Hongsheng Cheng,2 Takanori Kawamura,6 Karen TenDyke,1 Diana Liu,2 Yoshito Ki English ->Korean
Eisai Korea STUDY REPORT - ANTITUMOR EFFECTS OF E7389 AGAINST S.C. HT-1080 HUMAN FIBROSARCOMA XENOGRAFTS IN VIVO Revision No. 1 REPORT NUMBER: PPC2003-01 English ->Korean
Eisai Korea Study Report - ANTIPROLIFERATIVE EFFECTS OF E7389 COMBINATIONS WITH DOCETAXEL OR CARBOPLATIN AGAINST HUMAN CANCER CELLS IN VITRO STUDY NUMBER: SA030105 English ->Korean
Eisai Korea CANCER RESEARCH 61, 1013–1021, February 1, 2001 - In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B1 - Murray J. Towle, Kathleen A. Salvato, Jacqueline Budrow, Bruce F. Wels, Galina Kuznetsov, Kimberley English ->Korean
Eisai Korea Study Report - E7389-INDUCED NEUROPATHY EVALUATION IN MICE: The Effects of E7389 on nerve conduction velocity (NCV), amplitude and morphology in the BALB/c Mouse STUDY NUMBER: PPC-2009-01 English ->Korean
Eisai Korea Final Report - E7389: Effects on HERG Tail Currents Recorded from Stably Transfected HEK293 Cells Quintiles, Inc. Report No.: QKAN-2003-0272-SPC English ->Korean
Eisai Korea Final Report - E7389: Effects on General Physical Condition and Behavior by Intravenous Injection in Rats Quintiles, Inc. Report No.: QKAN-2003-0271-SPC English ->Korean
Eisai Korea Final Report - E7389: Effects on Action Potential Parameters in Isolated Cardiac Purkinje Fibers of Dog Quintiles, Inc. Report No.: QKAN-2003-0441-SPC English ->Korean
Eisai Korea Final Report - E7389: Effects on Respiratory Function by Intravenous Injection in Rats Quintiles, Inc. Report No.: QKAN-2003-0333-SPC English ->Korean
Eisai Korea Final Report - E7389: Effects on Cardiovascular System and Body Temperature by Intravenous Infusion in Conscious Dogs Quintiles, Inc. Report No.: QKAN-2003-0471-SPC English ->Korean
Eisai Korea Eisai Research Institute - Pharmacokinetics of Halichondrin B Analog NSC 707389-D Following Three 1-Hour CIV Infusions in Rats REPORT NO.: DSD2001-30 English ->Korean
Eisai Korea Eisai Research Institute - Pharmacokinetics of E7389 in Mice, Rats, and Dogs REPORT NUMBER: DSD2002-42 English ->Korean
Eisai Korea STUDY REPORT - PHARMACOKINETICS OF E7389 IN MICE AND RATS FOLLOWING SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS STUDY NUMBERS: DDDP2005-090 TO DDDP2005-095, DDDP2005-097, DDDP2005-153, AND DDDP2005-163 English ->Korean
Eisai Korea STUDY REPORT - TUMOR AND BRAIN PENETRATION OF E7389 IN LOX XENOGRAFT MICE FOLLOWING SINGLE AND MULTIPLE INTRAVENOUS ADMINISTRATIONS STUDY NUMBERS: DDDP2005-098 AND DDDP2005-135 English ->Korean
Eisai Korea STUDY REPORT - QUANTITATIVE TISSUE DISTRIBUTION OF DRUGRELATED MATERIAL USING WHOLE-BODY AUTORADIOGRAPHY FOLLOWING A SINGLE IV DOSE OF [14C]E814058 (1.5 mg/kg, as the salt form) TO MALE LONG-EVANS AND SPRAGUE DAWLEY RATS STUDY NUMBER: QPS45-0403 English ->Korean
Eisai Korea REPORT AMENDMENT - Quantitative Tissue Distribution and Human Dosimetry Predictions of Drug-Related Material Using Whole-Body Autoradiography Following a Single IV Dose of [14C]E814058 (0.75 mg/kg, as the salt form) to Male Long-Evans and Sprague Dawley R English ->Korean
Eisai Korea STUDY REPORT AND AMENDMENT NO. 1 - [14C]E-814058 METABOLITE IDENTIFICATION AND PROFILING IN PLASMA, URINE, BILE AND FECES FROM SPRAGUE-DAWLEY RATS FOLLOWING A SINGLE INTRAVENOUS ADMINISTRATION OF [14C]E-814058 (REVISION NO. 1) STUDY NUMBER: 45N-0405 English ->Korean
Eisai Korea STUDY REPORT & AMENDMENTS NO. 1, 2, & 3 - [14C]E-814058 METABOLITE IDENTIFICATION AND PROFILING IN PLASMA, URINE AND FECES FROM BEAGLE DOGS FOLLOWING A SINGLE INTRAVENOUS ADMINISTRATION OF [14C]E-814058 STUDY NUMBER: 45N-0406 English ->Korean
Eisai Korea STUDY REPORT AND AMENDMENT #2 - MASS BALANCE AND EXCRETION OF RADIOACTIVITY IN SPRAGUE-DAWLEY RATS FOLLOWING A SINGLE INTRAVENOUS BOLUS DOSE OF [14C]E-814058 QPS Project Number: 45-0404 English ->Korean
Eisai Korea STUDY REPORT - [14C]E-814058: A STUDY OF MASS BALANCE OF RADIOACTIVITY FOLLOWING A SINGLE INTRAVENOUS ADMINISTRATION OF 14C-LABELLED E-814058 TO BEAGLE DOGS STUDY NUMBER: 6212 English ->Korean
Eisai Korea KFDA Chapter 3 Drug Imprint Code Article 10 (Object of Drug Imprint Code) Article 11 (Drug Imprint Method) Article 12 (Registration of Drug Imprint Code) Article 13 (Drug Imprint Code Registration Authority) English ->Korean
Eisai Korea KFDA Chapter 3 Drug Imprint Code Article 14 (Coordinating Committee for Drug Imprint Code) Article 15 (Disclosure of Information) Article 16 (Reporting) Article 17 (Miscellaneous Provisions) Article 18 (Deadline for Re-review) Korean ->English
Eisai Korea Briefing Book - Data for Developing a Compound of Donepezil HCl and Memantine HC Ver. 2 - December, 2011 Daewoong / Eisai Korea, Inc. Korean ->English
Eisai Korea Journal of Non-Crystalline Solids 52 (1 982) 91-103 North-Holland Publishing Company - CHEMICAL DURABILITY OF GLASSES - H. SCHOLZE Fraunhofer-Institut für Silicatforschung, Würzburg, FRG English ->Korean
Eisai Korea KOREA PHARMACEUTICAL MANUFACTURERS ASSOCIATION Public Document - Notice of submission of required application documents for preliminary GMP evaluation by item Korean ->English
Eisai Korea Korea Food and Drug Administration Public Document - Request for GMP inspection result's supplementary data by item [Eisai Korea Inc. - Halaven (eribulin mesylate)] Korean ->English
Eisai Korea Attachment 1_KFDA_CAP-005_12 - NerPharMa - INSTALLATION & OPERATIONAL QUALIFICATION Protocol about Differential pressure Indicators - Protocol No.: SF. 793 IOQ Rev. 01 - 05.15.2012 Italian ->Korean
Eisai Korea Attachment 2_KFDA_CAP-005_12 - PHOTO 1 ~ PHOTO 3/b – SOP SF.DB 006 (Management of Solvent and Reagents) with mention of data logger management Italian ->Korean
Eisai Korea Attachment 4_KFDA_CAP-005_12 - NerPharMa - Eribulin Mesylate (P4114623) MASTER FORMULA SF 1 07SS03*Fa Versione 6 del Giugno 2012 Italian ->Korean
Eisai Korea NerPharMa - Challenge Test Protocol Doc nOINfCT 001 VERS.01 - Apparecchíatura: Línea dí rípartízíone MAR Matrícola: IN/LR/01 Italian ->Korean
Eisai Korea NerPharMa - Eribulin Mesylate (P4114623) - Injectables Italian ->Korean
Eisai Korea The Korean generic drug pharmaceutical industry will cover the costs of KRW 4 billion for the clinical reassessment, and EISAI will defray the additional costs. June 19, 2012 Korean ->English
Eisai Korea Proposition for joint clinical reassessment of DONEPEZIL HCI - Proposed date: Friday, May 25, 2012 Korean ->English
Eisai Korea KOREA PHARMACEUTICAL MANUFACTURERS ASSOCIATION Public Document - Korean pharmaceutical industry’s opinion about the joint participation in the clinical reassessment of DONEPEZIL HCI Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co., Ltd. - Agreement for Joint Clinical Trail Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Submission of application form and relevant documents for the drug re-assessment of items subject to the drug clinical trial Korean ->English
Eisai Korea Astellas Pharma GmbH, Germany / - Akademie der Wissenschaften der DDR Forschungszentrum für Molekularbiologie und Medizin Zentralinstitut für Mikrobiologie und experimentelle Therapie Jena Abt. Pharmakologie und Toxikologie - Subchronische Toxizitatsunter German->Korean
Eisai Korea Astellas Pharma GmbH, Germany / - CYTOSTASAN - Chrronische Toxizitätsprüfung der Substanz Cytostasan im Vergleich (VS) zu Chlorambuzi1 an der Ratte - August 1985 German->Korean
Eisai Korea Astellas Pharma GmbH, Germany / - RBM 0011971423 - BENDAMUSTIN HYDROCHLORIDE MAXIMUM TOLERATED DOSE AND FIVE DAY REPEATED DOSE STUDY – IN DOGS BY INTRA VENOUS INFUSION Report No.: 0640.98.C2.01 29 July 1998 English ->Korean
Eisai Korea Astellas Pharma GmbH, Germany / - RBM 003/974052 - BENDAMUSTIN HYDROCHLORIDE TOXICITY TO DOGS BY DAIL Y INTRA VENOUS INFUSION OVER A MINIMUM OF THREE 4-DAY CYCLES EACH FOLLOWED BY A PERIOD WITHOUT TREATMENT OF UPT031DAYS Report No.: 0640.98.C2.02 27 Jul English ->Korean
Eisai Korea Ribomustin Test 1 M4/ 4.2.3.3.1.1 Huntingdon-KPG-017-002582-ID639 - BENDAMUSTIN HYDROCHLORIDE BACTERIAL MUTATION ASSAY - Klinge Internal Report No. 0640.00.C4.01 - 12 MAY 2000 English ->Korean
Eisai Korea Ribomustin Test 1 M4/ 4.2.3.3.1.2 Huntingdon-KGP-018-002634-ID640 - BENDAMUSTIN HYDROCHLORIDE IN VITRO MAMMALIAN CHROMOSOME ABERRATION TEST IN HUMAN LYMPHOCYTES - Klinge Internal Report No. 0640.00.C4.02 - 6 JULY 2000 English ->Korean
Eisai Korea Astellas Pharma GmbH, Germany / - KGP 014/002753 - BENDAMUSTIN HYDROCHLORIDE PERIVENOUS & INTRA-ARTERIAL TOLERANCE STUDY IN ’fHE RABBIT– Report No.: 0640.00.C14.01 26 September 2000 English ->Korean
Eisai Korea Korea Food & Drug Administration - Narcotic and Neuropharmacological Drug Team Drug Evaluation Dept. - Guideline on Clinical Investigation of Medical Products for Dementia of Alzheimer’s Type - May 2007 Korean ->English
Eisai Korea Food and Drug Integrated Information Service Korea Food & Drug Administration (KFDA) - License for drug import item [Halaven (Eribulin mesylate)] Aug. 17, 2012 Korean ->English
Eisai Korea Alzheimer's research & therapy - Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer’s disease - Steven H Ferris1*, Frederick A Schmitt2, Judith Saxton3, Sharon Richardson4, Joan Mackell5, Yijun Sun6 and Yik English ->Korean
Eisai Korea RCC - CCR STUDY NUMBER 831200 - CHROMOSOME ABERRATION TEST IN HUMAN L YMPHOCYTES IN VITRO WITH HYDROXY-BENDAMUSTINE (HP1) FINAL REPORT June 28, 2004 English ->Korean
Eisai Korea FINAL REPORT - Study Title CEP-18083: Rat Bone Marrow Erythrocyte Micronucleus Test - Test Article CEP-18083 Authors Ljubica Krsmanovic, Ph.D. Tawney Huston, B.S. Study Completion Date 03 August 2007 English ->Korean
Eisai Korea Annals of Oncology 19 (Supplement 8): viii63–viii76, 2008 - breast cancer, advanced English ->Korean
Eisai Korea Annals of Oncology 21 (Supplement 8): viii96–viii121, 2010 - breast cancer, advanced English ->Korean
Eisai Korea BREAST CANCER—METASTATIC BREAST CANCER - 1081 General Poster Session (Board #27H), Sat, 2:00 PM - 6:00 PM Efficacy and safety of eribulin in Japanese patients (pts) with advanced breast cancer. 2010 American Society of Clinical Oncology English ->Korean
Eisai Korea Clinical Breast Cancer April 2010 - Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer - Clin Cancer Res 2009;15:4207-4212. Published online June 9, 2009. English ->Korean
Eisai Korea Clinical Breast Cancer 2009 - A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies Sanjay Goel, Alain C. Mita, Monica Mita, et al. Clin Cancer Res 2009;15:420 English ->Korean
Eisai Korea JOURNAL OF CLINICAL ONCOLOGY ORIGINAL REPORT - Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane - JUNE 20 2009 English ->Korean
Eisai Korea JOURNAL OF CLINICAL ONCOLOGY ORIGINAL REPORT -Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine SEPTEMBER 1 2010 English ->Korean
Eisai Korea Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study - Lancet 2011 English ->Korean
Eisai Korea NICE STA report - 9.3 Appendix 3: Quality assessment of RCT(s) Study name: EMBRACE (Study 305) English ->Korean
Eisai Korea Seoul Regional Korea Food & Drug Administration - Instructions for submission of imported drugs’ overseas factories history card - 16 Feburary 2012 Korean ->English
Eisai Korea Korea Food and Drug Administration Biopharmaceuticals Safety Bureau Evaluation Guide for Pharmaceuticals-65 - Guidance for Clinical Pharmacology Studies - in Healthy Adults - November 2011 Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : E2020K082418A Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : E2020K082418O Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : E2020K082418P Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : Aricept Tablet Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : Aricept Tablet 10 mg Placebo Korean ->English
Eisai Korea DAEWOONG Pharmaceutical Co, Ltd.- Packing Instruction and Record Book - Product Name : Aricept Tablet Placebo Korean ->English
Eisai Korea 4.2.3.2 反復投与毒性試験 - Final Report - 15-Week Intermittent Intravenous Infusion Toxicity and Toxicokinetic Study with CEP-18083 (Bendamustine) in Rats with a 4-Week Recovery Period Thomas E. Ryan, BS Diplomate, ABT - 24 August 2007 English ->Korean
Eisai Korea 4.2.3.2 反復投与毒性試験 - 5-Day Intermittent Intravenous Infusion Dose Range Finding Toxicity Study with CEP-18083 (Bendamustine) in Rats with a 16-Day Recovery Period - Thomas E. Ryan, BS, Diplomate, ABT 22 May 2007 English ->Korean
Eisai Korea Temmler Werke GmbH - Verpackungsanweisung/-protokoll - SYMBENDA 100 MG German->Korean
Eisai Korea Temmler Werke GmbH - Technische Hinweise zur Verpackungsvorschrift - SYMBENDA 100 MG 1 DEL/KR RMF 30.09.2011 German->English
Eisai Korea Temmler Werke GmbH - München - Retrospektive Oualifizierung (10) Hochleistungsdrucker Leibinger Typ JET 2 Serien-Nummer 06210249 - 04.2008 German->Korean
Eisai Korea Temmler Werke GmbH - München - Requalifizierung (IQIOQ) Etikettierrnaschine Schðfer SE 180- 08.2009 German->Korean
Eisai Korea Temmler Werke GmbH - München - Qualifizierungsplan Etikettiermaschine Schäfer SE 180 - 07.2009 German->Korean
Eisai Korea Temmler Werke GmbH - München - Requalifizierung Wiederinbetriebnahme Codelesegerät und Etikettenanwesenheitskontrolle für Schäfer Etikettierer - 07.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München - Verkürzte Qualifizierung (10/00) Inspektionsbox Nr. 2 für die visuelle Kontrolle von Bendamustin Vials - 12.2011 German->Korean
Eisai Korea Temmler Werke GmbH - München - Prospektive Oualifizierung Kompaktschrumpfgerät Kopp TMC 58 - 07.2012 German->Korean
Eisai Korea Regulations for Designation of Orphan Drugs - KFDA Notification No. 1998- 23 (established on April 16, 1998) ~ KFDA Notification No. 2013- 127 (revised on April 5, 2013) Korean ->English
Eisai Korea Form No. 1 - Application Form for Orphan Drug / Application Form for Orphan Drug in the Development Stage Korean ->English
Eisai Korea Form No. 2 - Letter of Recommendation for Designation of Orphan Drug / Letter of Opinion for Recommendation for Designation of Orphan Drug in the Development Stage Korean ->English
Eisai Korea Form No. 3 - Designation of Orphan Drug in Development Stage Korean ->English
Eisai Korea Appendix 1 - Designation of Rare Medications, Appendix 2 - Designation of Rare Medications Under Development Korean ->English
Eisai Korea Cenexi-laboratoires Thissen - PRELEVEMENTS DE ROUTINE POUR CONTROLES MICROBIOLOGIQUES ET PHYSICO-CHIMIQUES DES EAUX PURIFlEES ET EAUX NON NORMA TIVES SOP S 000-020/06 Date d’application: 0 5 AOUT 2013 - KFDA answers documentation A French->Korean
Eisai Korea Cenexi-laboratoires Thissen - RECEPTION DES MA TIERES CHIMIQUES, DES PRODUITS VRACS ET SEMI-CONDITIONNES SOP E 2100-001112 Date d’application: 07 AOUT 2013 - KFDA answers documentation C French->Korean
Eisai Korea Cenexi-laboratoires Thissen - FICHE DE PRELEVEMENT SOP S 000-018 Date d’application: 01 JUIL 2013 - KFDA answers documentation D French->Korean
Eisai Korea Cenexi-laboratoires Thissen - RECEPTION DU MATERIEL DE CONDlTIONNEMENT SOP E 1000-001110 Date d’application: 07 AOUT 2013 - KFDA answers documentation F French->Korean
Eisai Korea Cenexi-laboratoires Thissen - Liste des foumisseurs agréés - Date d’application: 3/07//2013 - KFDA answers documentation G French->Korean
Eisai Korea Agenxia Italiana del Farmaco (AIFA) Roma 03 augusto 2012 - Registri Farmaci sottoposti a Monitoraggio - Procedura di Gestione Rimborsi Payment by result - Specialità HALAVEN® Italian ->Korean
Eisai Korea Cenexi-laboratoires Thissen - QUALIFICATION DE L’AERAULIQUE DES ZONES CLASSEES SOP G 000-143/04 - Date d’application: 21 DEC 2012 - KFDA answers documentation B French->Korean
Eisai Korea Cenexi-laboratoires Thissen - P&ID production et distribution equ zone 900 - 2010/0007-J French->Korean
Eisai Korea Cenexi-laboratoires Thissen - PRELEVEMENTS DE ROUTINE POUR CONTROLES lICROBIOLOGIQUES ET PHYSICO-CHIMIQUES DES EAUX PURIFIEES ET EAUX NON NORMATIVES SOP S 000-020/06 Date d’application: 05 AOUT 2013 - KFDA answers documentation French->Korean
Eisai Korea Cenexi-laboratoires Thissen - RECEPTION DES MATIERES CHIMIQUES, DES PRODUITS VRACS ET SEMI-CONDITIONNES SOP E 2100-001112 - Date d’application: 07 AOUT 2013 - KFDA answers documentation French->Korean
Eisai Korea Clinical Trial Materials - E2007 SYNOPSIS 53 Files English ->Korean
Eisai Korea Cenexi-laboratoires Thissen - CONTROLE DELAVAPEURPROPRE SOP : C 000-029/07 - Date d’application: 15 NOV. 2013 - KFDA answers documentation E2-c French->Korean
Eisai Korea Cenexi-laboratoires Thissen - CONTRÔLE DES DÉSINFECT ANTS UTILISÉS EN PRODUCTION CLASSE A ET B SOP C 000-082/01 Date d’application: 4 NOV. 2013 - KFDA answers documentation F1 French->Korean
Eisai Korea Summary of the main contents of suggestion - 1. Opinions of pre-announcement of legislation and administration 2. Suggestion for the risk sharing system 3. Rationalization method for the value of new medicine Korean ->English
Eisai Korea Study Protocol - Protocol ver 1.0 27 Sep 2013 - A predictive capacity of power Doppler for patients presenting persistent arthritis English ->Korean
Eisai Korea Clinical Study Report - A Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) Phase 3 Study C18083/3070 English ->Korean
Eisai Korea Cenexi-laboratoires Thissen - QUALIFICATION DE L'’'AERAULIQUE DES ZONES CLASSEES SOP G 000-143/04 Date d’application: 21 DEC 2012 - #F2b - smoke test report. French->Korean
Eisai Korea Cenexi-laboratoires Thissen - Results of sterility tests on disinfectants - ESSAIS DE STERILlTE SOP MC 940-001/10 Date d’application: 17 JUIN 2013 - KFDA answers documentation French->Korean
Eisai Korea Cenexi-laboratoires Thissen - F2b Smoke test qualification report French->Korean
Eisai Korea Cenexi-laboratoires Thissen - ESSAIS DE STERILlTE SOP MC 940-001/11 Date d’application: 06 JAM 2014 - KFDA answers documentation French->Korean
Eisai Korea Activity Test Materials - E2007 SYNOPSIS 75 Files English ->Korean
Eisai Korea Korea Food & Drug Administration Public Document - Notice of civil petitions processing measure related to itemized pre-GMP evaluation check of imported drug products Korean ->English
Eisai Korea Temmler Werke GmbH - München - Steuerung von Produktänderungen (Regulatory Change Control) SOP Nr. 02.014 - 01.07.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Ablaufschema bei Produktänderungen Anlage 2 zu SOP 02.014 vom 01.07.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Personalhygiene in Produktion und CTM (Personnel hygiene in production and CTM) SOP Nr. 03.010 - 01.09.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München - Pausenordnung Bulkherstellung BT 56 und Abfüllung & Verpackung BT 30 SOP Nr. 03.010_a2 - September 2013 German->Korean
Eisai Korea Temmler Werke GmbH - München - INTERNER SCHRIFTVERKEHR QS-Bearbeitungs-Nr.: TÄ Anlage 1 zur SOP 04.040 vom 01.01.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München - Handverpackung (Manual Packaging) SOP Nr. 07.015 - 01.03.2014 German->Korean
Eisai Korea Temmler Werke GmbH - München - Anlage 4 zur SOP 08.011 vom 01.11.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Bewertungsbogen eines neuen Rohstoffes / Zwischenproduktes Anlage 2 zur SOP 08.029 vom 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Aktualisierung des Qualifizierungsstatus eines Lieferanten Anlage 3 zu SOP 08.029 vom 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Steuerung von Änderungen bei technischen Anlagen (Change Control of premises, utilities and equipment) SOP Nr. 04.040 - 01.01.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München - In Prozess Kontrolle 53: Fertigwarenkontrolle (In process control no. 53: Control of finished goods) SOP Nr. 07.166 - 01.03.2014 German->Korean
Eisai Korea Temmler Werke GmbH - München - In Prozess Kontrolle 55: Codeleser – Funktionskontrolle (In process control no. 55: code inspectors -function control) SOP Nr. 07.168 - 01.12.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München -In Prozess Kontrolle 61: Kontrolle Teilfertigpackungen (Flaschen, etikettierte Dosen, Dosen Twist-off, Röhrchen und Vials) (In process control no. 61: Control of partial finished goods (bottles, labelled cans, cans twist-off, German->Korean
Eisai Korea Temmler Werke GmbH - München - Probenahme, Prüfung und Statusvergabe bei Packmitteln (Sampling, testing and approval of packaging material) SOP Nr. 08.027 - 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Interner Schriftverkehr Verpackungstechnik (VPT) PC- Fax.-Nr.: 5485 Anlage 4 zur SOP 08.027 vom 01.04.2012, Anlage 5 zur SOP 08.027 vom 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Bearbeitung von technischen pharmazeutischen Reklamationen von Produkten von Auftraggebern (Treatment of technical pharmaceutical complaints of products of contractors) SOP Nr. 08.020 - 01.11.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München - Lieferantenqualifizierung Rohstoffe und Zwischenprodukte und Festlegung des Prüfumfanges (Supplier assessment raw materials, intermediates and determination of analytical testing scale) SOP Nr. 08.029 - 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Freigabe eines neuen Lieferanten (SOP 08.029) Anlage 1 zu SOP 08.029 vom 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Vorgehensweise bei der Qualifizierung und Bewertung von Packmittellieferanten (Qualification and evaluation of suppliers for packaging material) SOP Nr. 08.061 - 01.03.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Fragebogen für Hersteller pharmazeutisch verwendeter Packmittel und Medizinprodukte SOP Nr. 08.061_a1 - 01.03.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Qualifizierung eines Packmittel-Lieferanten Anlage 2 zu SOP 08.061 vom 01.03.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Prüfergebnisse außerhalb der Freigabe-Spezifikation (Out-of-Specification results) SOP Nr. 08.038 - 01.09.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München - OOS-ERGEBNIS – UNTERSUCHUNGSBERICHT Anlage 2 zur SOP 08.038 vom 01.09.2013, Seite 1 von 5 OOS-Nr.: English ->Korean
Eisai Korea Temmler Werke GmbH - München - GMP-Training, Training in Arbeitssicherheit und Umweltschutz (Training of personnel) SOP Nr. 03.015 - 01.11.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München - Reinigung und Desinfektion in der Produktion, in der Pharmazeutischen Entwicklung, in der Herstellung CTM und im Lager und Versand SOP Nr.04.010 - 01.03.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München -Maßnahmen bei Fehlern und Abweichungen in den Herstellungsbereichen und bei Auftragsherstellern (Measures in case of defects and deviations in the manufacturing areas and at contract manufacturers) SOP Nr.07.029- 01.11.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München -Fehler- und Maßnahmenkatalog Herstellung Anlage 2 zur SOP 07.029 vom 01.11.2013 / Fehler- und Maßnahmenkatalog Verpackung Anlage 3 zur SOP 07.029 vom 01.11.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München -Fehler- und Maßnahmenkatalog Herstellung CTM Anlage 4 zur SOP 07.029 vom 01.11.2013 / LOGBUCH ABWEICHUNGEN TECHNISCHE DEFEKTE Anlage 5 zur SOP 07.029 vom 01.11.2013 German->Korean
Eisai Korea Temmler Werke GmbH - München - Vorgehensweise bei der Prüfung und Dokumentation von Rohstoffen (System for the testing and documentation of raw material) SOP Nr. 08.011 - 01.11.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - Prüfergebnisse außerhalb der StabilitätsSpezifikation (Out-of-shelflife specification results) SOP Nr. 08.056 - 01.04.2012 German->Korean
Eisai Korea Temmler Werke GmbH - München - INTERNER SCHRIFTVERKEHR QS-Bearbeitungs-Nr. TÄ 10-385 Anlage 1 zur SOP 04.040 vom 01.01.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München - In Prozess Kontrolle 53: Fertigwarenkontrolle (In process control no. 53: Control of finished goods) SOP Nr. 07.166 - 01.03.2014 German->Korean
Eisai Korea Temmler Werke GmbH - München - In Prozess Kontrolle 55: Codeleser – Funktionskontrolle (In process control no. 55: code inspectors -function control) SOP Nr. 07.168 - 01.12.2010 German->Korean
Eisai Korea Temmler Werke GmbH - München -In Prozess Kontrolle 61: Kontrolle Teilfertigpackungen (Flaschen, etikettierte Dosen, Dosen Twist-off, Röhrchen und Vials) SOP Nr. 07.176 - 01.03.2014 German->Korean
Eisai Korea Clinical Trial Materials - 14C-E2007 SYNOPSIS 24 Files English ->Korean
Eisai Korea National Institute of Food and Drug Safety Evaluation (NIFDSE) Public Document - The first review results of drug’s prior review [Eisai Korea Inc. – Lenvima Korean ->English
Eisai Korea National Institute of Food and Drug Safety Evaluation (NIFDSE) Public Document - Appendix 2 - low diagram for determining the necessity of a Bridge study Korean ->English
Eisai Korea Health Insurance Review & Assessment Service (HIRA) - Valid Drug Barcode Manual - - Relating to serial number inclusion in a prescription drug barcode - May 30, 2014 Korean ->English
Eisai Korea MHRA GMP INSPECTION REPORT : GMP INSPECTION OF Eisai manufacturing Limited - GMP/GDP/IMP 32301/726219-0004 Inspection date: 10th_12th Julv 2012 English ->Korean
Eisai Korea Ministry of Government Legislation Korea Law Service Center - Regulations on Drug Identification Labeling [Enforced Dec. 22, 2009] [Food and Drug Safety Administration Notification No. 2009-205, Dec. 22, 2009, Revised by other laws] Food And Drug Safety Korean ->English
Eisai Korea FULL-LENGTH ORIGINAL RESEARCH - Perampanel for adjunctive treatment of partial-onset seizures: A pooled dose–response analysis of phase III studies - *Lynn D. Krame English ->Korean
Eisai Korea CNS Drugs (2013) 27:817–827 - Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy - Warrington W. Q. Hsu • C. W. Sing • Ying He • Alan J. Worsley • Ian C. K. Wong • Esther W. Chan English ->Korean
Eisai Korea Epilepsia, 54(8):1490–1497, 2013 - FULL-LENGTH ORIGINAL RESEARCH - Concentration–effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures *Barry E. Gidal, †Jim Ferry, ‡Oneeb Majid, and ‡Ziad Hussein English ->Korean
Eisai Korea Epilepsia, 54(8):1481–1489, 2013 - FULL-LENGTH ORIGINAL RESEARCH -Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies - *Bernhard J. Steinhoff, †Elinor Ben-Menachem, ‡ English ->Korean
Eisai Korea European Journal of Neurology 2013, 20: 1204–1211 - The adverse event profile of perampanel: meta-analysis of randomized controlled trials - G. Zaccaraa, F. Giovannellia, M. Cincottaa, A. Verrottib and E. Grilloc English ->Korean
Eisai Korea Epilepsy Research (2013) 103, 31 - 44 : Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: A meta-analysis of randomized placebo-controlled trials - Lan Gaoa, Li Xiab, Fe English ->Korean
Eisai Korea Neuropsychiatric Disease and Treatment - Dovepress open access to scientific and medical research REVIEW : Profile of perampanel and its potential in the treatment of partial onset seizures – 10 May 2013 English ->Korean
Eisai Korea Epilepsia, 54(1):126–134, 2013 - FULL-LENGTH ORIGINAL RESEARCH - Perampanel, a selective, noncompetitive a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results English ->Korean
Eisai Korea Epilepsia, 54(1):117–125, 2013 - FULL-LENGTH ORIGINAL RESEARCH - Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305 - *Jacqueline A. French, yGregory L. Krauss, zBernhar English ->Korean
Eisai Korea Supplemental data at www.neurology.org - Adjunctive perampanel for refractory partial-onset seizures - Randomized phase III study 304 Jacqueline A. French, MD Gregory L. Krauss, MD Victor Biton, MD David Squillacote, MD Haichen Yang, MD Antonio Laurenza, English ->Korean
Eisai Korea American Academy of Neurology - Randomized phase III study 306 - Adjunctive perampanel for refractory partial-onset seizures - G.L. Krauss, MD J.M. Serratosa, MD, PhD V. Villanueva, MD, PhD M. Endziniene, MD, PhD Z. Hong, MD J. French, MD H. Yang, MD D. S English ->Korean
Eisai Korea Acta Neurol Scand 2012: 125: 8–15 - Tolerability and safety of perampanel: two randomized dose-escalation studies - Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, Squillacote D, Kumar D. English ->Korean
Eisai Korea Epilepsy Research (2014) 108, 986 - 988 : A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria Bernhard J. Steinhoffa,∗, Hajo Hamerb, Eugen Trinkac, Andreas Schulze-Bonhaged, Christian Biene, Thomas Mayerf, Chri English ->Korean
Eisai Korea Epilepsia, 55(Suppl.1):16–18, 2014 - First clinical experiences with perampanel—The Kork experience in 74 patients - Bernhard J. Steinhoff, Matthias Bacher, Thomas Bast, Reinhold Kornmeier, Christoph Kurth, Julia Scholly, Anke M. Staack, and Ilona Wisniew English ->Korean
Eisai Korea Rote Liste - HALAVEN® 0,44 mg/ml Injektionslösung Zus.: 1 ml enth.: Eribulinmesylat (entspr. 0,44 mg Eribulin) - 2014 by Rote Liste Service GmbH German->Korean
Eisai Korea Annals of Oncology 23: 1441–1448, 2012 - A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer - K. Aogi1*, H. Iwata2, N. Masuda3, H. Mukai4, M. Yoshida5, Y. Rai6, K. Taguchi7, Y. Sasaki8 & S. Takashima1 English ->Korean
Eisai Korea Journal of Cancer 2014, Vol. 5 Research Paper - Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study - Teresa Gamucci1*, Andrea Michelotti2*, Laura Pizzuti3, Lucia Mentuccia1, Elisabetta Landucci2, Isabel English ->Korean
Eisai Korea Journal of Solid Tumors, 2013, Vol. 3, No. 1 CASE REPORT - Eribulin monotherapy in a patient with heavily pretreated metastatic breast cancer: Case study and review of the literature - Fariborz Gorouhi, Stefan Glück English ->Korean
Eisai Korea Acta Oncologica, 2014; Early Online: 1–3 - Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer - MAJA LYNGE RASMUSSEN 1 , GABOR LIPOSITS 2 , SUBETHINI YOGENDRAM 1 , ANDERS BONDE JENSEN 1 , S Ø REN LINNET 2 & SVE English ->Korean
Eisai Korea Academia-Pharma Intersect: Breast Cancer - Eribulin Monotherapy in Patients Aged 70 Years and OlderWith Metastatic Breast Cancer - HYMANMUSS,a JAVIERCORTES,b LINDA T.VAHDAT,c FATIMACARDOSO,dCHRIS TWELVES,e JANTIENWANDERS,fCORINA E.DUTCUS,g JAYYANG,h SETH English ->Korean
Eisai Korea Future Oncology RESEARCH ARTICLE - Eribulin mesylate in heavily pretreated metastatic breast cancer patients: current practice in an Italian community hospital - Paola Poletti*1, Valentina Ghilardi1, Luca Livraghi1, Laura Milesi1, Elena Rota Caremoli1 & C English ->Korean
Eisai Korea Clinical Study Report E2007-G000-235 - STUDY SYNOPSIS English ->Korean
Eisai Korea Clinical Study Report E2007-G000-307 - STUDY SYNOPSIS English ->Korean
Eisai Korea NDA 20-237/S012 - SALAGEN® Tablets (pilocarpine hydrochloride) - Each 5 mg SALAGEN® Tablet for oral administration contains 5 mg of pilocarpine hydrochloride. English ->Korean
Eisai Korea Novartis Pharmaceuticals UK Ltd - Salagen 5 mg Film Coated Tablets - (eMC) - Summary of Product Characteristics last updated on the eMC: 20/12/2012 English ->Korean
Eisai Korea e-CPS : e-CPS : Drug Monographs - Salagen (pilocapine HCL) Cholinomimetic Agent Phizer DIN(s): 02216345 Date of Revision: May 27 2013 English ->Korean
Eisai Korea Salagen® NOVARTIS PHARMA AMZV Filmtabletten à 5 mg. German->Korean
Eisai Korea 30 009 (Novartis Pharma) Salagen 5 mg Filmtabletten Rp ATC: N07AX01 Zus.: 1 Filmtbl. enth.: Pilocarpin HCL German->Korean
Eisai Korea SALAGEN Altri farmaci del sistema nervoso - Sostanze medicineali pilocarpina cloridrato (FU) ATC N07AX01 Italian ->Korean
Eisai Korea SALAGEN® pilocarpine FORMES/Présentations French->Korean
Eisai Korea pilocarpine hydrochloride(JP) [필로카핀염산염] 녹내장 치료제, 구강건조증상 개선제 131, 239 - 정제 살라겐 2013년 10월 개정, 점안액 산필로 2013년 7월 개정 Japanese->Korean
Eisai Korea Application Form / Compliance Self Check List / Date (yyyy-mm-dd): 2014-10-10 Korean ->English
Eisai Korea Regulations on Expense and Expenditure Management ̶ Revised on Apr. 1, 2014 Korean ->English
Eisai Korea Accounting Standards - Amended on Apr, 1, 2014 Korean ->English
Eisai Korea NDA 20-237/S012 - SALAGEN® Tablets (pilocarpine hydrochloride) - DESCRIPTION: SALAGEN® Tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. English ->Korean
Eisai Korea Fachinformation des Arzneimittel-Kompendium der Schweiz® - Salagen® Novartis Pharma Schweiz AG Galenische Form und Wirkstoffmenge pro Einheit Filmtabletten à 5 mg. German ->Korean
Eisai Korea CLINICAL STUDY REPORT - Study Protocol Number E2020-J081-341 English ->Korean
Eisai Korea CLINICAL STUDY REPORT - Study Protocol Number E2020-J081-431 English ->Korean
Eisai Korea CLINICAL STUDY REPORT - Study Protocol Number E2020-J081-432 English ->Korean
Eisai Korea E2020 Statistical Analysis Report - Population Pharmacokinetics Analysis (Revised) - Study Title: Population Pharmacokinetics Analysis of E2020 using Data from E202-J081-162 and E2020-J081-231 Trials Protocol Numbers: E202-J081-162, E202-J081-231 English ->Korean
Eisai Korea Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Proposed Rules - DEPARTMENT OF JUSTICE Drug Enforcement Administration - 21 CFR Part 1308 [Docket No. DEA–374] Schedules of Controlled Substances: Placement of Perampanel into Schedule III English ->Korean
Eisai Korea PinneyAssociates, Inc. - Review of the FDA/DEA Rationale for Placement of Perampanel in Schedule III English ->Korean
Eisai Korea Global Compliance Survey - CHINA & ASIA: TOTAL 21 QUESTIONS REVISED AS OF JUNE 24, 2015 English ->Korean
Eisai Korea POPULATION ANALYSIS REPORT - CPMS- E2020-001R-v2 - Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Donepezil in Subjects with Dementia with Lewy Bodies (E2020-J081-341) Date: 5 February 2013 English ->Korean
Eisai Korea Clinical Study Report E2020-E044-316 - Donepezil (Aricept®) Protocol Number: E2020-E044-316- 16 February 2010 English ->Korean
Eisai Korea A. Applicant’s Opinion O Regarding the Adequacy of Reimbursement Regarding Insurance Reimbursement Basis O The Requested Price by Pharmaceutical Company B. Evaluation Results O Reimbursement Criteria (Proposal) C. Evaluation Criteria O Necessity for Medic Korean ->English
Eisai Korea Aricept 2.5 CLINICAL OVERVIEW English ->Korean
Eisai Korea 2016 Guideline for the Handling of Civil Petitions Pertaining to Pre-GMP Assessment for Import Drugs Korean ->English
Eisai Korea Fachinformation des Arzneimittel-Kompendium der Schweiz® - Ribomustin® Mundipharma Medical Co.- Galenische Form und Wirkstoffmenge pro Einheit Lyophilisat für Infusionslösung. Durchstechflaschen zu 25 mg und 100 mg Bendamustinhydrochlorid. German ->Korean
Eisai Korea TLV (TANDVÅRDS- OCH LÄKEMEDELSFÖRMÅNSVERKET) SAKEN Ansökan inom läkemedelsförmånerna SÖKANDE Eisai AB - BESLUT - Lenvima Hårda kapslar 4 mg / 10 mg Swedish->Korean
Eisai Korea Fachinformation des Arzneimittel-Kompendium der Schweiz® - Halaven® Eisai Pharma AG AMZV Indikationen/Anwendungsmöglichkeiten / Dosierung/Anwendung German ->Korean
Eisai Korea Halaven® E7389 Activity Test materials Abstract - A673 English ->Korean
Eisai Korea Halaven® E7389 Activity Test materials Abstract - SK-LMS-1 English ->Korean
Eisai Korea Summary of in Vivo Activity of Eribulin - Phase I - PPTP English ->Korean
Eisai Korea Summary of in Vivo Activity of Eribulin - Phase II - PPTP English ->Korean
Eisai Korea Activity Test Materials - E7389 SYNOPSIS 5 Files English ->Korean
Eisai Korea Korea Food and Drug Administration Drug Evaluation Department - Guideline to Setting Dissolution Specifications for Orally Administered Drug Products - Feb. 2005 Korean ->English
Eisai Korea Purified Water n.14.PD.001 + 16 files (Drawings) Italian ->Korean
Eisai Korea BioTrends - Statistische risultati dei Campionamenti 01/01/2015 - 31/12/2015 + 3 files [Air_Class A, PW_ST3_2015, Surfaces_Class A, WFI_ST3_2015] Italian ->Korean
Eisai Korea ORIGINAL ARTICLE—ALIMENTARY TRACT -Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled tri English ->Korean
Eisai Korea ORIGINAL ARTICLE - Multinational, double-blind, randomised, placebocontrolled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER* study - Kentaro Sugano, 1 Myung-Gyu Choi,2 J English ->Korean
Eisai Korea PHARMACOEPIDEMIOLOGY AND PRESCRIPTION - Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan - Choitsu Sakamoto . Kentaro Sugano . Shinichi Ota . Nobuhiro Sakaki .Shin’ichi Takahashi . English ->Korean
Eisai Korea Thrombosis Research - Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation - Seiji Hokimoto a,⁎, Michio Mizobe a, Tomonori Akasaka a, Yuichiro Arima a, Koichi Ka English ->Korean
Eisai Korea Clinical Trial Materials - AKUGAKU ZASSHI 130(12) 1743-1750 (2010) The Pharmaceutical Society of Japan English ->Korean
Eisai Korea Management Regulation of Fixed Assets - -Revised, October 1, 2016 Korean ->English
Eisai Korea Document Management Regulation - Revised November 1, 2016 Korean ->English
Eisai Korea Official Seal Management Regulation - Revised August 1, 2016 Korean ->English
Eisai Korea Fund Management Regulation - Revised September 1, 2016 Korean ->English
Eisai Korea National Institute of Food and Drug Safety Evaluation (NIFDSE) Gastroenterology and Antimicrobial Product Division, Drug Evaluation Department - Frequently Asked Questions Regarding Bridging Studies . December, 2015 Korean ->English
Eisai Korea Rote Liste - HALAVEN® 0,44 mg/ml Injektionslösung Zus.: 1 ml enth.: Eribulinmesylat (entspr. 0,44 mg Eribulin). German ->Korean
Eisai Korea HALAVEN 0,44 mg/ml sol inj Mise à jour : 19 Octobre 2016 - FORMES et PRÉSENTATIONS Solution injectable IV à 0,44 mg/mL (limpide ; aqueuse ; incolore) : Flacon de 2 mL, boîtes de 1 et de 6. French->Korean
Eisai Korea INFORMATION TRANSMISE SOUS L’AUTORITE DE L’ANSM - Lettre aux professionnels de santé -> INFORMATION PROVIDED UNDER THE AUTHORITY OF ANSM - Letter to healthcare professionals French->English
Eisai Korea Expenditure Management Regulations - Revised on November 1, 2016 Korean ->English
Eisai Korea Accounting Regulations - Revised on May 1, 2017 Korean ->English
Eisai Korea Levact 2.5 mg/ml powder for concentrate for solution for infusion - 4. Clinical particulars English ->Korean
Eisai Korea AHFS Drug Information 2017 English ->Korean
Eisai Korea Ribomustin® Mundipharma Medical Company - Indikationen/Anwendungsmöglichkeiten / Dosierung/Anwendung German ->Korean
Eisai Korea Drug Facts and Comparisons 2017 English ->Korean
Eisai Korea Drugs in Japan 2017 Japanese->Korean
Eisai Korea Linformatore Farmaceutico 2016 Italian ->Korean
Eisai Korea PDR 2017 - PHYSICIAN'S DESK REFERENCE - Partial translation English ->Korean
Eisai Korea Rote Liste - Levact® 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Zus.: 1 Durchstechfl. enth.: Bendamustin-HCl 25 mg/100 mg German ->Korean
Eisai Korea LEVACT 2,5 mg/ml pdre p sol diluer p perf Mise à jour : 06 Mars 2017 - Classification pharmacothérapeutique VIDAL : French->Korean
Eisai Korea Global Compliance Survey Asia - ASIA: TOTAL 66 QUESTIONS July 05, 2017 English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.2 Introduction 2.2 Introduction English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.3.I INTRODUCTION English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.3.P DRUG PRODUCT English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.3.R REGIONAL INFORMATION English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.3.S DRUG SUBSTANCE English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.4 Nonclinical Overview English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.5 CLINICAL OVERVIEW English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.6.1 Nonclinical Summary - Introduction English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.6.2 Pharmacology Written Summary English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.6.4 Pharmacokinetics Written Summary English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.6.6 Toxicology Written Summary English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.7.2 Summary of Clinical Pharmacology Studies English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.7.3 Summary of Clinical Efficacy English ->Korean
Eisai Korea Newron Pharmaceuticals CTD 2.7.4 SUMMARY OF CLINICAL SAFETY English ->Korean
Eisai Korea Korea Food and Drug Administration Department of Drug Administration Drug Safety Bureau - Guidance on Drug Advertising and Specialty Medicine Information -For Inquiry- December 2016 Korean ->English
Eisai Korea Product Approval Transfer Agreement Korean ->English
GlaxoSmithKline Korea
Company Project Language
GlaxoSmithKline Korea Ovarian cancer; gynecologic cancer; pazopanib; GW786034 - Protocol Amendment Number: 01 - JUL-2010 English ->Korean
GlaxoSmithKline Korea Informed Consent Form - A Study to Evaluate Efficacy and Safety of Pazopanib Monotherapy in Asian Women Who Have Not Progressed After First-line Chemotherapy for Advanced Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma – An Extension Study to VEG1 English ->Korean
GlaxoSmithKline Korea GlaxoSmithKline Korea - LOCAL STANDARD OPERATING PROCEDURE - Procedure to update product safety information - LSOP No.. / Version : RA-002/02 - Review Date : Oct. 2012 Korean ->English
GlaxoSmithKline Korea Konkuk University School of Medicine - Te Korean Society of Gastroenterology DOI: 10.4166/kjg.2010/56/2/117 - A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis B Korean ->English
GlaxoSmithKline Korea Pusan National University School of Medicine - Asthma / Allergy Vol.30, No.2, Jun, 2010 - A Case of Ranitidine-Induced Anaphylaxis Korean ->English
GlaxoSmithKline Korea Ministry of Health and Welfare KFDA Regulation - 약국 및 의약품 등의 제조업·수입자 및 판매업의 시설기준령 시행규칙 - [시행 2011. 7. 7] [보건복지부령 제69호, 2011. 7. 7, 일부개정] Korean ->English
GlaxoSmithKline Korea KFDA Guideline - 의약품등의 안정성 시험 기준 / 시험성적서 Korean ->English
GlaxoSmithKline Korea Paradontax Fluorid data, Paradontax Fluorid Product Shipped Approval and Consumer Consulting contents Korean ->English
GlaxoSmithKline Korea Korea Testing & Research Institute Report Korean ->English
GlaxoSmithKline Korea Polident Q&A 保麗淨假牙清潔錠常見問題答問集 (폴리덴트 의치세정제에 관한 Q&A) Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea Denture adhesive Medical Paper abstract (의치접착제 의학 논문 요약 자료) Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea Polident 의치세정제 및 의치접착제 Product brochure - Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea VIASYS Healthcare Clinical Services GmbH - MasterScope® CT - User‘s Manual - FFA109684/FFA109685/FFA109687 English ->Korean
GlaxoSmithKline Korea GlaxoSmithKline Korea - LOCAL STANDARD OPERATING PROCEDURE - Procurement Procedure - LSOP No./Version : LSOP-FNP-001-v3 - Review Date: January 2010 Korean ->English
GlaxoSmithKline Korea Nasal Device Leaflet (For GW685698 Nasal Spray Studies) - Patient Instructions for the Study Nasal Device English ->Korean
GlaxoSmithKline Korea Second Audit Result - 8. Audit Area Korean ->English
GlaxoSmithKline Korea 保麗淨假牙黏著劑 (Polident denture adhesive cream) 對咬力之影響 Presentation data - Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea 假牙黏著劑之臨床應用 Presentation data - Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea GlaxoSmithKline Korea - STANDARD OPERATING PROCEDURE - Consumer Healthcare Inventory Management (Inventory Management , Order, Return & Sample)- SOP No. / Version : KCXSCO002- Review Date : July 2008 Korean ->English
GlaxoSmithKline Korea Polident Adhesive brochure - Polident® Denture Adhesive gives your denture patients the confidence to get on with their lives English ->Korean
GlaxoSmithKline Korea Polident - 保麗淨假牙清潔錠 (폴리덴트 의치세정제) Presentation - Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea Sensodyne toothpaste product manual - Traditional Chinese->Korean Traditional Chinese->Korean
GlaxoSmithKline Korea Polident - 保麗淨假牙黏着劑 (폴리덴트 의치접착제) Presentation - Traditional Chinese into Korean Traditional Chinese->Korean
GlaxoSmithKline Korea Brand Detailing Card & Brand Card - Sensodyne, Paradontax & Polident toothpaste English ->Korean
GlaxoSmithKline Korea Sensodyne, Paradontax & Polident toothpaste - Pre & Post test( for training) - 05.30.2007 English ->Korean
GlaxoSmithKline Korea GSK Sensodyne, Paradontax & Polident toothpaste FAQ - 30 May 2007 English ->Korean
GlaxoSmithKline Korea DENTINAL Hypersensitivity - Etiology, Nature, Diagnosis and Treatment - Brought to you by an Educational Grant from Block Drug Company Inc., makers of Sensodyne® English ->Korean
GlaxoSmithKline Korea Paradontax Key messages presentation English ->Korean
GlaxoSmithKline Korea Paradontax Detailing presentation English ->Korean
GlaxoSmithKline Korea Parodontax – the product Module 2 - January 2007 English ->Korean
GlaxoSmithKline Korea Paradontax - Disease Background Module 1 - January 2007 English ->Korean
GlaxoSmithKline Korea GSK DD training: WSFE Approach for DD Presentation data - Prepared on 2 Jun 2007 English ->Korean
GlaxoSmithKline Korea GSK DD Training: 1st Module – Dental Industry 17 May 2007 English ->Korean
GlaxoSmithKline Korea Daily FOCUS - Approaching a PI Disaster: “Preparation for Survival” - Dr. Dirk Poelaert, Director of the Influenza Division at GSK Biologicals is explaining previous pandemic influenza outbreaks, such as that of Spanish Influenza. 23-Feb-07 Korean ->English
GlaxoSmithKline Korea The Hankyoreh 21 - Vaccinations turn out to be human trials - Clinical trials on children by the multinational pharmaceutical giant GlaxoSmithKline (GSK) in the Volgograd Railway Hospital in Russia revealed in court - 10-Apr-07 Korean ->English
GlaxoSmithKline Korea Medical mensuration & quantitative method data Korean ->English
GlaxoSmithKline Korea IJSFA Admin Training Contents, IJSFA Full Reference Guide, Welcome IJSFA Admin Training data (Total: 3 files 42,637 Eng. words) English ->Korean
GlaxoSmithKline Korea GlaxoSmithKline plc (GSK) Survey data English ->Korean
GlaxoSmithKline Korea GSK Policy Human Biological Samples Policy POL-GSK-410 FINAL 26 March 2008 English ->Korean
NOVARTIS
Company Project Language
NOVARTIS Novartis Pharma AG - Novartis Lung Canser Symposium 2017 - Novartis_Zykadia_Symosium.mp4 - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - THE BURDEN AND UNMET NEEDS IN PSORIASIS (PsO) - Clinical aspects of Cosentyx - Dr. Lorne Albrecht, MD, FRCPC Director, Enverus Medical Research, Surrey, Canada - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Novaetis Lecture video - Cosentyx's development journey, Gerard Bruin- English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Medipana News - Interleukin–17A inhibitor - Receiving Positive Reviews from Doctors - Very effective at treating inflammatory diseases such as psoriasis, psoriatic arthritis and ankylosing spondylitis - Proven efficacy and safety English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Ubiqus/Nation-Wide Reporting & Convention Coverage - prIME ONCOLOGY ESMO 2016 GI NETs - Capdevila - Video script translation English ->Korean video script translation
NOVARTIS Novartis Pharma AG - Ubiqus/Nation-Wide Reporting & Convention Coverage - prIME ONCOLOGY ESMO 2016 GI NETs - Pavel - Video script translation English ->Korean video script translation
NOVARTIS Novartis Pharma AG - Ubiqus/Nation-Wide Reporting & Convention Coverage - prIME ONCOLOGY ESMO 2016 GI NETs - Singh - Pavel - Video script translation English ->Korean video script translation
NOVARTIS Novartis Pharma AG - Ubiqus/Nation-Wide Reporting & Convention Coverage - prIME ONCOLOGY ESMO 2016 GI NETs - Singh - Pavel - Video script translation English ->Korean video script translation
NOVARTIS Novartis Pharma AG - Ubiqus/Nation-Wide Reporting & Convention Coverage - prIME ONCOLOGY ESMO 2016 GI NETs - Yao - Pavel - Video script translation English ->Korean video script translation
NOVARTIS Novartis Pharma AG - Acromegaly patients require individualized treatment options - Guidelines for the treatment of acromegaly - Signifor® LAR (pasireotide) - May 2015 English ->Korean
NOVARTIS Novartis Pharma AG - Novartis’ Commitment to Innovation for Patients With Pituitary Disorders -Sandostatin® LAR® (octreotide acetate for injectable suspension) - 2016 Novartis English ->Korean
NOVARTIS Novartis Pharma AG - Novartis Exelon Efficacy_PART 1_v10_FINAL - Alzheimer’s disease - English into Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Novartis Exelon Efficacy_PART 2_v08_FINAL.mp4 - Alzheimer’s disease -Exelon patch 10 - English into Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Novartis Exelon Efficacy_PART 3_v06_FINAL - Alzheimer’s disease -Exelon patch 15 - English into Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Exelon Tolerability_v08_FINAL - The Exelon transdermal patch is an important treatment option for patients with Alzheimer’s disease, offering many clinical advantages over conventional oral therapy. - English->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG -ESMO RCC Clinical Practice Guidelines_Upadated (2016)_mp4 - Virtual meeting from Novartis, Vasil - MC - Dr. Escudier, Speakers: Gustave Rousy, Tom Powles, Emiliano Calvo - English ->Korean video dictation & translation, Running time: 2 English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Dr. Mok: I'm Dr. Mok from the Chinese University of Hong Kong & Dr. Thanyanan from Thailand meeting - 7ALK+ NSCLC (as of 7 ALK+ NSCLC (as of 7-1.16) 360 - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma-Novartis Exelon Manufacturing_v08- Exelon's optimized patch composition and tightly designed manufacturing process ensures high quality products with precise levels of skin adhesion & drug release, as well as batch-to-batch reproducibility English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 1. Recent insights into the biology of RCC VEGFmTORc-MET pathways.avi - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 2. VEGFR-TKI therapy in aRCC selection and considerations.avi - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 3. The role of patient preference when choosing a VEGFR-TKI.avi - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 4. Adverse event management strategies for targeted aRCC therapies (1).avi - English ->Korean video dictation & translation English ->Korean
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 5. What can we do for peri‐surgical RCC patients, ~58;24.avi - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - EGM 7th Annual Core Symposium - 6. The evolving role for mTOR inhibitors in the treatment of aRCC1, ~35;57.avi - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Consortia, which are addressing questions of real-world treatment of mRCC- 001_1300_1730_DD2_SAT_part_001.wmv - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Adverse event management in RCC patients, Dr. Volkova - 002_1300_1730_DD2_SAT_part_002-FINAL.wmv - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Adverse event management in RCC patients, Dr. Volkova - 002_1300_1730_DD2_SAT_part_002-FINAL.wmv - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Talk about the first line treatment on mRCC - 003_EGM_845_1200_Part003_16;20~39;23.wmv - English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Healthy Body Healthy Mind - Dr. Scott McFarland- Cushing's disease is a rare disorder that has been around for hundreds of years, but it is just now beginning to be understood by the medical community. - E->K video dictation, transla English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Major funding for Healthy Body Healthy Mind has been provided by Amgen, a biotechnology company committed to providing novel therapeutics to address unmet medical needs in the treatment of cancer patients and by Novartis oncology. Dr. English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - IL-17 is a regulatory cytokine able to amplify the inflammatory reaction, both at the local and the systemic level. - Pierre Miossec, France English ->Korean video dictation & translation English ->Korean video dictation & translation
NOVARTIS Novartis Pharma AG - Information and Subject Consent as a Model Adult Patient of Protocol Korean ->English
NOVARTIS Novartis Pharma AG - Model patient information/informed consent form Study No. CSTI571B2404 additional data Korean ->English
NOVARTIS Novartis A.G. NVS generic e-mail, NVS portal: p_nvs English ->Korean
NOVARTIS Novartis A.G. NVS generic e-mail, NVS portal: p_nvs additional data English ->Korean
NOVARTIS Novartis Oncology Clinical Trial Protocol (Final) Protocol No. CICL670ATR01 - 08-Apr-2008 English ->Korean
NOVARTIS NOVARTIS PHARMA - Guidelines for the interpretation and implementation of NP4 - July 16th, 2008 English ->Korean
NOVARTIS NOVARTIS PHARMA - Principles & Practices for Professionals (NP4) - January 22nd, 2008 English ->Korean
NOVARTIS Novartis Pharma AG - Integrity & Compliance at Novartis English ->Korean
NOVARTIS Novartis International AG Novartis Global Communications MEDIA RELEASE - RAD001 more than doubles time without tumor growth after failure of standard treatment in patients with advanced kidney cancer - Basel, May 19, 2008 English ->Korean
NOVARTIS Novartis labor union member's letter Korean ->English
NOVARTIS Novartis - Constituents of Switzerland medicine and medical supplies - Alca-C, Alcacyl®, Alcacyl® 500 Instant - Powder Korean ->English
NOVARTIS Novartis Comtan Tablets 100mg - 末梢COMT阻害剤 -日本標準商品分類番号 - 871169 - 【組成・性状】, 【効能又は効果】, 【用法及び用量】, 【使用上の注意】, 【薬物動態】, 【臨床成績】, 【有効成分に関する理化学的知見】, 【包装】コムタン錠100mg:100錠(PTP)500錠(PTP)500錠(バラ) Japanese->Korean
NOVARTIS Investigators’ Meeting for Novartis to discuss the drug Exelon - Thailand, Bangkok - Simultaneous Interpretation services Korean ->English Interpreting
NOVARTIS Novartis Training Videos Script translation English ->Korean video script translation
NOVARTIS Novartis AG Website L10N &Novartis Compliance Training Sheet English ->Korean
NOVARTIS Novartis News Release English ->Korean
Pfizer Ltd.
Company Project Language
Pfizer Ltd. Pfizer The Blue Book - Summary of Pfizer Policies on Business Conduct English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/diflucanpi.html - Diflucan English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/ariceptpi.html - Aricept English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/viagrapi.html - Viagra English ->Korean
Pfizer Ltd. 1-1-02-03 (OneShot) H. Serum Potency Assay, 1-1-03-06 Calfguard, 1-1-14-01 (cattlemaster 4), H. Inactivation Confirmation Test, 1-2-02-03 (Respisure and Respisure One) F. Potency Test for Antigen and Antibody, 1-2-02-10 (Litterguard LTC) etc. Korean->English Proofreading
Pfizer Ltd. Pfizer.com/hml/pi's/zyrtecpi.html - Zyrtec English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/zithromaxpi.html - Zithromax English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/zoloftpi.html - Zoloft English ->Korean
Pfizer Ltd. Pfizer.com/hml/pi's/glucotrolpi.html - Glucotrol English ->Korean
Pfizer Ltd. MINISTÉRIO DA AGRICULTURA SECRETARIA NACIONAL DE DEFESA AGROPECUARIA PORTARIA Nº 190 DE 21 DE DEZEMBRO DE 1978 Portuguese->Korean
Pfizer Ltd. MINISTÉRIO DA AGRICULTURA, PECUÁRIA E ABASTECIMENTO GABINETE DO MINISTRO INSTRUÇÃO NORMATIVA Nº 7, DE 10 DE MARÇO DE 2006 Portuguese->Korean
Pfizer Ltd. FORT DODGE - SOP-PO.VI.134.02 Portuguese->Korean
Pfizer Ltd. Medicine and medical supplies training manual English ->Korean
Pfizer Ltd. FORT DODGE - SOP-IT.VI.110.00 Portuguese->Korean
Pfizer Ltd. FORT DODGE - SOP-PO.171 Portuguese->Korean
Pfizer Ltd. 1-1-02-03 (OneShot) H. Serum Potency Assay, 1-1-03-06 Calfguard, 1-1-14-01 (cattlemaster 4), H. Inactivation Confirmation Test, 1-2-02-03 (Respisure and Respisure One) F. Potency Test for Antigen and Antibody, 1-2-02-10 (Litterguard LTC) etc. Korean ->English
Pfizer Ltd. Pfizer.com/hml/pi's/cardurapi.html - Cardura English ->Korean
IBM
Company Project Language
IBM IBM Broadband data English->Korean
IBM Contract English->Korean
IBM Agreement English->Korean
IBM Financial data English->Korean
IBM Information Technology data English->Korean
IBM Information Technology articles English->Korean
IBM IBM Website L10N English->Korean
IBM Foundation agreement Korean ->English
IBM Foundation agreement Korean->English Proofreading
IBM Tivoil catalogue Japanese->Korean
IBM Consulting Firm Loses Control at USD$3-Million English ->Korean
IBM BEA User Survey Korean ->English
IBM BEA User Survey Korean->English Proofreading
IBM Contract and indemnification for damage Korean ->English
IBM Contract and indemnification for damage Korean->English Proofreading
IBM Financial data English->Korean
IBM IBM Cluster system English->Korean
IBM Sustainable growth through CSR White paper English->Korean
IBM Financial Management in Growth Planning English ->Korean
IBM AP sustainability management report Korean ->English
IBM AP sustainability management report Korean->English Proofreading
IBM IBM Lotus Symphony English->Korean
IBM Agreement for special project English->Korean
IBM Forms for Submission and Notice Korean ->English
IBM Forms for Submission and Notice Korean->English Proofreading
IBM Green computing era. Revolution of Hostway and role of CIO - video script Korean ->English
IBM IBM Rational AppScan Express Edition English->Korean
IBM Agreement for Special Projects – First of a Kind Project English->Korean
IBM IBM System Cluster 1350 FINAL English->Korean
IBM Agreement for Establishment of Samsung SDS- IBM Korea Korean ->English
IBM Agreement for Establishment of Samsung SDS- IBM Korea Korean->English Proofreading
IBM Case Study, Sparkassen Informatik’s New Enterprise Data Cente English->Korean
IBM IBM Chinese brochure Chinese->Korean
IBM Navigating toward net-centricity PoV English->Korean
IBM schedule-A application maintenance service Korean ->English
IBM schedule-A application maintenance service Korean->English Proofreading
IBM AP fusion confusion notebook English->Korean
IBM AP Fusion Confusion and WebSphere® [R]Evolution English->Korean
IBM RFP - New Pharmacy Integration System Implementation Project (Ilyang Pharmaceutical Co., Ltd.) Korean ->English
IBM RFP - New Pharmacy Integration System Implementation Project (Ilyang Pharmaceutical Co., Ltd.) Korean->English Proofreading
IBM build on blue 624 English->Korean
IBM IBM Global Business Services, Healthcare 2015 and care delivery English->Korean
IBM IBM Institute for Business Value DATA English->Korean
IBM IBM Dispatch service (Translators) Korean ->English dispatch service
IBM IBM Dispatch service (Translators) Korean ->English dispatch service
IBM 2441 IBM Information Infrastructure Overview - CARS - video script English->Korean
IBM 2441 IBM Information Infrastructure Overview - CARS - video script subtitling English->Korean subtitling
IBM Cognos performance buleprint 17 files English->Korean
IBM A leader in web 2.0 technologies English->Korean
IBM System x Enterprise Server Storyboard template English->Korean
IBM IBM software License compliance programme English->Korean
IBM IBM Business Partner Agreement English->Korean
IBM Cognos Now! FS and IBM Cognos 8 BI Analysis for Microsoft Excel® (13 files) English->Korean
IBM IBM Lotus Software: Green is the new business imperative—and IBM Lotus software can help. English ->Korean
IBM IBM Lotus Software: Typex Group fosters communication and collaboration inside and outside the organization with IBM Lotus software English ->Korean
IBM IBM Lotus Software: IBM Lotus Sametime software integration with Microsoft applications. English ->Korean
IBM IBM Lotus Software: Discover the IBM Lotus Notes and Lotus Domino software platform English ->Korean
IBM IBM Lotus Software: IBM Lotus Forms 3.5 and IBM Lotus Forms Turbo English ->Korean
IBM IBM Lotus Software: Taking team collaboration to the next level ...IBM Lotus Quickr software. English ->Korean
IBM IBM Rational Software: IBM Rational Requirements Composer English ->Korean
IBM The Business Partner Leadership Agenda(BPLA): Building a Smarter Planet Video translation & subtitling English ->Korean video translation
IBM IBM Rational Software: Improving Your Web Application Software Development Life Cycle’s Security Posture with IBM Rational AppScan English ->Korean
IBM IBM White Paper: The real truth about eDiscovery. - What they don’t teach you in law school English ->Korean
IBM Korea Bank CRM Landscape Korean->English Proofreading
IBM Korea Bank CRM Landscape Korean ->English
IBM Smarter Education Website L10N English ->Korean
IBM Education for a Smarter Planet White Paper: The Future of Learning English ->Korean
IBM IBM White Paper: Transforming performance management in an SAP environment - Considerations for Finance English ->Korean
IBM IBM White Paper: Seven S&OP Reports Every Manufacturing Executive Needs - Sales & operations planning excellence with IBM Cognos software English ->Korean
IBM Let’s Build a Smarter Planet: Telecommunications English ->Korean
IBM Let’s Build a Smarter Planet: Insurance English ->Korean
IBM Let’s Build A Smarter Planet: Government English ->Korean
IBM Let’s Build a Smarter Planet: Financial Services English ->Korean
IBM Let’s Build a Smarter Planet: Retail English ->Korean
IBM Customer Agreement Exhibit for zNALC License Charges & zNALC Annual Eligibility Certification Form English ->Korean
IBM IBM Agreement for Acquisition of Software Maintenance & IBM Customer Agreement English ->Korean
IBM Concept definition of forward and reverse e-Tax invoice issuing, and sender. Korean->English Proofreading
IBM Concept definition of forward and reverse e-Tax invoice issuing, and sender. Korean ->English
IBM Standard e-Tax Invoice (v3.0) Development Guide v1.0 - Korea Institute For Electronic Commerce Korean->English Proofreading
IBM Standard e-Tax Invoice (v3.0) Development Guide v1.0 - Korea Institute For Electronic Commerce Korean ->English
IBM How to issue an amended tax invoice under the e-Tax invoicing policy Korean->English Proofreading
IBM How to issue an amended tax invoice under the e-Tax invoicing policy Korean ->English
IBM Let’s Build a Smarter Planet: Oil and Gas English ->Korean
IBM Let’s Build a Smarter Planet: Energy and Utilities English ->Korean
IBM The IBM Cognos Statement of Direction - The next wave of IBM Cognos innovation English ->Korean
IBM IBM eCatalog 22 html files (May) Website L10N English ->Korean
IBM IBM Application Management Services helping to reduce the total cost of ownership English ->Korean
IBM IBM WebSphere Application Server Hypervisor Edition & IBM WebSphere CloudBurst Appliance English ->Korean
IBM The reality of living in a globally integrated world is upon us. English ->Korean
IBM IBM eCatalog 45 html files (June) Website L10N English ->Korean
IBM CSR Survey Business Byliner Final For Sustainability, Mind the Gap English ->Korean
IBM Information On Demand - Part 2 – Developing Your Information Agenda English ->Korean
IBM Information Agenda, Consistency amid the chaos: an enterprise approach to data integration. English ->Korean
IBM IBM BladeCenter and System x AMD Portfolio Storyboard English ->Korean
IBM IBM Comprehensive Data Protection Solution (CDPS) English ->Korean
IBM IBM KYI Business Partner Resources and Tools for Selling into the Midmarket Storyboard English ->Korean
IBM Express Seller Q2 Intel Increase Performance.Lower Costs 2 Product Full Page Ad - IBM SYSTEM X3650™ M2 EXPRESS English ->Korean
IBM Express Seller Q2 Intel Increase Performance, Lower Costs Fractional Print Ad. - IBM SYSTEM x3550™ M2 EXPRESS English ->Korean
IBM KYI Module 1 Discover IBM Express Seller Storyboard template English ->Korean
IBM IBM System x Single and Dual Socket Systems with Intel technology Storyboard English ->Korean
IBM NEW INTELLIGENCE data English ->Korean
IBM IT Funding and Financing: Strategies in a Changed World Event ID: 147375 English ->Korean
IBM CIO Program Sales Handbooks - Stop selling and start listening : 10 best practices for building relationships with CIOs English ->Korean
IBM IBM Lotus Software: IBM LotusLive™ Engage Security English ->Korean
IBM IBM Lotus Software: Need to reach more customers, more often and still provide quality customer service on a shrinking travel budget? We have your answer! English ->Korean
IBM IBM Lotus Software: With IBM LotusLive Meetings, online collaboration has never been easier or smarter. English ->Korean
IBM Cloud-based collaboration - A comparison of LotusLive Engage and Google Apps for Business English ->Korean
IBM IBM Lotus Software: Online collaboration solutions for the business world English ->Korean
IBM The Economics of Embedded Development, Testing, Deployment and Support - Embedded Market Forecasters English ->Korean
IBM Model-driven development White paper: Smarter system development: a systems engineering trade study to support green initiatives with model-driven development. English ->Korean
IBM Business Event Processing Use Case Results Summary English ->Korean
IBM HOSPITALITY CBM data English ->Korean
IBM eX4 Technologies - System x x3850 & x3950 M2 English ->Korean
IBM Federated SOA Connectivity – Integration Across the Enterprise English ->Korean
IBM Information Agenda Overview - • Information Management Software Solutions English ->Korean
IBM IBM Cognos Business Intelligence Competency Center Service - Accelerating your success English ->Korean
IBM IBM Cognos Business Intelligence Competency Center: Driving repeatable, sustainable, manageable deployment of IBM Cognos BI solutions English ->Korean
IBM You should’ve used Informix – it never crashes. Video script translation & subtitling English ->Korean video translation
IBM IBM u-Health - Virtual Exercise data Korean ->Chinese
IBM IBM u-Health - Virtual Exercise data Korean ->Japanese
IBM IBM u-Health - Virtual Exercise data Korean ->English
IBM COLLABORATIVE RESEARCH AGREEMENT English ->Korean
IBM Six + Six Reasons to Upgrade to IBM i 6.1 English ->Korean
IBM IBM eCatalog 10 html files (July) Website L10N English ->Korean
IBM IBM Smarter Planet Social Media Video translation & subtitling English ->Korean video translation
IBM An Alinean White Paper: Server Consolidation with IBM System x and BladeCenter Power by Intel® Xeon® Processors: Lowering Total Cost of Ownership English ->Korean
IBM CFO test & Successfully Selling to the CFO English ->Korean
IBM IBM Global Business Services(Strategy and Change) : The R-O-I of globally integrated operations English ->Korean
IBM Introducing the IBM Security Framework and IBM Security Blueprint to Realize Business-Driven Security English ->Korean
IBM GSS: Save the Deal Online Challenge - Save the deal: Situation English ->Korean
IBM Global Sales School: Save the Deal Call Taker Guide Version 2.1 English ->Korean
IBM Global Sales School: Feed the Pipeline Call Taker Guide Version 2.1 English ->Korean
IBM Feed the pipeline: Situation English ->Korean
IBM GSS: Develop a Winning Solution Online Challenge - Develop a winning solution: Situation English ->Korean
IBM GSS: Develop a Winning Proposal Online Challenge - Develop a winning proposal: Situation English ->Korean
IBM Global Sales School: Close the Deal Call Taker Guide Version 2.0 English ->Korean
IBM GSS: Close the Deal Online Challenge - Close the deal: Situation English ->Korean
IBM Working Smarter with Analytics. & IBM Smart Analytics System English ->Korean
IBM Quarter 3/2009 IBM SYSTEMS MAGAZINE, ASIA PACIFIC EDITION - Best practices to get the most out of your IBM i system English ->Korean
IBM Software Value Incentive - Business Partner Operations Guide Version 2.2.1 English ->Korean
IBM Transaction Agreement - Remarketer Special Bid Addendum & IBM Remarketer Special Bid Pricing Application English ->Korean
IBM IBM Business Park Relocation Project Contingency Plan for Saint-Gobain Korean->English Proofreading
IBM IBM Business Park Relocation Project Contingency Plan for Saint-Gobain Korean ->English
IBM Terms and conditions - IBM agreement for courses and education materials English ->Korean
IBM IBM Quote specifications Form English ->Korean
IBM 2009 IBM Inovation Forum: Leadership Forum for Sustainable Growth & Registration Form Korean->English Proofreading
IBM 2009 IBM Inovation Forum: Leadership Forum for Sustainable Growth & Registration Form Korean ->English
IBM IBM SMARTER PLANET TV Video dicatation, translation & subtitling English ->Korean video translation
IBM IBM Rational Performance Tester & IBM Rational Functional Tester English ->Korean
IBM Introduction to the IBM Global Asset Recovery Services (GARS) affinity program English ->Korean
IBM IBM World Wide Client Technology Centers: Best Practices Recommendations for Executive Solution Sellers English ->Korean
IBM Hyundai H&S LOL & indemnification_EN Korean->English Proofreading
IBM Hyundai H&S LOL & indemnification_EN Korean ->English
IBM HMCIB LOL & indemnification_EN Korean->English Proofreading
IBM HMCIB LOL & indemnification_EN Korean ->English
IBM ING Life Insurance Product Factory Presentation Korean->English Proofreading
IBM ING Life Insurance Product Factory Presentation Korean ->English
IBM IBM Global Technology Services: IBM Internet Security Systems™ X-Force® 2009 Mid-Year Trend and Risk Report English ->Korean
IBM IBM Global Business Services Executive Report (Government ) : A vision of smarter cities - How cities can lead the way into a prosperous and sustainable future English ->Korean
IBM Dear S-Oil CEO Subaey and chief executives Korean ->English
IBM IBM International Passport Advantage Agreement Special Terms Addendum English ->Korean
IBM AGENCY AGREEMENT (For Reseller) English ->Korean
IBM ANNOTATIONS, GUIDELINES AND ALTERNATE LANGUAGE For ELA Contracts English ->Korean
IBM RENTAL AGREEMENT & asset substitution Encumbrance English ->Korean
IBM IBM 2008 Corporate Responsibility Report English ->Korean
IBM Confidentiality Agreement Korean->English Proofreading
IBM Confidentiality Agreement Korean ->English
IBM IBM PartnerWorld : Put the power of IBM behind your business - Greater innovation. Sustained strength. Improved access to a world of opportunity. English ->Korean
IBM Business Partner References for Midsize Businesses - Let’s build a Smarter Planet together. English ->Korean
IBM IBM PartnerWorld Program Guide: Put the power of IBM behind your business - Greater innovation. Sustained strength. Improved access to a world of opportunity. English ->Korean
IBM JumpStart Your Business Now! - external landing page English ->Korean
IBM Riding the Next Wave of Enterprise Consolidation - PowerVM Lx86 provides the capability for cross-platform virtualization English ->Korean
IBM New Intelligence Video Script AP translation & subtitling English ->Korean video translation
IBM Service Management is a $150-200B cross-IBM opportunity for HW, SW, and Services with double-digit growth rate. English ->Korean
IBM Request for Proposal: E-Mart Mall Re-development Project Korean->English Proofreading
IBM Request for Proposal: E-Mart Mall Re-development Project Korean ->English
IBM IBM MCIF for CIO Forum data English ->Korean
IBM IBM White Paper: IBM XIV® Storage System - Ideal Storage for the New Media Era English ->Korean
IBM IBM White Paper: IBM XIV® Storage System: Thin Provisioning Reinvented English ->Korean
IBM IBM White Paper: IBM XIV® Storage System - Snapshots Reinvented English ->Korean
IBM Case Reference #3 - VCUHS: IBM XIV Storage System helps lower patient risk at Virginia Commonwealth University Health System (VCUHS) English ->Korean
IBM Case Reference #1 _Gerber: Making the case for migration: Gerber Scientific selects IBM XIV Storage System for its SAP production environment English ->Korean
IBM IBM XIV Landing page, IIBM XIIV® Storage System: Optimizing Enterprise Storage Total Cost of Ownership (TCO) with IBM XIV English ->Korean
IBM [Stories behind DI specialty elite partners] Partner name: Computer Solution Technology & Personal Stories behind DI Practicum: Company: Unipoint Korean->English Proofreading
IBM [Stories behind DI specialty elite partners] Partner name: Computer Solution Technology & Personal Stories behind DI Practicum: Company: Unipoint Korean ->English
IBM Application Resources properties.txt English ->Korean
IBM ILOG Brochure 5 files translation English ->Korean
IBM 2660_A IBM Dynamic Infrastructure Launch Convergence of Business & IT VO Animation As Produced Transcript Video translation & subtitling English ->Korean video translation
IBM About Express Advantage page Copy Deck English ->Korean
IBM Coca Cola Bottling swaps out Oracle for DB2 English ->Korean
IBM IBM System z10™ Mainframe, HP Integrity, No Contest! English ->Korean
IBM IBM Case Study: The Department of the Interior’s National Business Center ― Using System z as a Strategic Enterprise Cloud Platform English ->Korean
IBM INTEGRATION SYSTEMS, INC: The z10 is Not Your Father’s Mainframe English ->Korean
IBM Part 2. The Age of Global Competition, the New Paradigm of the Knowledge-Based Society (SMART WORK) & Session 3, New Opportunity of ‘Green’ Era, Green & Beyond (25 minutes) Korean ->English
IBM Part 1. New Intelligence, analysis and prediction of valuable information (25 min) & Dynamic Infrastructure – Talking Points Korean ->English
IBM IBM eCatalog 11 html files (Semtember) Website L10N English ->Korean
IBM There’s the other way to manage storage. Then there’s the IBM way. English ->Korean
IBM Exhibit B Responsibility for Service and Support HMCIB EN Korean->English Proofreading
IBM Exhibit B Responsibility for Service and Support HMCIB EN Korean ->English
IBM State of Wyoming saves by having IT service cost information at their fingertips English ->Korean
IBM IBM Application management solutions White Paper : Quickly isolate, diagnose and fix transaction performance problems within your business-critical applications. English ->Korean
IBM Public Sector IT Organization boosts productivity, improves services with IBM Tivoli Usage Accounting Manager English ->Korean
IBM Leading manufacturer improves manufacturing efficiency and IT productivity by leveraging IBM Tivoli® solutions English ->Korean
IBM IBM Tivoli Software: Know what IT costs - IT Resource Allocation - Accounting and Chargeback Tivoli Usage and Accounting Manager (ITUAM) English ->Korean
IBM Improving Operational Efficiency with a Strategic Approach to Enterprise Management Tools Acquisitions English ->Korean
IBM IBM Tivoli Software: Implement an energy dashboard to communicate performance and deliver operational insight English ->Korean
IBM IDC White Paper: Profitability and OSS Support: A Return on Investment Analysis of IBM Tivoli Netcool English ->Korean
IBM IBM Tivoli Software: IBM reduces costs of its mainframe environment with service management initiative English ->Korean
IBM IBM Tivoli Software: Bryant University aligns energy usage with server workloads to reduce energy costs by 15 percent English ->Korean
IBM British-based financial services group automates job scheduling with IBM Tivoli® Workload Scheduler English ->Korean
IBM IBM service management solutions White paper: IBM Service Management for the Intelligent Utility Network. English ->Korean
IBM Print AD copy & BANNER copy English ->Korean
IBM R-HEROES EPISODE : RATIONAL REQUIREMENTS COMPOSER DRAFT V 3 – FINAL Video dictation & subtitling English ->Korean
IBM Proposal for IBM Telecom Expenses Management (TEM) Project Proposal to < > & IBM Telecom Expense Management Services - assessment English ->Korean
IBM CIO Leadership Exchange in Barcelona, Spain on March 9-10, 2010 Invitation Letter English ->Korean
IBM WW Q4 2009 Intel “Reduce Costs” English ->Korean
IBM Why Dow Jones Picked DB2 - Video dictation, translation & subtitling English ->Korean video translation
IBM Manufacturing Integration Framework - Assembling custom fit solutions with IBM industry frameworks and products English ->Korean
IBM IBM Global Business Services White Paper(Strategy & Transformation) : Unlocking the value of an integrated fraud strategy English ->Korean
IBM IBM banking solutions: IBM Banking Industry Framework for integrated risk management: Manage your risks for improved financial performance English ->Korean
IBM IBM worked with our RND labs around the world and our services team in Korea to help SK Telecom build a workload optimized, service management enabled deliver platform for cloud computing. Video dictation and translation English ->Korean video translation
IBM IBM Global Business Services: Extending the life of your existing data centers. - Smart execution helps IBM Lexington data center double IT capacity in the same footprint English ->Korean
IBM IBM Global Business Services Executive Report (Strategy and Change) :IBM – Delivering performance through continuous transformation English ->Korean
IBM The instance when Hyundai Swiss Bank’s Integrated Management Information System (MIS) infrastructure converted to the IBM System z from SUN Fire 6800, 280R, and 220R. Korean ->English
IBM IBM’s Strategy for Dynamic Infrastructure - Delivering superior business and IT services with agility and speed English ->Korean
IBM IBM WebSphere Software: Business agility now: establishing a dynamic business network through highly agile, interconnected processes. English ->Korean
IBM IBM WebSphere Software: Business agility now: working smarter through dynamic business networks and highly agile processes. English ->Korean
IBM Global presentation deck for working smarter – READ THIS FIRST English ->Korean
IBM Smarter Planet TVC Video dictation, translation & subtitling English ->Korean video translation
IBM IBM Global Business Services:Extending the life of your existing data centers. - Smart execution helps IBMLexington data center double IT capacity in the same footprint English ->Korean
IBM bridging business and technology skill English ->Korean
IBM Lina TM Project Korean->English Proofreading
IBM Lina TM Project Korean ->English
IBM IBM Global Business Services(Insurance) :Balancing the scales - Toward a stable and dynamic insurance future English ->Korean
IBM IBM Cognos Performance Events - Better Intelligence. Better Business. English ->Korean
IBM Migration Advisor Installation Guide, Migration Advisor User’s Guide - For Super-users & Migration Advisor Usage Scenario Korean->English Proofreading
IBM Migration Advisor Installation Guide, Migration Advisor User’s Guide - For Super-users & Migration Advisor Usage Scenario Korean ->English
IBM IBM Tivoli Unified Process (ITUP) - Control Batch Operations English ->Korean
IBM IBM eCatalog 11 html files (August) Website L10N English ->Korean
IBM IBM eCatalog 25 html files (October) Website L10N English ->Korean
IBM Deliver Robust Product, Rational software can help you, Enterprise modernization, Help ensure Web site security and compliance & Services 5 html files Website L10N English ->Korean
IBM IBM CREDIT LLC - DEFERRED PAYMENT PLAN AGREEMENT English ->Korean
IBM Statement of Work for IBM as Subcontractor for Services English ->Korean
IBM SK Telecom Customer Information & SK Telecom’s recent development of a cloud computing platform Korean->English Proofreading
IBM SK Telecom Customer Information & SK Telecom’s recent development of a cloud computing platform Korean ->English
IBM IBM Global Business Services Executive Report : The path forward - New models for customer-focused leadership The 2009 Global CRM Leaders Study English ->Korean
IBM BTM Presentation for IBM Business : Business Agility Now! – keynote presentation English ->Korean
IBM BTM Presentation for IBM Business : The Art & Science of Business Agility: By Converging Business and Technology Management English ->Korean
IBM GBS “Door Openers” - Compelling offerings to create and starburst opportunity in the new economy English ->Korean
IBM Agreement for Modification of IBM Lease Contract Korean->English Proofreading
IBM Agreement for Modification of IBM Lease Contract Korean ->English
IBM Written Oath - NS Home Shopping New Personnel / Finance System Project Korean->English Proofreading
IBM Written Oath - NS Home Shopping New Personnel / Finance System Project Korean ->English
IBM New Intelligence Overview: Discover a new kind of intelligence through an information-led transformation 5 html files Wesite L10N English ->Korean
IBM IBM Poughkeepsie Green Data Center showcases a Dynamic Infrastructure By Elisabe th Stahl English ->Korean
IBM The scope of the project described in this Appendix B-1. Disaster Recovery Service (hereinafter “Statement of Work (SOW)”) is as follows. Korean->English Proofreading
IBM The scope of the project described in this Appendix B-1. Disaster Recovery Service (hereinafter “Statement of Work (SOW)”) is as follows. Korean ->English
IBM IBM DB2 pureScale: Unlimited capacity with continuous availability English ->Korean
IBM Renew your IBM Software Subscription and Support today! & 4 html files Website L10N English ->Korean
IBM Workforce & Talent Healthcheck, GIE Opportunity Assessment, IT Strategy & Performance Assessment, Enterprise Asset Management - BVA & Supply Chain Rapid ROI English ->Korean
IBM Cognos Application Healthcheck, Fraud & Abuse Diagnostic, Cash Optimization Assessment & Strategic Profit Improvement English ->Korean
IBM Application Portfolio Assessment, Information Security Assessment, Intial Testing Assessment & Business Analytics and Optimization Jumpstart English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Telecommunications Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Retail Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Midsize Organization Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Media and Entertainment Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Life Sciences Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Insurance Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Healthcare Providers Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Global Government Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Energy and Utilities Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Electronics Industry Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Consumer Products Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Chemicals and Petroleum Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Banking and Financial Markets Executive Summary English ->Korean
IBM The New Voice of the CIO: Insights from the Global Chief Information Officer Study - Preview of Automotive Industry Executive Summary English ->Korean
IBM Status of Cloud Computing and Promotion of an Efficient IT Infrastructure Korean->English Proofreading
IBM Status of Cloud Computing and Promotion of an Efficient IT Infrastructure Korean ->English
IBM "Virtualization without limits" Video dictation, translation & subtitling English ->Korean video translation
IBM Migration Services for Oracle to DB2 for SAP English ->Korean
IBM Customer SAP Instance Migration English ->Korean
IBM IBM Information on Demand Infrastructure Services – Data Management : Education Module for Opportunity Owners English ->Korean
IBM Information Infrastructure Overview English ->Korean
IBM Pepco Holdings, Inc. - Intelligent Utility Network (IUN) makes smart sense for utility company English ->Korean
IBM Smarter Collaboration is about HOW people work Work Smarter English ->Korean
IBM UC + Social Networking = Big Business Value! Video translation English ->Korean video translation
IBM Taking Communications & Collaboration to the Next Level...in the Context of Business Processes Video translation English ->Korean video translation
IBM IBM Lotus Sametime software demo Video translation English ->Korean video translation
IBM IBM Lotus® Forms® White Paper: “Politics without Principle, Education without Character, Science without Humanity and Commerce without Morality are not only useless, but positively dangerous” English ->Korean
IBM IBM WebSphere Portal 6.1 Demo script Video translation English ->Korean video translation
IBM Empowering people: IBM Employee Self-service Demo Video translaiton English ->Korean video translation
IBM IBM Lotus Software White Paper: Automate your business processes with flexible forms, portals and process-based solutions from IBM. English ->Korean
IBM LG Display - MDW To-BE Architecture Directional Evaluation -Technology Architecture- Korean->English Proofreading
IBM LG Display - MDW To-BE Architecture Directional Evaluation -Technology Architecture- Korean ->English
IBM IBM-SK Telecom “Cloud Computing Platform” Building Project Korean->English Proofreading
IBM IBM-SK Telecom “Cloud Computing Platform” Building Project Korean ->English Video translaion
IBM S&S Newsletter Article : IBM Software Subscription and Support: Helping “Insure” Your Success English ->Korean
IBM IBM Rational Insight - Make better decisions with deeper insight into your organization English ->Korean
IBM IBM Rational DOORS software - Meet customer needs and business objectives with IBM Rational DOORS software English ->Korean
IBM The IBM Rational System Architect solution. - Actionable Enterprise Architecture English ->Korean
IBM Self-Assessment tool – screen shots translation English ->Korean
IBM IBM eCatalog 11 html files (December) Website L10N English ->Korean
IBM S&S Newsletter Article : IBM Software Subscription and Support: Helping “Insure” Your Success English ->Korean
IBM IBM System x and BladeCenter eX5 NDA Customer Presentation English ->Korean
IBM What is eX5 English ->Korean
IBM Rational Software Platform for Systems English ->Korean
IBM Measured Capability Improvement Framework (MCIF) English ->Korean
IBM Enterprise architecture management (EAM) connects the business and technology needs of an organization into a cohesive and dynamic blueprint, providing key capabilities for managing the impact of business-driven change. English ->Korean
IBM GTS for General Business - AP Mid Market Offerings Enablement - Korea English ->Korean
IBM Smarter cities Shanghai Attendee invitation English ->Korean
IBM USED EQUIPMENT PURCHASE AGREEMENT English ->Korean
IBM DI - GMU Sales Program Draft v.1.6(Korea, DI Scenarios & GMU Dynamic Infrastructure Sales Launch V3 English ->Korean
IBM 2841 IBM Information-Led Transformation Video translatiion & subtitling English ->Korean video translation
IBM InfoSphere Warehouse Developer Edition English ->Korean
IBM Highlights, Fast ROl & Tech topics Website L10N English ->Korean
IBM ACCEPTANCE LETTER - Smarter Cities Shanghai, China / Version 3: Standard Package, Invitee Manager Signature English ->Korean
IBM IMPACT 2010 Web Transation & IMPACT2010 Top 5 English ->Korean
IBM Webcast IBM Rational Event ID: 165501 English ->Korean
IBM eBook - Smart Work in Action – Customer Stories English ->Korean
IBM HP Pre-call Education, HP Competitive Call Guide (First Call) & HP Competitive Call Guide (Second Call) English ->Korean
IBM HP-Itanium Competitive Campaign - “Why IBM Power” Your IT provider should move you forward. Not hold you back. English ->Korean
IBM Mad Science: Micro-Forecasting & Mad Science: Smart Grid Video dictation, translation & subtitling English ->Korean video translation
IBM SPSS predictive analytics software and solutions English ->Korean
IBM Smarter Insurance Processes in 2010 - Streamline Insurance Processes with Business Rules English ->Korean
IBM Smarter Healthcare Processes in 2010 - Healthcare Revitalized Reduce Costs, Increase Productivity, Deliver Best Outcomes with IBM ILOG Business Rule Management System (BRMS) and Optimization Software English ->Korean
IBM Smarter State Government Processes in 2010 - Delivery and Reducing Costs with IBM WebSphere® ILOG Business Rule Management System (BRMS) Technology English ->Korean
IBM Smarter Banking Processes in 2010 - Shrink Costs, Build Profitability and Respond Dynamically with Business Rules in Banking English ->Korean
IBM eSN Special Report - Cloud Computing ... English ->Korean
IBM Now is a fantastic time to be an IBM business partner. Video script translation English ->Korean video translation
IBM IBM's approach to company-building and brand-building. English ->Korean
IBM Tivoli Software solutions: Addressing today's challenges and tomorrow's opportunities. English ->Korean
IBM IBM Systems Magazine Q110 Cover Story - Turning up the Power English ->Korean
IBM IBM Cognos® Express is the first and only integrated business intelligence (BI) and planning solution purpose-built to meet the needs of midsize companies. English ->Korean
IBM IBM Portable Modular Data Center Overview - IBM Site and Facilities Services English ->Korean
IBM A Mandate for Smart Work Website L10N English ->Korean
IBM IBM Global Business Services Executive Report (Business Analytics and Optimization) :Breaking away with business analytics and optimization - New intelligence meets enterprise operations English ->Korean
IBM Pathways to New Intelligence: Pursuing an information-led transformation English ->Korean
IBM IBM Global Business Services Executive Report : Breaking away with business analytics and optimization - New intelligence meets enterprise operations English ->Korean
IBM IBM Power Systems Facts and Features POWER7 Servers English ->Korean
IBM IBM Power Systems : Capacity on demand User’s Guide English ->Korean
IBM IBM® Systems Director Overview - Systems Software leadership for innovation English ->Korean
IBM IBM Power Systems Qs and As - Announcement Overview English ->Korean
IBM IBM Power Systems Announcement Overview - POWER7 technology – greater performance, virtualization without limits, intelligent systems software English ->Korean
IBM Power your planet - Smarter systems for a smarter planet English ->Korean
IBM A Comparison of PowerVM and x86-Based Virtualization Performance English ->Korean
IBM MadScience SmartWater Transcript Video translation & subtitling English ->Korean video translation
IBM IBM eCatalog 5 html files (January) Website L10N English ->Korean
IBM ILOG Prospecting Guidance by Industry English ->Korean
IBM IBM Global Technology Services Data Sheet(Customer Relationship Management) : Gain insight into how well you are serving your key users across channels and determine how to improve the quality of your brand experience English ->Korean
IBM IBM Global Technology Services Data Sheet(Application Services) : Leverage your enterprise architecture to successfully achieve your business strategy, goals, and needs - IBM Enterprise Architecture Assessment English ->Korean
IBM IBM Global Technology Services Data Sheet(Business Analytics & Optimization) : Smarter Decisions for Optimized Performance - Business Analytics and Optimization Jumpstart English ->Korean
IBM Microsoft Master broadband, SAP Master broadband, VMware Master broadband Video translation English ->Korean
IBM IBM System x Business, IBM System x and BladeCenter, IBM System x High Volume Servers and Options Video script translation English ->Korean video translation
IBM Would you like to take a trip down to IBM Business Park? Video script translation and subtitling Korean->English Proofreading
IBM Would you like to take a trip down to IBM Business Park? Video script translation and subtitling Korean ->English Video translaion
IBM Power your planet with smarter systems. & System x Launch email & LP text copy English ->Korean
IBM IBM Global Business Services Executive Report: Fit, focused and ready to fight How banks can get in shape for the battle ahead English ->Korean
IBM Key Themes Driving Strategy in 2010 English ->Korean
IBM Achieve predictability in desired business outcomes through requirements-driven quality. - Requirement-driven quality solutions To support your business objectives English ->Korean
IBM IBM Case Study QuickView: New Zealand healthcare provider improves software development process with the help of IBM Rational software English ->Korean
IBM IBM White paper: Build your bottom line: Drive innovation with a collaborative requirements-driven quality solution. English ->Korean
IBM Innovate2010 The Rational Software Conference English ->Korean
IBM IBM Global Business Services Government: Intelligent transport - How cities can improve mobility English ->Korean
IBM Oracle Acquisition of Sun FAQ English ->Korean
IBM The State of Work Today: Survey Findings on Working Smarter English ->Korean
IBM Work Faster, Work Better, Work Smarter - Building agile, collaborative, and connected business environments English ->Korean
IBM Increasing Sales, Improving Efficiency, Working Smarter in Retail. - The new science of selling, from supply chain to point of sale and beyond English ->Korean
IBM Increasing Efficiency, Improving Outcomes and Working Smarter in Healthcare. - Connecting patients, healthcare organizations and the information they need English ->Korean
IBM Smarter Planet Solutions and Messaging Guide English ->Korean
IBM IBM Rational AppScan Source Edition - Reducing overall organizational risk English ->Korean
IBM IBM Rational Rhapsody Developer - Improving software delivery with a model-driven development environment English ->Korean
IBM IBM Express Remote Managed Infrastructure Services Video script translation & subtitling English ->Korean video translation
IBM IBM Security Solutions: IBM X-Force Threat Insight Quarterly English ->Korean
IBM Managing Risk_for Seller Newsletter - Managing Risk” Customer Presentation English ->Korean
IBM Asset and service management solutions to manage federal government assets. - Solutions for federal government agencies and contractors To support your business objectives English ->Korean
IBM IBMTivoli Foundations Service Manager - Improve your service support through a service desk that is operational in hours English ->Korean
IBM IBMTivoli Foundations Application Manager - Manage and monitor your infrastructure within a click of a button English ->Korean
IBM What is an Industry Framework ? English ->Korean
IBM Butler Group VIEW. TECHNOLOGY AUDIT - IBM Rational Software Delivery Platform English ->Korean
IBM The IBM Rational Jazz Strategy for Collaborative Application Lifecycle Management English ->Korean
IBM JK Enterprises Video script translation & subtitling English ->Korean video translation
IBM IBM Rational Software Analyzer, Version 7.0.1 - Centralize and automate defect identification earlier in the development lifecycle English ->Korean
IBM IBM Rational Application Developer for WebSphere Software, Version 7.5 English ->Korean
IBM IBM WebSphere Message Broker, Version 7.0 - Fast and flexible access to business information anywhere with universal integration English ->Korean
IBM IBM WebSphere Enterprise Service Bus, Version 7.0 - Increase agility and optimize cost by untangling costly and debilitating IT complexity English ->Korean
IBM IBM WebSphere and POWER7: Powering performance for Smarter Planet Solutions English ->Korean
IBM IBM Growth Markets Software Industry Solutions Portfolio English ->Korean
IBM Three ways to go further with business analytics & Optimizing with Information Governance Website L10N English ->Korean
IBM IBM® WebSphere® Application Server Migration Toolkit English ->Korean
IBM DBS Communications Case Study: Optim™ Oracle® E-Business Suite Solution English ->Korean
IBM IBM Case Study: British Telecom takes control of Amdocs CRM data growth to maintain service level agreements. English ->Korean
IBM IBM Case Study: Vodafone Spain supports expansive business and marketing initiatives by managing Amdocs CRM data growth. English ->Korean
IBM IBM Case Study: Finlay archives GEMS application data to improve performance and service levels. English ->Korean
IBM Eagle Family Foods, Inc. Case Study: Optim™ PeopleSoft® Enterprise Solution English ->Korean
IBM Discovery Health Case Study: Princeton Softech Optim™ English ->Korean
IBM CIGNA Healthcare Corporation Case Study: A major US health insurance company is now better equipped to protect sensitive data for compliance with HIPAA requirements with the implementation of an IBM Optim software solution English ->Korean
IBM Chivas Brothers Case Study: Optim™ PeopleSoft® Enterprise Solutiton English ->Korean
IBM RCI Banque - POSITIONED FOR BUSINESS GROWTH English ->Korean
IBM Massachusetts Mutual Life Insurance Company English ->Korean
IBM MAIF - INFORMATION SYSTEM SUPPORTS INSURANCE OPERATIONS English ->Korean
IBM IBM Case Study: Cetelem enhances test data management processes to support worldwide business operations. English ->Korean
IBM IBM Case Study: Arek Oy deploys IBM Optim to deliver one of the largest J2EE-based information management systems in Finland. English ->Korean
IBM Clarica - BUSINESS GROWTH EXPANDS APPLICATION REQUIREMENTS English ->Korean
IBM lToronto-Dominion Bank English ->Korean
IBM IBM Case Study : Safeco improves PeopleSoft application performance and supports business continuity with archiving. English ->Korean
IBM Independence Blue Cross, Discovery Health & First Health Services Corporation archives health claim data to control data growth and lower costs. English ->Korean
IBM IBM Case Study : Allianz Seguros, Barcelona, implements Optim to improve the delivery of new insurance products and services. English ->Korean
IBM Data Matters TV Video translation & subtitling English ->Korean video translation
IBM IBP Animation Video dictation, translation & subtitling Korean ->English Video translaion
IBM Mark's Work Wearhouse.wmv & Moosejaw short.mpg Video translation & subtitling English ->Korean video translation
IBM Cardiff Excerpts, Moosejaw short transcript & SBI Sumishin Net Bank Video translation & subtitling English ->Korean video translation
IBM 2768_N Marks Work Wearhouse CR As Produced Transcript & Cardiff Excerpts Video translation & subtitling English ->Korean video translation
IBM 2768_F IBM Smarter Planet Customer Reference Queensland Motorways LTD. & G Bharti transcript translaiton & subtitling English ->Korean video translation
IBM 2388D ATLAS AIR CUSTOMER REFERENCE AS PRODUCED TRANSCRIPT & 1-800-Flowers.com As Produced Transcript Video translation & subtitling English ->Korean video translation
IBM 2010 Smarter Insurance Study – Terms & Conditions of Participation & IBM Benchmarking : IBM SURVEY Participation English ->Korean
IBM CFO videos: Finance efficiency and business insight are more than just buzzwords. Watch interviews with top CFOs around the globe pertaining to lessons learned and essential study findings. English ->Korean
IBM Finance’s Role in Managing Risk & Delivering Financial Data Promptly Video translation & subtitling English ->Korean video translation
IBM Business Analytics: Keeping Your Company Well Informed & CFOs Need to Understand How the Business Ticks Video translation and subtitling English ->Korean
IBM IBM Information Agenda Solutions Overview: Major multi-national financial institution leverages Information Agenda to improve customer service, boost revenues, manage risk and lower costs. English ->Korean
IBM IBM Case Study: IBM and Neocol eDiscovery and email archiving solution enables Toyota Financial Services to have immediate access to critical information English ->Korean
IBM IBM Security Solutions X-Force® 2009 Trend and Risk Report: Annual Review of 2009 English ->Korean
IBM Discovery Workshops, Structured Solution Development in a 2 day Package & SFMI Loan Business BRMS Discovery Workshop Itinerary English ->Korean
IBM MadScience SmartWater Video translation & subtitling English ->Korean video translation
IBM MANAGING SALES AND DELIVERY CONFERENCE - Event Video Transcript: Smarter Planet: Health animation Video translation & subtitling English ->Korean video translation
IBM We know we’ve fostered eminence when… & 10 Bold Plays for Sales Eminence English ->Korean
IBM Sales Eminence: From Initiative to Transformation English ->Korean
IBM G1K VISION & 2010 G1K PRIORITIES Korean->English Proofreading
IBM G1K VISION & 2010 G1K PRIORITIES Korean ->English
IBM Short Proposal on Grow Your Power Base with HP/Sun/Dell x86 Consolidation on Power Large Enterprises English ->Korean
IBM IBM Power 750 Express server 09 February 2010 announcement English ->Korean
IBM "Value One" -- Dedication to every client's success -- is, of course, nothing new to IBM. In fact, the IBM tradition of superior customer service is legendary English ->Korean
IBM IBM Global Technology Services: Weathering the storm: IT challenges and opportunities during an economic downturn. English ->Korean
IBM Years with TUX data & Optimize BI English ->Korean
IBM http://www.ibmsystemsmagmainframedigital.com/nxtbooks/ibmsystemsmag/mainframe_20100304 Website L10N English ->Korean
IBM IT Market Strategy: Data Growth Challenges Demand Proactive Data Management English ->Korean
IBM Integrated Data Management Solutions - Closing the data privacy gap: Protecting sensitive data in non-production environments English ->Korean
IBM IBM Customer Agreement - Attachment for IBM System z Midrange Workload License Charges English ->Korean
IBM IBM Customer Agreement - IBM System z Midrange Workload License Charges Exhibit English ->Korean
IBM IBM Data Sheet: IBM Cognos Express - Essential BI and planning for midsize companies English ->Korean
IBM SOFTWARE VALUE INCENTIVE - Budget Authority Need Timeframe (BANT) Criteria Template v6.0 English ->Korean
IBM InfoSphere Foundation Tools & Solving Information Infrastructure Challenges With IBM InfoSphere Software English ->Korean
IBM IBM InfoSphere Global Name Recognition & IBM Smart Analytics System English ->Korean
IBM Guardium provides the simplest, most robust solution for safeguarding your entire application and database infrastructure English ->Korean
IBM Data and Process Models for Your Industry English ->Korean
IBM Cloud Computing and IBM InfoSphere Information Server English ->Korean
IBM IBM Data Sheet: IBM Cognos Go! Mobile - Business intelligence on the belt English ->Korean
IBM Why Data Matters: Extracting Insights, Making Better Decisions - Video script translation & subtitling English ->Korean video translation
IBM IBM Commercial: Intelligent Data Management and Analysis For A Smarter Planet & IBM Commercial: Making Sense of Data On A Smarter Planet Video script translation & subtitling English ->Korean video translation
IBM IBM Commercial: A Smarter Planet Relies On Data Analysis & IBM Commercial: Identifying Patterns in Data Reveals Insights into the Future - Video script translation & subtitling English ->Korean video translation
IBM MANAGING SALES AND DELIVERY CONFERENCE - Event Video Transcript: Smarter Planet: Health animation / Video translation & subtitling English ->Korean video translation
IBM The IBM software team is excited about the new eX5 Systems. - Video translation & subtitling English ->Korean video translation
IBM IBM eCatalog 14 html files (February) Website L10N English ->Korean
IBM IBM InfoSphere Streams enables continuous and extremely fast analysis of massive volumes of information-in-motion to help improve business insights and decision making. English ->Korean
IBM IBM Tivoli Storage Manager - Leverage next-generation data storage and unified recovery management capabilities English ->Korean
IBM IBM Data Reduction Solutions - Manage More Data with Less Infrastructure English ->Korean
IBM IBM_X3850M2_CUSTOMER_PRES_033109/Selling 5.5 High End Value English ->Korean
IBM IBM_X3850M2_CUSTOMER_PRES_033109/Selling 5.5 High End Value English ->Korean
IBM Next wave of Enerprise consolidation English ->Korean
IBM Government guideline to purchase Security Product & Standards and Procedures for the Introduction of Information Protection Products for Governmental or Public institutions Korean->English Proofreading
IBM Government guideline to purchase Security Product & Standards and Procedures for the Introduction of Information Protection Products for Governmental or Public institutions Korean ->English
IBM IBM White Paper: Top ten reports every insurance executive needs : - Executive insight with IBM Cognos software English ->Korean
IBM IBM White Paper: Insurance performance management: - Four ways to win with IBM Cognos software English ->Korean
IBM IBM White Paper: Better planning for insurance companies - Technology and best practices for profitability management English ->Korean
IBM Smartwork Videos & A New Way of Working English ->Korean
IBM Request for Proposal (RFP) for Establishing the Enterprise Cloud Strategy and the Implementation Plan - KT ITEC TFT (provisional) Korean->English Proofreading
IBM Request for Proposal (RFP) for Establishing the Enterprise Cloud Strategy and the Implementation Plan - KT ITEC TFT (provisional) Korean ->English
IBM IBM Social Computing Guidelines English ->Korean
IBM IBM 2010 Global Technology Outlook Booklet English ->Korean
IBM Dear valued customers: Greetings! Korean ->English
IBM Speakers’ Profile English ->Korean
IBM Smart Work Advisor - Questions that visitors answer to customize the content English ->Korean
IBM Delivering Smarter Commerce & IBM WebSphere Commerce V7.0 Sales Kit English ->Korean
IBM MBPS Website L10N English ->Korean
IBM IBM Managed Business Process Services - Increase business value with outsourcing that combines process, people and technology English ->Korean
IBM Smart spending: a new approach that can help you optimize your procurement spend English ->Korean
IBM Magic Quadrant for Comprehensive HR BPO English ->Korean
IBM IBM Managed Business Process Services – Finance and Administration - Gain more than operational savings with a proven, self-paced approach to F&A process optimization English ->Korean
IBM Speeding the path to financial resiliency: Why leading CFOs view business process outsourcing as a means to success English ->Korean
IBM IBM Analytics Business Process Services for customer management English ->Korean
IBM Managed Business Process Services: Speeding the path to financial resiliency: Why leading CFOs view business process outsourcing as a means to success English ->Korean
IBM IBM Global Technology Services Data Sheet: IBM Business Process Services for Technicaland Product Support English ->Korean
IBM IBM Global Technology Services Data Sheet(Managed Business Process Services) : IBM Business Process Services for Technica land Product Support English ->Korean
IBM How outsourcing Finance and Administration processes can enable English ->Korean
IBM Finance Healthcheck (S&T – FM) English ->Korean
IBM Insurance Core System Transformation BVA English ->Korean
IBM Allianz How to Cost Optimize for Sustainable & Profitable Growth English ->Korean
IBM Enhancement of Projection Capability for the Maximization of Business Performance Korean->English Proofreading
IBM Enhancement of Projection Capability for the Maximization of Business Performance Korean ->English
IBM 2010 IBM CFO Forum: For the company to grow as a value integrator, the plans to enhance financial efficiency through integrated risk management are suggested along with some examples of finance holding companies. Korean->English Proofreading
IBM 2010 IBM CFO Forum: For the company to grow as a value integrator, the plans to enhance financial efficiency through integrated risk management are suggested along with some examples of finance holding companies. Korean ->English
IBM Accelerating Efficiency in Providing a “Global Single Truth” for Appropriate Decision-Making Presentation data Korean->English Proofreading
IBM Accelerating Efficiency in Providing a “Global Single Truth” for Appropriate Decision-Making Presentation data Korean ->English
IBM Repositioning Finance as a Trusted Advisor based on Business Insight Presentation data Korean->English Proofreading
IBM Repositioning Finance as a Trusted Advisor based on Business Insight Presentation data Korean ->English
IBM Real Time Analytic Processing with IBM InfoSphere Streams V1.2 English ->Korean
IBM IBM Insurance Seminar data English ->Korean
IBM 2010 IBM Dynamic Infrastructure (DI) Business Partner Program – April 15 Announcement English ->Korean
IBM Smarter Planet GMU Client References Update English ->Korean
IBM Let’s build a smarter planet: Toronto East General Hospital secures its staff and equipment with an integrated wireless infrastructure. English ->Korean
IBM Building a Smarter Planet: Netherlands Railways: Growing ridership with minimum congestion and maximum efficiency English ->Korean
IBM Building a Smarter Planet: Repsol shows the future of offshore exploration with more powerful and detailed seismic imaging English ->Korean
IBM Power your planet. Smarter Systems for a Smarter Planet - Power Systems preannouncement education English ->Korean
IBM Forrester Consulting: The Total Economic Impact Of IBM Lotus Notes/Domino 8.5 Upgrade Multicompany Study English ->Korean
IBM www.ovum.com White Paper: Collaboration 2.0 - Taking Collaboration to the Next Level: From the E-mail and Document-centric World of ‘Enterprise 1.0’ to the People-centric World of Enterprise 2.0 English ->Korean
IBM IBM Lotus Notes and Lotus Domino software. - A better way to create, connect and collaborate English ->Korean
IBM Story Line and Messaging for April Launch - Smarter Systems for a Smarter Planet English ->Korean
IBM Power and System x Selection Guide for Business Partners Leveraging IBM technology advantages for client success English ->Korean
IBM April Launch Client Presentation - Smarter Systems for a Smarter Planet English ->Korean
IBM BPA for SW Reseller Authorization Operations Guide V1.0_AP draft Nov 24_SPF_clean_KOREA English ->Korean
IBM ㅇㅇㅇㅇ ERP System Outsourcing Operation Contract Project Requirements Korean->English Proofreading
IBM ㅇㅇㅇㅇ ERP System Outsourcing Operation Contract Project Requirements Korean ->English
IBM IBM XIV and Vinci PLC Video script translation & subtitling English ->Korean video translation
IBM IBM XIV and the City of Norfolk Video script translation & subtitling English ->Korean video translation
IBM Designing IBM Leadership Data Centers English ->Korean
IBM Migrating 3rd Party Applications on Oracle Database to DB2 Prospecting Guide English ->Korean
IBM Data Center Virtualization & Consolidation Prospecting Guide English ->Korean
IBM Scaling Business Process Management Prospecting Guide English ->Korean
IBM Prospecting: WAS vs. Oracle BEA WebLogic Server or Oracle Application Server English ->Korean
IBM SAP on DB2 / IBM Server Prospecting Guide English ->Korean
IBM Oracle Database / Oracle RAC to DB2 pureScale or DB2 for z/OS Prospecting Guide English ->Korean
IBM IBM Smart Analytics System Prospecting Guide English ->Korean
IBM Oracle-Sun Attack Winning the Infrastructure Battle: Setting the Agenda for Workload Optimized Systems & Attacking Oracle-Sun where they are weak English ->Korean
IBM Oracle-Sun Competitive Messages English ->Korean
IBM IBM Techline CompeteCenter: Six Talking points against Oracle Exadata V2 English ->Korean
IBM AUTHORITY TO PAY for the Independent Systems Integrators Pty Ltd & NEW IBM EQUIPMENT TO BE PLACED UNDER FINANCE WITH IBM GLOBAL FINANCING AUSTRALIA LIMITED English ->Korean
IBM ES Q1 Intel Print Advertising 'Future Growth'_Growth Market_print_FPO_x3500 English ->Korean
IBM EX 1 Allocate Quota FLSM Guide Handout update & FLSM_2 Exercise 4 Sales Manager V0.3 English ->Korean
IBM FLSM 2 Report to Exec Video Transcript V3 translation & subtitling English ->Korean video translation
IBM IBM exec cadence call v2 subtitled.wmv Video translaion & subtitling English ->Korean video translation
IBM Product development White paper: Requirements engineering for systems and software product lines. English ->Korean
IBM Product development White paper: Requirements engineering for mobile telecommunications technology development. - Improving the product development process using IBM Rational DOORS software English ->Korean
IBM Product development White paper: Requirements engineering for the medical device manufacturing industry. - Improving the product development process using IBM Rational DOORS software English ->Korean
IBM Product development White paper: Requirements engineering for the automotive industry. - Improving the product development process using IBM Rational DOORS software English ->Korean
IBM Product development White paper: Requirements engineering for the aerospace and defense industry. - Improving development processes using IBM Rational DOORS software English ->Korean
IBM Banner Q1 System x Future Growth Banners English ->Korean
IBM IBM Power Systems Announcement Overview: POWER7 technology now available for BladeCenter, enhanced systems management software, solutions for a Smarter Planet English ->Korean
IBM IBM Product Showcase : Smarter Systems for a Smarter Planet Products Announced by IBM in April 2010 English ->Korean
IBM Power in numbers: The twelve-member Global Intelligent Utility Network Coalition advances English ->Korean
IBM www.lotusknows.com Website L10N English ->Korean
IBM www.lotusknows.com Video 15 files dictation, translation & subtitling English ->Korean video translation
IBM IBM Global Business Services Executive Report (Strategy and Change) : IBM – Delivering performance through continuous transformation English ->Korean
IBM IBM eCatalog 46 html files (March) Website L10N English ->Korean
IBM Our planet is getting smarter by the city: Dubuque, Bordeaux, Taipei and more English ->Korean
IBM IDC LINK: Real-time IDC Research® opinion on IT, consumer and communications news, trends and events - IBM System z: The Mainframe Is Now in the Cloud English ->Korean
IBM Clabby Analytics : Case Study The Department of the Interior’s National Business Center ― Using System z as a Strategic Enterprise Cloud Platform English ->Korean
IBM Clabby Analytics : Case Study India’s ELCOT: A Next Generation Mainframe Cloud Services Provider? English ->Korean
IBM Lotus Software-"Together, we can work smarter." Video translation & subtitling English ->Korean video translation
IBM KIBS / Foreign Exchange (FX) Outward Remittance T/T Korean->English Proofreading
IBM KIBS / Foreign Exchange (FX) Outward Remittance T/T Korean ->English
IBM IBM Smarter Planet positioning against Oracle / Sun English ->Korean
IBM Workload-Optimized Systems for a Smarter Planet English ->Korean
IBM IBM Global Procurement: Supplier Questionnaire English ->Korean
IBM Smarter Planet Video #2 – Work, IBM Commercial Data Baby & Why Data Matters Video dictation, translation & subtitling English ->Korean video translation
IBM Innovation that matters -- for our company and for the world English ->Korean
IBM IBM Global Business Services Executive Report (Working smarter) : A new way of working - Insights from global leaders English ->Korean
IBM IBM 6 Differentiated Proposals - ING Korean ->English
IBM Market at a Glance (1): Insurance Market, (2): IT Market, Challenges in ING: ING To-be IT Governance Korean ->English
IBM STATEMENT OF WORK for TEM OPTIMIZATION SERVICES Between IBM Korea (‘IBM’) and LINA LIFE INSURANCE English ->Korean
IBM IBM eCatalog 15 html files (April) Website L10N English ->Korean
IBM IBM SINGAPORE PTE LTD - MASTER AGREEMENT FOR ASSET DISPOSITION AND SUPPORT SERVICES English ->Korean
IBM IBM Power Systems - Consolidated Launch Deck for 8/17/10 launch English ->Korean
IBM GEODIS Base Agreement English ->Korean
IBM PowerVM™ Quick Reference Guide English ->Korean
IBM Desktop Cloud Questionnaire English ->Korean
IBM IBM ILOG Elixir Enterprise extends the Adobe® Flex® and Adobe AIRTM platforms by adding user interface controls for more intuitive, interactive displays.Video English ->Korean
IBM IBM Systems and Technology Group System Storage: IBM Data Center Networking - It is time to start thinking differently about your data center network English ->Korean
IBM IBM Scalable Modular Data Center: The art of the possible. - Rapidly deploying cost-effective, energy-efficient data centers Japanese ->Korean
IBM IBM Global Technology Services: Taking a strategic approach to optimizing the data center portfolio. - Comprehensive planning is the key to availability, adaptability and efficiency English ->Korean
IBM The IBM Information Governance White Paper: Leveraging Information Governance Best Practices to Optimize the Information Supply Chain English ->Korean
IBM IBM Cloud Computing Seller education module for opportunity identifiers - Collaboration Workload / IBM LotusLive™Services - smarter collaboration in the cloud English ->Korean
IBM IBM Cloud Computing Q&A Guide Cloud Strategy and Portfolio - Frequently Asked Questions for Sales and Marketing English ->Korean
IBM IBM Cloud Computing: Smarter Planet: Using cloud computing to deliver innovation and efficiency English ->Korean
IBM Workload-Optimized Systems for a Smarter Planet: Transaction Processing and Database English ->Korean
IBM Workload-Optimized Systems for a Smarter Planet: Business Process Management English ->Korean
IBM Workload-Optimized Systems for a Smarter Planet: - IBM Business Intelligence and Analytics English ->Korean
IBM IBM Consolidation and Virtualization: Workload-Optimized Systems for a Smarter Planet: Virtualization English ->Korean
IBM IBM Korea Company Info Korean->English Proofreading
IBM IBM Korea Company Info Korean ->English
IBM Korean Air - PSS Integration Platform Solution Summary Korean->English Proofreading
IBM Korean Air - PSS Integration Platform Solution Summary Korean ->English
IBM Smarter systems for a smarter planet English ->Korean
IBM The IBM Smart Analytics System offers a wide range of analytics capabilities, enabling you to consume information in the most digestible format, gain insight, and make smarter decisions today and into the future. English ->Korean
IBM The IBM Smart Analytics System is an integrated platform that provides broad analytics capabilities on a powerful warehouse foundation with IBM server and storage English ->Korean
IBM IBM Smart Analytics System 5600 provides warehousing and analytics capabilities designed for growth at an attractive entry point. English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Retail - Streamline business processes & manage performance of your operations English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP - Reduce cost of your SAP data management English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: CSP – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Retail - Optimize supply chain & Improve time to market by managing product & vendor information effectively English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Retail - Combine customer, merchandise & sales data to drive successful marketing campaigns; Deliver consistent customer experience English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Save money by finding & disposing of duplicate content English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Reduce the cost of your SAP data management English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Optimize the allocation of financial capital and ensuring compliance to Solvency II English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Improve claims administration efficiency and multi-channel distribution English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Create a single view of your information English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Analyze customer behavior to reduce attrition & improve marketing English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Insurance - Analyze customer behavior to reduce attrition & improve marketing English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Healthcare Providers – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Healthcare Providers – Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Healthcare Providers – Improve Clinical Outcomes & Patient Safety with Health English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Transition to a member-centric focus with new emphasis on individual services and retention with Member 360 English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Health Plans - Save money by finding & disposing of duplicate content English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Health Plans – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit - Improve Your Analytical & Decision Support Capabilities With IBM Smart Analytics System English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Government – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Government - Increase revenue optimization and improve taxpayer services English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Government - Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Government - Create a single view of your information English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Government - Use predictive analytics and data mining to improve public safety English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities - Reduce cost of your SAP data management English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities - Optimize asset operations to cut costs, increase revenue & improve compliance English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities – Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities - Create a single view of your information English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Energy & Utilities - Address regulatory compliance and minimize costs, fines and penalties English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP - Reduce cost of your SAP data management English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP – Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP - Improve new product introduction & customer service to drive higher revenue English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: CSP - Analyze customer behavior to reduce churn & improve marketing campaign efficiency English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Banking & FM – Save money by finding & disposing of duplicate content English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Banking & FM – Reduce the cost of your operations English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Banking & FM – Reduce costs by managing your data growth English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Banking & FM – Manage risk and compliance to optimize your business results English ->Korean
IBM Information & Analytics sales kit -Quick Reference Guide: Banking & FM – Improve your analytical & decision support capabilities English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Banking & FM – Improve cross-selling and customer service to drive higher revenue English ->Korean
IBM Information & Analytics sales kit - Quick Reference Guide: Banking & FM – Create a single view of your information English ->Korean
IBM B2B Shopping Portal Building Proposals - i-Market Koea Korean->English Proofreading
IBM B2B Shopping Portal Building Proposals - i-Market Koea Korean ->English
IBM IBM IMPACT 2010 DAY 1 ~ 2 OPENING VIDEO / MULTI-MEDIA EXPERIENCE dictation, translation & subtitling English ->Korean video translation
IBM Insurance Industry Executive Summary: Capitalizing on Complexity English ->Korean
IBM Insurance Industry Perspective - The Global Insurance CEO Study 2010 English ->Korean
IBM Banking and Financial Markets Industry Executive Summary: Capitalizing on Complexity - Insights from the Global Chief Executive Officer Study English ->Korean
IBM Korea Green Data Center Conference: IBM Data Center Operations and Management Services ECC Health Check Workshop - Provide efficiency savings and optimization of the service delivery and management of your Data Center operations environment English ->Korean
IBM IBM's Presentation for the Implementation of an Enhanced Backup System for Hana HSBC Life Insurance Korean->English Proofreading
IBM IBM's Presentation for the Implementation of an Enhanced Backup System for Hana HSBC Life Insurance Korean ->English
IBM IBM Software for a Smarter Planet : Strategies, Expertise and Services For Moving to IBM - Approach for Workload Migrations English ->Korean
IBM IBM Smarter Systems Tour 2010: IBM Strategies to Reduce I/T Costs English ->Korean
IBM Smarter Cities data English ->Korean
IBM New GBS S&T service line English ->Korean
IBM IBM Power Systems - Consolidated Launch Deck for 8/17/10 launch English ->Korean
IBM Impact 2010 The Premier Conference for Business and IT Leaders: TCE-1475 : Integrate NetSuite and Your Enterprise Applications In Days with Cast Iron Systems English ->Korean
IBM Lombardi Overview Presentation data : Why Companies Choose Lombardi English ->Korean
IBM IBM Software WebSphere: IBM WebSphere Application Server Family - Providing the right application foundation to meet your business needs English ->Korean
IBM IBM Software WebSphere eXtreme Scale: IBM WebSphere eXtreme Scale V 7.1 and WebSphere Data Power XC10 Appliance English ->Korean
IBM IBM Software WebSphere Data Sheet: IBM WebSphere DataPower Low Latency Appliance XM70 - Make better business decisions with faster access to critical information English ->Korean
IBM IBM Software WebSphere Data Sheet: IBM WebSphere DataPower B2B Appliance XB60 - Increase the speed and reliability of extending your business beyond organizational walls English ->Korean
IBM IBM WebSphere Adapters V7.0 - Unlock siloed information, extend applications to promote reuse and maximize ROI English ->Korean
IBM IBM Software WebSphere Data Sheet: IBM WebSphere DataPower Integration Appliance XI50 - Easy-to-deploy, highly scalable hardware untangles costly and debilitating IT complexity English ->Korean
IBM IBM Software WebSphere Data Sheet: IBM WebSphere DataPower XML Security Gateway XS40 - Enforce policies and secure services, applications and data with customizable, scalable and automated service visibility and governance English ->Korean
IBM IBM WebSphere Enterprise Service - Increase agility and optimize cost by untangling costly and debilitating IT complexity English ->Korean
IBM IBMWebSphere Message Broker, Version 7.0 - Fast and flexible access to business information anywhere with universal integration English ->Korean
IBM IBM Software Group Industry Software: IBM WebSphere Remote Server, Version 7.1 - Providing a scalable, flexible platform for integrating new, innovative technologies into your retail distributed environment English ->Korean
IBM IBM Software Business Process Management: IBM WebSphere Lombardi Edition - The platform for process applications English ->Korean
IBM Re: Request for Interim Support Services for Passport Advantage Software English ->Korean
IBM 2010 BRMS User Survey, 2010 BRMS User Survey rawdata v1.0(1) edited_FN Questionnaire v1.4 BRMS krg[1] edited_FN & - Knowledge Research Group Korean->English Proofreading
IBM 2010 BRMS User Survey, 2010 BRMS User Survey rawdata v1.0(1) edited_FN Questionnaire v1.4 BRMS krg[1] edited_FN & - Knowledge Research Group Korean ->English
IBM Request for Interim Support Services for Passport Advantage Software English ->Korean
IBM IBM Power 7 Request for Proposal (RFP) & IBM Request For Proposal (RFP) Summary For Doosan Engineering & Construction Co., Ltd. Consolidation Information System Business Korean->English Proofreading
IBM IBM Power 7 Request for Proposal (RFP) & IBM Request For Proposal (RFP) Summary For Doosan Engineering & Construction Co., Ltd. Consolidation Information System Business Korean ->English
IBM IBM Tivoli® Software: IBMTivoli Service Automation Manager - Automate requesting, deployment, monitoring and management of cloudcomputing services English ->Korean
IBM IBM Tivoli® Software: IBMTivoli Business Service Manager - Maximize performance with real-time service visibility and intelligence English ->Korean
IBM IBM Proventia Network IntrusionPrevention System - Protecting the network ahead of the threat English ->Korean
IBM IBM Tivoli® Software: Netcool/Realtime Active Dashboards - Understand the real-time impact of IT and business activity on services English ->Korean
IBM IBM Tivoli® Software: IBMTivoli Netcool/Impact - Streamline event and alert management, and incident and problemmanagement processes English ->Korean
IBM IBM Tivoli® Software: IBM Tivoli Netcool Performance Manager - Performance management for wireless, wireline and convergent networks English ->Korean
IBM IBM Tivoli® Software: IBM Tivoli Netcool/OMNIbus - Consolidated operations management for real-time service management English ->Korean
IBM IBM Software Tivoli : IBM Maximo technology for business and IT agility - IBM asset and service management solutions English ->Korean
IBM IBM workload optimized systems - Integrating software, hardware and services for better performance at lower cost English ->Korean
IBM What's the story of the ATandT / Apple iPad data breach? English ->Korean
IBM IBM eCatalog 17 html files (May) English ->Korean
IBM Proventia Network Intrusion Prevention System English ->Korean
IBM LotusLive Notes eCatalog 5 files (May) English ->Korean
IBM Cloud Computing - Whiteboard Study Guide English ->Korean
IBM Innovation Discovery Workshop Plan - DongBu Insurance Korean ->English
IBM LOTUS Mobile Reference: Ministry of Economy - Republic of Poland English ->Korean
IBM Mobile and enterprise access solutions White paper: Stay connected: A successful mobile device strategy drives productivity. English ->Korean
IBM Mobile collaboration from IBM—support for fast-moving businesses. / Mobile business collaboration solutions and services keep employees on the go and in the loop English ->Korean
IBM Proposal for IT Service Transition & Development for Allianz Life Insurance Korean ->English
IBM Summary of the Proposal for the Allianz Data Center Transition Project - HANJIN INFORMATION SYSTEMS & TELECOMMUNICATION CO., LTD. Korean ->English
IBM Summary of IBM Proposal for the Transition of the Allianz Data Center Korean->English Proofreading
IBM Summary of IBM Proposal for the Transition of the Allianz Data Center Korean ->English
IBM Samsung Electronics Printer Division eSLM Assessment Proposal Korean->English Proofreading
IBM Samsung Electronics Printer Division eSLM Assessment Proposal Korean ->English
IBM IBM Proposal for the Allianz Oracle DB Upgrade Korean ->English
IBM Proposal for the Allianz Oracle DB Upgrade Korean ->English
IBM Oracle DB Upgrade Proposal Korean ->English
IBM IBM Tivoli® Software: Help maximize operational efficiencies and business resiliency through dynamic, service-based workload management. English ->Korean
IBM IBM Tivoli Software White Paper: Realizing business value with mainframe security management English ->Korean
IBM Insurance Industry Overview & Agenda for the CEO Korean ->English
IBM Case study presentation for next-generation system development using a Java-based framework Korean ->English
IBM Daishin Securities IBM WAS/XD Case Korean ->English
IBM What is Watson? Video translation & subtitling English ->Korean video translation
IBM Accelerate Value And Business Insight From Your BPM and Business Analytics Investments English ->Korean
IBM Accelerate Value And Business Insight From Your BPM and Business Analytics Investments English ->Korean
IBM SOW AND THE APPROPRIATE SCHEDULE data 4 files English ->Korean
IBM 2654 IBM System z 45th Anniversary Animation As Produced Transcript video translation & subtitling English ->Korean video translation
IBM SMARTER THAN YOU THINK - What Is I.B.M.’s Watson? English ->Korean
IBM To Tell The ^Entire Truth - IBM’s Workload Optimized System Versus Oracle-Sun’s Product Disarray English ->Korean
IBM WOS Captions Video translation & subtitling English ->Korean video translation
IBM 2843_A IBM Project Avalanche Compilation Video As Produced Transcript translation English ->Korean video translation
IBM 2843_C IBM IOD EMEA Customer Reference Video – Creating Insight As Produced Transcript transltion English ->Korean video translation
IBM Smarter Systems World Tour :30 video script translation & subtitling English ->Korean video translation
IBM IBM Smarter Systems World Tour video translation & subtitling English ->Korean video translation
IBM Social Computing Guidelines English ->Korean
IBM Winning with DB2 pureScale on Power Systems - Power Systems and System z Sellers Call English ->Korean
IBM IBM Software Group IBM Software for Power Systems English ->Korean
IBM IBM GLobal business services Telecommunications Executive Summary: Telco 2015 - Five telling years, four future scenarios English ->Korean
IBM Proposal for the Phase 3 ERP Implementation with IBM Servers at HKMC Headquarters Korean->English Proofreading
IBM Proposal for the Phase 3 ERP Implementation with IBM Servers at HKMC Headquarters Korean ->English
IBM You Are Cordially Invited to the 2010 IBM Innovation Forum. Korean ->English
IBM Successful business model innovation requires alignment -internally with the customer value proposition and externally with a network of customers, partners and suppliers. English ->Korean
IBM IBM Global Business Services Executive Rep : Seizing the advantage - When and how to innovate your business model English ->Korean
IBM olleh KT - Rack Cooling Solution (RDHx) Proposal for GDC Cheonan Center High-density System Korean->English Proofreading
IBM olleh KT - Rack Cooling Solution (RDHx) Proposal for GDC Cheonan Center High-density System Korean ->English
IBM IBM e-Catalog 17 html files (June) English ->Korean
IBM External Questionnaire- Reference Clients only - Arun English ->Korean
IBM External Questionnaire- Non-reference Clients - Arun English ->Korean
IBM External Questionnaire- ISV & BPs - Arun English ->Korean
IBM External Questionnaire- Industry Association - Arun English ->Korean
IBM Additional Service Agreement - (Additional Service Agreement for Online Visitor Customer Experience Analysis) Korean ->English
IBM Solution Agreement Statement of Work Korean ->English
IBM Non Technology Service Agreement Statement of Work Korean ->English
IBM Agreement for the Amorepacific AP 2.0 Online Operation Outsourcing Service - Schedule B Charge Korean ->English
IBM Agreement for the Amorepacific AP 2.0 Online Operation - Schedule A Statement of Work and Service Level Management Korean ->English
IBM Agreement for the Amorepacific AP 2.0 Online Operation Outsourcing Service Korean ->English
IBM IBM BPM Suite Guidance - Selecting the Right IBM BPM Platform for Your Opportunity English ->Korean
IBM Lombardi Customer Stories and Patterns in a Matrix View English ->Korean
IBM IBM Software WebSphere Thought Leadership White Paper: Making the case for BPM - A benefits checklist English ->Korean
IBM IBM WebSphere Lombardi Edition and IBM BPM Blueprint Sales kit English ->Korean
IBM IBM Global Business Services Government Executive Report: Smarter cities for smarter growth - How cities can optimize their systems for the talent-based economy English ->Korean
IBM IBM Global Business Services Government Executive Report:How Smart is your city? - Helping cities measure progress English ->Korean
IBM Annex D. Financial Guarantee Template English ->Korean
IBM TESCO - IBM Proposals to Establish TESCO Booking System Korean->English Proofreading
IBM TESCO - IBM Proposals to Establish TESCO Booking System Korean ->English
IBM August 2010 Power Systems Launch for Mid-market English ->Korean
IBM IBM BUILDING A SMARTER PLANET “Data Transportation” :30 As Recorded Video dictation, translation & subtitling English ->Korean video translation
IBM IBM BUILDING A SMARTER PLANET “Data Energy” :30 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM Smarter Planet Videos Transcript: Smarter Cities Suite 2: Health, Work, Cities Video dictation, translation & subtitling English ->Korean video translation
IBM We can build a smarter planet, city by city. Video translation & subtitling English ->Korean video translation
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Scott Taylor EDUCATION Video translation & subtitling English ->Korean video translation
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Rudy Provoost ENERGY + UTILITIES Video translation & subtitling English ->Korean
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Marilyn Chow HEALTHCARE Video translation & subtitling English ->Korean video translation
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Fernando Garcia-Ruiz PUBLIC SAFETY Video translation & subtitling English ->Korean video translation
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Carlos van de Wiejer TRANSPORTATION Video translation & subtitling English ->Korean video translation
IBM IBM SMARTER PLANET SMARTER CITIES EXPERT VIDEOS Annemarie Jorritsma Video translation & subtitling English ->Korean video translation
IBM IBM Global Business Services White Paper: Driving Productivity through Smarter Sourcing English ->Korean
IBM A Global Innovation Outlook 3.0 Report: The New New Media - Global lessons on the future of media, content, and messaging. English ->Korean
IBM IBM Business Consulting Services Media and Entertainment: The end of television as we know it - A future industry perspective English ->Korean
IBM IBM GLobal business services Media and Entertainment Executive Summary: Media’s looming revenue gap - Digital-driven challenge for traditional business models English ->Korean
IBM IBM Global Business Services Media and Entertainment: Beyond advertising - Choosing a strategic path to the digital consumer English ->Korean
IBM IBM INVESTOR RELATIONS: IR PODCAST IBM AND THE FUTURE OF TV English ->Korean
IBM Blue Cross Blue Shield of Michigan Introduction Video dictation, translation & subtitling English ->Korean video translation
IBM TO-BE Architecture and Step-by-Step Implementation - Benefits > Performance, Benefits> Performance and Environmental Factors, Benefits> Green IT, Cost Analysis> TCO Korean ->English
IBM OCI - Benefits and TCO Analysis> 5yr Growth and Benefits of Step-by-step Introduction Korean ->English
IBM Power your planet. Smarter Systems for a Smarter Planet English ->Korean
IBM Smarter Systems for a Smarter Planet Updated Speaker Notes English ->Korean
IBM Impact 2010 Successful Strategies for BPM Adoption & Rapid Deployments Session #2469 English ->Korean
IBM Definition of business and IT needs – Analysis framework Korean ->English
IBM Jazz Revolution Transcript Video translation English ->Korean video translation
IBM IBM’s Corporate Environmental Affairs Policy English ->Korean
IBM WebSphere Sensor Events provides the core platform for developing, deploying, and managing end-to-end solutions that exploit the new real-world information available from networked sensors. WebSphere Sensor Events: English ->Korean
IBM WebSphere® Multichannel Bank Transformation Toolkit V7.0 helps accelerate multi-channel application development for banking and financial industry. English ->Korean
IBM IBM® WebSphere® Commerce Professional provides a next-generation solution designed to address a company's e-commerce needs English ->Korean
IBM IBM® WebSphere® Commerce - Express is a complete solution to help growing mid-market companies do business on the Web English ->Korean
IBM IBM® WebSphere® Commerce Enterprise, used by top enterprises, is widely regarded as an industry-leading e-commerce solution English ->Korean
IBM IBM® WebSphere® Commerce Developer editions provide a team-based integrated development environment for e-commerce sites English ->Korean
IBM WebSphere Application Server Hypervisor Edition offers all of the robust features of the WebSphere Application Server Family for virtual environments English ->Korean
IBM IBM Tivoli® Provisioning Manager helps organizations optimize efficiency, accuracy and service delivery by automating best practices for data center provisioning activities. English ->Korean
IBM LotusLive Events is an online event management service with a full-featured Web conferencing service. LotusLive Events provides you all the tools you need to manage registration, host your event and follow up with post event analysis. English ->Korean
IBM LotusLive Meetings is a full-function Web meetings service, perfect for ad-hoc conferences inside and outside of an organization where presentations or applications need to be shared with a small group of a few or on a Web event of a thousand. English ->Korean
IBM IBM LotusLive Connections is a unique on-line social networking and collaboration service similar to LotusLive Engage yet perfect for customers who do not require a Web conference service or may already have an in-house solution. English ->Korean
IBM IBM LotusLive Engage is a unique on-line social networking, collaboration and Web meeting service designed for businesses. It offers a rich set of business tools which allows subscribers to work seamlessly with people – outside or inside their company. English ->Korean
IBM LotusLive Notes - All the power of Lotus Notes, delivered as a Service by IBM. English ->Korean
IBM LotusLive iNotes - LotusLive iNotes provides essential web-based email and calendaring capabilities, without the hassle of running it yourself. English ->Korean
IBM Tivoli Storage Productivity Center for Disk Midrange Edition - Advanced performance management for your IBM System Storage DS3000, DS4000 and DS5000 Storage Infrastructure English ->Korean
IBM Tivoli Storage Productivity Center for Disk - Consolidate and centralize administration of your SAN storage devices English ->Korean
IBM Tivoli Storage Productivity Center for Data - Manage the capacity utilization of your file systems and databases English ->Korean
IBM Tivoli Storage Productivity Center Basic Edition - Discover and Manage IBM and Heterogeneous Storage - Basic Device Management English ->Korean
IBM Driving Business Agility in Retail Banking: Corporate Payments English ->Korean
IBM Driving Business Agility in Global Retail Banking: Account Opening English ->Korean
IBM Driving Business Agility in Retail: Multi-Channel Demand Driven Inventory Locator English ->Korean
IBM Driving Business Agility in Retail: Promotions, Planning and Execution English ->Korean
IBM IBM Software Tivoli Solution Brief: IBM Tivoli Netcool network management solutions for the enterprise environment - The big picture view that focuses on optimizing complex environments English ->Korean
IBM SPSS Commercial Perpetual License IBM ELA Template & SPSS Commercial Perpetual Sales Schedule for IBM ELA English ->Korean
IBM IBM Power Systems Announcement Overview English ->Korean
IBM Cross-IBM communications “cheat sheet” Core content to help formulate communications planning around the August 17 launch English ->Korean
IBM IBM Security Solutions: IBM X-Force Threat Insight Quarterly English ->Korean
IBM 2010 IMPACT Offering Announcements English ->Korean
IBM IBM Power Systems Express Rack & Tower Servers Smarter Systems for a Smarter Planet English ->Korean
IBM IBM's 2010 Global CEO Study Participant Feedback Report English ->Korean
IBM IBM Global Technology Services Thought Leadership White Paper: Transforming your voice, video and collaboration infrastructure - The IBM journey toward unified communications English ->Korean
IBM IBM Global Business Services Government Executive Report: The world’s 4 trillion dollar challenge / Using a system-of-systems approach to build a smarter planet English ->Korean
IBM Cloud computing White paper - IBM Point of View: Security and Cloud Computing English ->Korean
IBM IBM USED EQUIPMENT SALES MASTER AGREEMENT FOR BROKERS English ->Korean
IBM IBM USED EQUIPMENT SALES MASTER AGREEMENT English ->Korean
IBM Contract for using the bulk transfer service of transaction with other banks Korean ->English
IBM Power your planet. Midsized businesses are the engines of a Smarter Planet. English ->Korean
IBM IBM Power Systems Express Rack & Tower Servers Smarter Systems for a Smarter Planet English ->Korean
IBM Consolidated Launch Deck for 8/17/10 launch English ->Korean
IBM Addendum to IBM International Program License Agreement for IBM ILOG Per Application Licensing Option English ->Korean
IBM IBM SYSTEMS AND TECHNOLOGY GROUP (STG): IBM STG SYSTEMS SOFTWARE FAST FACTS GUIDE English ->Korean
IBM PowerVM Editions: Tailored to client needs English ->Korean
IBM IBM POWER7 System - Smarter Systems for a Smarter Planet English ->Korean
IBM IBM Power Systems - Power your planet. Smarter Systems for a Smarter Planet. English ->Korean
IBM IBM Power Systems Express Rack & Tower Servers Smarter Systems for a Smarter Planet English ->Korean
IBM IBM Power Systems - Cloud on Power English ->Korean
IBM INVENTORY FINANCING AGREEMENT English ->Korean
IBM C-Suite Program in Korea - 2010 Smart Work Common Deck English ->Korean
IBM IBM Smart Work with WebSphere, Dynamic Business Processes & SOA English ->Korean
IBM IBM Smarter Industries Symposium English ->Korean
IBM 9. Smarter Retail 10. Smarter Transportation English ->Korean
IBM 1. Smarter Banking and Financial Markets 2. Smarter Communications 3. Smarter Electronics, Automotive and Aerospace 4. Smarter Energy and Utilities 5. Smarter Governments 6. Smarter Healthcare 7. Smarter Insurance 8. Smarter Oil and Gas English ->Korean
IBM IBM X-Force® 2010 Mid-Year Trend and Risk Report English ->Korean
IBM The Total Economic Impact™ Of IBM InfoSphere Foundation Tools English ->Korean
IBM IBM CLE Videos CIO-1 TITLE: IBM presents: Smarter Leadership Video dictation, translation & subtitling English ->Korean video translation
IBM IBM CLE Videos CIO-2 Title: IBM presents: Smarter Leadership Video dictation, translation & subtitling English ->Korean video translation
IBM IBM CLE Videos CIO-3 - Title: IBM Presents: Smarter Leadership Video dictation, translation & subtitling English ->Korean video translation
IBM IBM SMARTER PRODUCTS “Home Smart Home v1” :30 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM SMARTER SECURITY “Family Dinner v1” :30 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM SMARTER SECURITY “Follow That Pill v2” :30 Video dictation, translation & subtitling English ->Korean video translation
IBM LotusLive Notes - All the power of Lotus Notes, delivered as a Service by IBM. English ->Korean
IBM IBM ILOG ODM Enterprise helps you build and deploy analytical decision support applications based on optimization technology. English ->Korean
IBM IBM ILOG CPLEX Optimizer - High-performance mathematical programming solver for linear programming, mixed integer programming, and quadratic programming English ->Korean
IBM IBM ILOG CPLEX Optimization Studio - CPLEX Optimization Studio speeds development and deployment of optimization models, combining leading solver engines with a tightly integrated IDE and modeling language. English ->Korean
IBM Tivoli Service Request Manager - Integrated Service Desk and Service Catalog for 'One Touch' IT English ->Korean
IBM IBM Tivoli® Key Lifecycle Manager helps IT organizations better manage the encryption key lifecycle by enabling them to centralize and strengthen key management processes. English ->Korean
IBM This CCMDB software from Tivoli® automates data, workflows and policies to align IT infrastructure management with business priorities. English ->Korean
IBM Tivoli Business Continuity Process Manager - Enables a comprehensive business continuity solution that integrates the management of people and process with the underlying technology solutions. English ->Korean
IBM IBM® Rational® Application Developer for WebSphere® Software V8.0 provides optimized development for IBM middleware. English ->Korean
IBM Rational Software Architect for WebSphere Software is the optimized environment for designing and developing WebSphere applications English ->Korean
IBM The IBM® Tivoli® Storage Productivity Center (TPC) for Replication V4.2 includes new capabilities and enhancements: English ->Korean
IBM Tivoli Composite Application Manager for Microsoft Applications - Manage critical Microsoft and other resources via enhanced visibility and automation English ->Korean
IBM IBM Smart Analytics System 7700 delivers a complete data warehouse infrastructure for analytics with cost-efficient, flexible design, and mission-critical reliability. English ->Korean
IBM IBM Smart Analytics System 2050 offers pre-integrated analytics capabilities on a powerful, cost-efficient system. English ->Korean
IBM IBM Smart Analytics System 1050 offers pre-integrated analytics capabilities on a powerful, compact, cost-efficient system. English ->Korean
IBM Service Delivery Manager - A pre-integrated software stack, deployed as set of virtual images that automate IT service deployment and provide resource monitoring and cost management in a cloud. English ->Korean
IBM Maximo Everyplace - Accessing IBM Maximo on a mobile device provides several benefits English ->Korean
IBM Rational Software Architect Simulation Toolkit allows you to validate the architecture before the implementation phase. English ->Korean
IBM Rational Software Architect Extension for Communications Applications provides the support for key communications standards and protocols English ->Korean
IBM Rational Software Architect Extension for SOA and WebSphere extends Rational Software Architect to help you design and deliver solutions using SOA and targeting WebSphere. English ->Korean
IBM Extend the value of IBM® Rational® Software Architect to solutions that include C++ English ->Korean
IBM Rational Software Architect Extension for Deployment Planning helps reduce deployment risks and improve development-operations communications through deployment specifications English ->Korean
IBM Rational Software Architect Extension for Integrated Architecture Frameworks extends Rational Software Architect to help integrate business requirements to solution designs. English ->Korean
IBM Rational Software Architect - A flexible, extensible, easy to use platform for delivering high quality architectures English ->Korean
IBM IBM Systems and Technology System x Data Sheet: IBM CloudBurst - Rapidly create and manage a private cloud environment English ->Korean
IBM The IBM Software Story: Helping the Planet to Become Smarter English ->Korean
IBM Business Partnership with IBM For good growth of Kyobo Information & Communication Co. Ltd. Korean ->English
IBM IBM System x3690 X5 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3850 X5 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System BladeCenter HS22V Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System BladeCenter HX5 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3500 M3 and x3400 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3755 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3650 M3 / x3550 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3630 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3620 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM IBM System x3250 M3 / x3200 M3 Video dictation, translation & subtitling English ->Korean video translation
IBM Cognos TM1: IBM Cognos® TM1 is enterprise planning software that provides a complete, dynamic environment for developing timely, reliable and personalized forecasts and budgets. English ->Korean
IBM Cognos Statistics: IBM Cognos® Statistics software powered by IBM SPSS Statistics engine adds statistical results to business reports so you can more easily analyze patterns and trends. English ->Korean
IBM Cognos Planning: IBM Cognos Planning® is enterprise planning software that helps you develop budgets and forecasts faster and more efficiently. English ->Korean
IBM Cognos Mobile: IBM Cognos® Mobile extends interactive Cognos Business Intelligence to mobile devices such as BlackBerry, iPhone, iPad and others. English ->Korean
IBM Cognos Mashup Service: Cognos Mashup Service exposes content from Cognos Business Intelligence (such as reports, queries, analyses and metrics) as a Web Service. English ->Korean
IBM Cognos For Microsoft Office: Deliver Cognos Business Intelligence to users who prefer to work with applications such as Microsoft® Excel®, PowerPoint®, or Word. English ->Korean
IBM Cognos Business Intelligence: Cognos® Business Intelligence delivers the full range of BI capabilities - query and reporting, analysis, dashboards, scorecards and more to support how people think and work. English ->Korean
IBM Cognos Business Insight: IBM Cognos Business Insight enables users to assemble and explore all types of data in any time horizon through a dynamic, highly personalized interface. English ->Korean
IBM Cognos Analysis for Microsoft Excel: IBM Cognos® Analysis for Microsoft Excel makes it possible to analyze business data in a working environment you already know. English ->Korean
IBM Did You Know? (1) The differences IBM made along the way - 100 years of history English ->Korean
IBM IBM SurePOS 300 Express Korean ->English
IBM IBM Systems and Technology Retail Store Solutions Data Sheet: IBM SurePoint Touch Display - Making retail smarter starts with innovative IBM touchscreens at the point-of-sale English ->Korean
IBM IBM Global Business Services Strategy and Change White Paper: Capturing the Potential of Cloud - How cloud drives value in enterprise IT strategy English ->Korean
IBM Dynamic Infrastructure: The Benefits of Cloud Computing / A new era of responsiveness,effectiveness and efficiency in IT service delivery. English ->Korean
IBM Streamline requirements definition for product and service development: IBM Rational Requirements Composer English ->Korean
IBM Manage online risk and compliance with an automated solution: IBM Rational Policy Tester English ->Korean
IBM Power innovation with IBM Rational software - Rational application development tools for IBM Power Systems solutions English ->Korean
IBM IBM Rational Developer for System z Version 7.6 - Providing System z developers with tools for building traditional z/OS and modern multiplatform applications in an SOA and Web 2.0 environment English ->Korean
IBM Mazda North American Operations English ->Korean
IBM Unica® PredictiveInsight - Give Marketing Users the Power of Predictive Analytics English ->Korean
IBM Unica® Optimize - Optimize Results by Balancing Marketing Goals, Contact Preferences, and Business Constraints English ->Korean
IBM Unica® NetInsight® OnDemand - Gain Deep Web Insights Quickly and Easily with No Infrastructure Investment English ->Korean
IBM Unica® NetInsight® - Gain Deeper Insights More Quickly and Easily with Unica’s Next-Generation Web Analytics English ->Korean
IBM Unica® Marketing Operations OnDemand - Streamline Marketing Processes and Better Manage Programs and Creative Projects English ->Korean
IBM Unica® Leads - Deliver Quality Leads in a Timely Manner to Improve Close Rates and Increase Revenue English ->Korean
IBM Unica® Marketing Operations - Streamline Marketing Processes and Improve Marketing Management English ->Korean
IBM Unica® Interactive Marketing OnDemand - Make Interactive Marketing Easier, Faster, and More Effective with Unified Analytics, Email, and Web Personalization English ->Korean
IBM Unica® eMessage - Engage Customers and Prospects with Timely, Personalized Email and Mobile Messages English ->Korean
IBM Unica® Distributed Marketing - Empower Local Marketing Teams to Build Contact Strategies and Execute Campaigns English ->Korean
IBM Unica® Detect - Improve Cross-Sell and Retention by Detecting When Customers Are Most Receptive to Offers English ->Korean
IBM Unica® CustomerInsight - Visually Explore Customer Data, Identify Opportunities, and Take Action Immediately English ->Korean
IBM Unica® Campaign - Deliver Personalized, Relevant Marketing Messages Across All Channels English ->Korean
IBM Unica® Interactive Marketing Suite Overview English ->Korean
IBM IBM Software IBM BPM Blueprint - Process improvement is everybody’s business English ->Korean
IBM Vision 2020, the Global Profit Analysis System (GPAS) connects to GSI, builds the global business management system Korean ->English
IBM Case Study: ⎸ IBM BA’s Success Story, Pantos Logistics “Global Profit Analysis System” Korean ->English
IBM Easily automate lifecycle management of user roles, identities and access rights: IBM Tivoli Identity Manager English ->Korean
IBM Facilitate security audits and monitor privileged users through a robust security compliance dashboard: IBM Tivoli Compliance Insight Manager English ->Korean
IBM IBM Software Tivoli Data Sheet: IBM Tivoli Access Manager for e-business / Implement a highly scalable and security-rich user authentication, authorization and Web SSO solution English ->Korean
IBM Protecting corporate data with preemptive risk identification: IBMProventia Network Enterprise Scanner English ->Korean
IBM KCB Executive Summary & Samsung SDI Executive Summary Korean->English Proofreading
IBM KCB Executive Summary & Samsung SDI Executive Summary Korean ->English
IBM MANAGEMENT BRIEF: Cost/Benefit Case for IBM Informix / Compared to Microsoft SQL Server for Midsize Organizations English ->Korean
IBM A Forrester Total Economic Impact™ Study Prepared For IBM : The Total Economic Impact™ Of IBM Informix Database Server - A Single-Company Analysis English ->Korean
IBM Information and Analytics: Enabling Business Optimization English ->Korean
IBM IBM Rational Team Concert for System z Version 2.0 - Energize software development with an agile collaborative cross-platform environment English ->Korean
IBM Component reuse with IBM Rational DOORS Business Case Study: Delphi unites global teams for more cost-effective component reuse with IBM Rational DOORS. English ->Korean
IBM Hughes Telematics helps steer the future of the auto industry’s “next big thing” English ->Korean
IBM LEGAL LANGUAGE SERVICES TRANSCRIPTION OF AUDIO: dictation, translation and subtitling English ->Korean video translation
IBM IBM Cloud Computing - Video Script dictation, translation, subtitling English ->Korean video translation
IBM Optimize business performance by working smarter English ->Korean
IBM Introducing IBM Project Northstar... English ->Korean
IBM IBM Software Tivoli Solution Brief: Unified Management Platform from BigFix, an IBM company / Single pane of glass for all assets—fixed or mobile, physical or virtual, regardless of platform English ->Korean
IBM BigFix Endpoint Management: Providing Answers to Questions You Didn’t Know You Had English ->Korean
IBM IBM Rational software: the fuel for innovation / Drive innovation at optimal speed, enhanced efficiency and reduced cost English ->Korean
IBM IBM Software Rational Electronics: Cutting-edge multicore development techniques for the next wave of electronics products English ->Korean
IBM IBM Business Case Study: Philips Medical Systems Increases Efficiency of Geographically Distributed Development with IBM Rational Software Development Platform English ->Korean
IBM WebSphere ILOG Business Rules for z/OS - WebSphere ILOG Business Rules for z/OS provides two separate rule-execution capabilities, offering flexibility when adopting a business rules approach on the mainframe. English ->Korean
IBM WebSphere Decision Server - WebSphere Decision Server combines business rules management and business event processing technologies in a single offering. English ->Korean
IBM IBM Smart Grid Transcription English ->Korean video translation
IBM 2011 Operational Goals of a System for the Enhancement of Shopping Mall Businesses & Description of the Call Korean ->English
IBM Introducing IBM 1401, the First Computer in Korea, at the National Statistics Office of the Economic Planning Board on June 24, 1967 Korean ->English
IBM IBM Software Group Telecommunications Case Study: Implementing BPM to drive profitable sales in TeliaSonera Finland English ->Korean
IBM IBM Software Group Financial Markets Case Study: Streamlining credit management processes English ->Korean
IBM IBM Software Insurance Case Study: Large insurance provider automates invoice disputes English ->Korean
IBM IBM Software Supply Chain, Manufacturing Case Study: Minimizing distressed shipments English ->Korean
IBM IBM Software Pharmaceutical Case Study: Global life sciences corporation optimizes compensation process English ->Korean
IBM IBM Software HR/Retail Case Study: Major grocer upgrades HR processes English ->Korean
IBM IBM Global Business Services Executive Report - Beyond content / Capitalizing on the new revenue opportunities English ->Korean
IBM Proposals for the National Fusion Research Institute: Purchasing high performance cluster computers for nuclear fusion simulation Korean->English Proofreading
IBM Proposals for the National Fusion Research Institute: Purchasing high performance cluster computers for nuclear fusion simulation Korean ->English
IBM IBM Software Group White Paper - IBM Cognos 10: Intelligence unleashed / Freedom to make smarter decisions that drive better business results English ->Korean
IBM IBM Software Group White Paper - IBM Cognos Business Intelligence Query and Reporting: Gain insight and outperform English ->Korean
IBM InfoSphere Information Server - IBM® InfoSphere™ Information Server is IBM's market-leading data integration platform that helps understand, cleanse, transform & deliver trusted information to business initiatives including business analytics, data wareho English ->Korean
IBM The differences IBM made along the way - 100 years of history (2) English ->Korean
IBM IBM Global Business Services Business Analytics and Optimization Executive Report - Analytics: The new path to value: How the smartest organizations are embedding analytics to transform insights into action English ->Korean
IBM Rational Build Forge Enterprise Edition - IBM® Rationa®l Build Forge® Enterprise Edition automates software assembly English ->Korean
IBM Rational Functional Tester - Rational Functional Tester is an automated functional testing and regression testing tool. English ->Korean
IBM Rational AppScan Standard Edition - IBM Rational® AppScan® Standard Edition is a Web application security testing tool that automates vulnerability assessments. English ->Korean
IBM Rational AppScan Express Edition - IBM Rational® AppScan® Express Edition is a Web application security testing tool that automates vulnerability assessments. English ->Korean
IBM Cognos TM1 - IBM Cognos® TM1 is enterprise planning software that provides a complete, dynamic environment for developing timely, reliable and personalized forecasts and budgets. English ->Korean
IBM CICS Transaction Gateway - CICS Transaction Gateway (CICS TG), is IBM’s market-leading Enterprise connector, production proven in over a thousand customers for enterprise modernization of CICS assets. English ->Korean
IBM InfoSphere Information Server - IBM® InfoSphere™ Information Server is IBM's market-leading data integration platform that helps understand, cleanse, transform & deliver trusted information to business initiatives including business analytics, data wareho English ->Korean
IBM WebSphere Enterprise Service Bus - IBM WebSphere Enterprise Service Bus helps enable fast and flexible application integration with reduced cost and bridging to next-generation interconnectivity English ->Korean
IBM Tivoli System Automation Application Manager - Use a single point of control to manage heterogeneous business application landscape English ->Korean
IBM Rational Developer for Power Systems Software - IBM® Rational® Developer for Power Systems Software™ provides integrated development and debug tools for AIX®, IBM i, and Linux. English ->Korean
IBM Rational ClearCase - IBM® Rational® ClearCase® offers complete software configuration management English ->Korean
IBM Rational Asset Manager - Catalogue, organize, use, reuse, manage and report on any type of asset – business, technology or software – across your enterprise. English ->Korean
IBM Optim High Performance Unload for DB2 for Linux, UNIX and Windows - Optim High Performance Unload for DB2 for Linux, UNIX and Windows improves data availability, mitigates the risks, and accelerates the value delivery of database migrations. English ->Korean
IBM InfoSphere Data Architect - InfoSphere Data Architect is an enterprise data modeling and integration design tool. English ->Korean
IBM Cognos Planning - IBM Cognos Planning® is enterprise planning software that helps you develop budgets and forecasts faster and more efficiently. English ->Korean
IBM Cognos Statistics - IBM Cognos® Statistics software powered by IBM SPSS Statistics engine adds statistical results to business reports so you can more easily analyze patterns and trends. English ->Korean
IBM Cognos Mobile - IBM Cognos® Mobile extends interactive Cognos Business Intelligence to mobile devices such as BlackBerry, iPhone, iPad and others. English ->Korean
IBM Cognos For Microsoft Office - Deliver Cognos Business Intelligence to users who prefer to work with applications such as Microsoft® Excel®, PowerPoint®, or Word. English ->Korean
IBM Cognos Mashup Service - Cognos Mashup Service exposes content from Cognos Business Intelligence (such as reports, queries, analyses and metrics) as a Web Service. English ->Korean
IBM Cognos Analysis for Microsoft Excel - IBM Cognos® Analysis for Microsoft Excel makes it possible to analyze business data in a working environment you already know. English ->Korean
IBM Cognos Business Intelligence - Cognos® Business Intelligence delivers the full range of BI capabilities - query and reporting, analysis, dashboards, scorecards and more to support how people think and work. English ->Korean
IBM Cognos Business Insight - IBM Cognos Business Insight enables users to assemble and explore all types of data in any time horizon through a dynamic, highly personalized interface. English ->Korean
IBM WebSphere ILOG Business Rules for z/OS - WebSphere ILOG Business Rules for z/OS provides two separate rule-execution capabilities, offering flexibility when adopting a business rules approach on the mainframe. English ->Korean
IBM InfoSphere Optim Application Repository Analyzer - Explores and analyzes the application repository to identify the complex customizations of data model & other custom implemented modules within your Oracle® applications. English ->Korean
IBM Informix TimeSeries Real-Time Loader - IBM® Informix® TimeSeries Real-Time Loader DataBlade module is specifically designed to load time-stamped data and make the data available to queries in real time. English ->Korean
IBM Informix TimeSeries DataBlade - The IBM® Informix® TimeSeries DataBlade™ module greatly expands the functionality of your database by adding sophisticated support for managing time-series and temporal data. English ->Korean
IBM Informix JDBC - IBM® Informix® Java™ Database Connectivity (JDBC) is the JavaSoft specification of a standard API that allows Java programs to access database management systems. English ->Korean
IBM Informix Client Software Development Kit - IBM® Informix® Client Software Development Kit (CSDK) offers a single packaging of several APIs that are optimized for developing applications for Informix servers. English ->Korean
IBM Informix Choice Edition - The IBM® Informix® Choice Edition enables you to develop and deploy low-cost, enterprise-class functionality for departmental or small- and medium-sized business solutions. English ->Korean
IBM WebSphere Decision Server - Flexibly create responsive, intelligent decision automation solutions English ->Korean
IBM WebSphere Process Server Hypervisor Edition - Optimized to run in server virtualization environments English ->Korean
IBM WebSphere MQ Advanced Message Security - Provides application-level data security that supports PCI DSS compliance, protecting information end to end English ->Korean
IBM WebSphere Message Broker Hypervisor Edition - Optimized to run in server virtualization environments English ->Korean
IBM InfoSphere Optim System Analyzer for SAP Applications - A web-based diagnostic tool that automatically identifies SAP system changes and understands their impact English ->Korean
IBM DB2 Advanced Enterprise Server Edition - New! Now more capabilities for DBAs and developers. English ->Korean
IBM ETNews Articles - Segmenting even customers that seem identical to achieve ‘Customized Marketing’ / Segmenting even customers that seem identical to achieve ‘Customized Marketing’ Korean ->English
IBM Pathways to interaction How to build more powerful interaction points in insurance by Christian Bieck, Mareike Bodderas, Peter Maas and Tobias Schlager English ->Korean
IBM Introducing the breakthrough IBM® zEnterprise™ System (zEnterprise) English ->Korean
IBM The Chevrolet Volt Video dictation, translation, subtitiing English ->Korean video translation
IBM Rational System Architect - Strategize, execute, and manage change with IBM Enterprise Architecture solutions English ->Korean
IBM Rational DOORS - A requirements management tool for systems and advanced IT applications English ->Korean
IBM InfoSphere Identity Insight - Entity resolution and analysis platform for fighting threat and fraud. English ->Korean
IBM InfoSphere Change Data Capture English ->Korean
IBM Content Manager OnDemand for Multiplatforms English ->Korean
IBM Cognos Business Viewpoint - Coordinating information to drive business analytics English ->Korean
IBM Lotus Quickr - Team collaboration software for the social enterprise English ->Korean
IBM Cognos Business Viewpoint English ->Korean
IBM InfoSphere Warehouse Pack for Supply Chain Insight English ->Korean
IBM IBM Integrated Information Core English ->Korean
IBM Unica® Interact - Determine the Right Message to Present in Inbound Marketing Channels –In English ->Korean
IBM Case Study: University College London Hospitals (UCLH) English ->Korean
IBM IBM Assessment report English ->Korean
IBM Case Study: Non-profit healthcare organization - Streamlines new hire on-boarding process English ->Korean
IBM Case Study: Mortgage company improves lending process English ->Korean
IBM Case Study: Streamlining credit management processes English ->Korean
IBM Case Study: U.S. Federal Agency - Successfully fulfills requirements of the Homeland Security Presidential Directive 12 (HSPD-12) using BPM English ->Korean
IBM Case Study: Toy company improves supply chain efficiency English ->Korean
IBM Thought Leadership White Paper - Eleven habits for highly successful BPM programs : Proven steps for getting started with process improvement English ->Korean
IBM Thought Leadership White Paper - CIO perspective: To be great at IT, you must be great at BPM English ->Korean
IBM IBM Global Process Services - Meet the next-generation of BPO. English ->Korean
IBM Global Telecom Consumer Survey English ->Korean
IBM SOM Contract Change Details & IBM TERM LEASE MASTER AGREEMENT English ->Korean
IBM USED EQUIPMENT PURCHASE AGREEMENT English ->Korean
IBM SPSS Data Collection Data Model: Full support for the survey life-cycle English ->Korean
IBM SPSS Data Collection Data Entry: A modern approach to entering survey data English ->Korean
IBM SPSS Data Collection Paper: Help your team produce appealing paper surveys easily, every time English ->Korean
IBM SPSS Data Collection Author Professional: Create unique, sophisticated surveys with a powerful scripting language English ->Korean
IBM SPSS Data Collection Survey Reporter Professional: Use a powerful scripting language to turn survey results into insight English ->Korean
IBM SPSS Data Collection Interviewer Desktop: A modern approach to entering survey data English ->Korean
IBM SPSS Data Collection Author: Create compelling, visually appealing surveys that participants will want to complete English ->Korean
IBM SPSS Data Collection Survey Reporter: Quickly deliver insight to enable smarter decision-making English ->Korean
IBM SPSS Data Collection Phone Interviews: Get deep insights and broad representation from telephone interviews – or combine with web surveys for quick turnaround English ->Korean
IBM SPSS Data Collection Web Interviews: Conduct web interviews quickly and efficiently English ->Korean
IBM SPSS Visualization Designer: Charting your course just got easier English ->Korean
IBM SPSS Text Analytics for Surveys: Analyze survey text and discover valuable, hidden insights English ->Korean
IBM SPSS SamplePower: Get the right sample size the first time English ->Korean
IBM SPSS Amos: Take your analysis to the next level and get your research noticed English ->Korean
IBM SPSS Statistics Developer: A Complete Workbench for R and Python Programmers to Integrate Analytical Functionality and Procedures English ->Korean
IBM SPSS Statistics Premium: An "all-in-one" edition designed for enterprise businesses with multiple advanced analytics requirements English ->Korean
IBM SPSS Statistics Professional: Tools to address the challenges of the entire analytic lifecycle English ->Korean
IBM SPSS Statistics Standard: The essential tools for your analytical projects English ->Korean
IBM SPSS Regression: Improve the Accuracy of Predictions with Powerful Regression Procedures English ->Korean
IBM SPSS Neural Networks: Find more complex relationships in your data English ->Korean
IBM SPSS Missing Values: Build Better Models When You Estimate Missing Data English ->Korean
IBM SPSS Forecasting: Build Expert Time-series Forecasts — in a Flash English ->Korean
IBM SPSS Exact Tests: More Accurately Analyze Small Datasets or Those with Rare Occurrences English ->Korean
IBM SPSS Direct Marketing: The analytical toolkit marketers need to easily identify the right customers and improve campaign results. English ->Korean
IBM SPSS Decision Trees: Easily identify groups and predict outcomes English ->Korean
IBM IBM Software License Compliance Programme English ->Korean
IBM IBM Business Partner Agreement English ->Korean
IBM SPSS Data Preparation: Improve Data Preparation for More Accurate Results English ->Korean
IBM SPSS Custom Tables: Easily analyze and communicate your analytical results English ->Korean
IBM SPSS Conjoint: Easily discover what people value English ->Korean
IBM SPSS Categories: Predict outcomes and reveal relationships in categorical data English ->Korean
IBM SPSS Bootstrapping: Create More Reliable Models and Generate More Accurate Results English ->Korean
IBM SPSS Advanced Statistics: More Accurately Analyze Complex Relationships Using Powerful Univariate and Multivariate Analysis English ->Korean
IBM SPSS Statistics Base: The core capabilities you need to take the analytical process from start to finish English ->Korean
IBM SPSS Statistics GradPack: Affordable versions of SPSS software for student learning English ->Korean
IBM SPSS Statistics Faculty Pack: The cost-effective way for faculty to integrate analytics into curricula English ->Korean
IBM SPSS Statistics Campus: Provide unlimited numbers of users with access to analytics English ->Korean
IBM SPSS Statistics Server English ->Korean
IBM SPSS Advantage for Microsoft Excel English ->Korean
IBM SPSS Statistics Programmability Extension English ->Korean
IBM SPSS Data Collection Survey Reporter Developer Kit English ->Korean
IBM SPSS Data Collection Remote Administration English ->Korean
IBM Smarter Oil and Gas Transforming Oil and Gas Exploration, Production, Refining and Distribution - IBM Oil and Gas Industry Value Proposition English ->Korean
IBM Smarter Healthcare Transforming patient value, outcomes and sustainability - IBM Value Proposition – Client References English ->Korean
IBM Smarter Government: IBM Value Proposition English ->Korean
IBM Making Retail Smarter - IBM Retail Industry Value Proposition English ->Korean
IBM Smarter Consumer Electronics - IBM Electronics Industry Value Proposition: Consumer Electronics Segment English ->Korean
IBM Smarter Energy Transforming Energy Generation, Distribution and Consumption: IBM Energy and Utilities Industry Value Proposition English ->Korean
IBM Let’s Build a Smarter Planet: Banking and Financial Markets Value Proposition English ->Korean
IBM Smarter Transportation: IBM Smarter Transportation Value Proposition English ->Korean
IBM Telecommunications: Core Value Proposition English ->Korean
IBM IBM InfoSphere Content Collector software: more than e-mail, more than archiving, more than an isolated solution. English ->Korean
IBM IBM FileNet Business Process Manager software. - Unifying content and process for improved agility, process performance, business efficiency and compliance English ->Korean
IBM IBM CommonStore for SAP, Version 8.4 English ->Korean
IBM The Road to a Smarter Enterprise: IBM’s Transformation Journey English ->Korean
IBM A comprehensive deck introducing Sterling Commerce as a company, their capabilities, the value of a combined IBM and Sterling portfolio and the vision we have going forward on various portfolio items English ->Korean
IBM Coremetrics “6 in 20” (six slides in 20 minutes) Your quick guide on the Coremetrics acquisition English ->Korean
IBM IBM Software Portfolio Evolution Coremetrics Drill-Down English ->Korean
IBM Mastering the Art of Relentless Marketing English ->Korean
IBM General Motors/IBM Event: Chevrolet Volt for a Smarter Planet Video dictation, translation and subtitling English ->Korean video translation
IBM Total Economic ImpactTM Of IBM Social Collaboration Tools English ->Korean
IBM Engage and delight more customers with an exceptional web experience - Exceed the expectations of web-savvy users with marketplace-leading software solutions English ->Korean
IBM Exceptional experiences: The key to customer engagement / IBM’s vision for driving next-generation web experiences English ->Korean
IBM Current State of the KT cloud infrastructure establishment & SAS with Hadoop: Hadoop Technology Review Korean ->English
IBM Multicompany Case Study - Measuring The Total Economic Impact Of IBM InfoSphere Information Server English ->Korean
IBM IBM System x and BladeCenter Business Partner Guidebook English ->Korean
IBM Korea Bootcamp EMC Unified Storage Positioning English ->Korean
IBM IBM j-type m-series Ethernet Routers Business Presentation English ->Korean
IBM IBM j-type e-series Ethernet Switch Product and Technology Overview English ->Korean
IBM Building Data Center Solutions with IBM j-type Ethernet Switches and Routers English ->Korean
IBM IBM Data Center Networking English ->Korean
IBM IBM Ethernet Switches & IP Routers English ->Korean
IBM IBM Data Center Networking for a dynamic infrastructure English ->Korean
IBM EMC Celerra Competitive Overview English ->Korean
IBM IBM® System Storage™ N3400 series Customer Presentation English ->Korean
IBM IBM System Storage N series Customer Presentation English ->Korean
IBM New IBM® System Storage™ N series Bundles English ->Korean
IBM IBM® zEnterprise™ BladeCenter® Extension (zBX) 2458-002 Systems Assurance Product Review Guide Technical and Delivery Assessment English ->Korean
IBM IBM Power Systems - PowerHA™ SystemMirror for AIX V6.1 English ->Korean
IBM The nmon Manual English ->Korean
IBM AIX Enterprise Edition 6 English ->Korean
IBM POWER7® System RAS Key Aspects of Power Systems™ Reliability, Availability, and Serviceability English ->Korean
IBM What IBM Performance Management for Power Systems and the IBM Systems Workload Estimator can do for you For the IBM AIX operating environment English ->Korean
IBM IBM Power Systems - PowerVM Editions Comparative Overview English ->Korean
IBM IBM Power Systems - The Advantages of POWER7 over HP/Sun/Dell x86 English ->Korean
IBM IBM Power Systems - Resiliency Without Downtime – PowerHA English ->Korean
IBM AIX: The Future of UNIX English ->Korean
IBM AIX 5.2 Workload Partitions for AIX 7 English ->Korean
IBM IBM EnergyScale for POWER7 Processor-Based Systems English ->Korean
IBM Power Systems Capacity on demand English ->Korean
IBM IBM Systems and Technology Group: storyline for IBM Power Systems English ->Korean
IBM IBM Global Technology Services Thought Leadership White Paper - Extending the life of your existing data center assets / How the IBM Lexington data center grew IT capacity eight times without expanding its energy footprint English ->Korean
IBM http://www.youtube.com/watch?v=-gMgU2vg87w & http://www.youtube.com/watch?v=KPTSeAh77qQ English ->Korean video translation
IBM IBM Global Technology Services - Business continuity and resiliency services from IBM / Strengthen your business with cloud computing—delivering greater resiliency and a more globally accessible environment English ->Korean
IBM IBM Global Technology Services Thought Leadership White Paper - Integrated service management and cloud computing: More than just technology best friends English ->Korean
IBM IBM Global Technology Services Thought Leadership White Paper - Leveraging security from the cloud / The who, what, when, why and how of cloud-based security services English ->Korean
IBM IBM Financial Services Sector Solution Brief - Cloud computing for financial services: test and development in the Cloud English ->Korean
IBM IBM Global Technology Services - Security strategy roadmap for cloud computing/ Augment your cloud computing strategy with a sound security approach English ->Korean
IBM Cloud security Strategy roadmap English ->Korean
IBM Cloud infrastructure strategy and design Flash demos English ->Korean
IBM IBM Global Technology Services - Strategy and design services for a cloud infrastructure / Develop an optimum implementation road map for cloud computing English ->Korean
IBM Realize the potential of cloud computing & IBM Smart Business Cloud Computing - Business leaders / Cloud is an enabler of business transformation. English ->Korean
IBM Case study QuickView - IBM applies cloud environment to create a virtual benchmark center for high-performance computing English ->Korean
IBM Case Study QuickView - Cloud Computing Saves Time, Money and Shortens Production Cycle English ->Korean
IBM BlueLock redefines its business model to provide best-in-class security services through its cloud computing hosting services. English ->Korean
IBM Ecomanage Network Corporation develops a service offering for manufacturers to fully manage wastes and meet disposal regulations English ->Korean
IBM Ecomanage Network Corporation develops a service offering for manufacturers to fully manage wastes and meet disposal regulations English ->Korean
IBM Wuxi builds engine for economic growth with cloud computing solution from IBM English ->Korean
IBM NC State makes a breakthrough in improving access to academic computing resources English ->Korean
IBM Kantana Animation Studios Client Reference Video English ->Korean video translation
IBM Nedbank-Client Video English ->Korean video translation
IBM Centennia l Boo k Preview - Think: The Ideas that Built IBM and Changed the Way the World Works English ->Korean
IBM 2010 Next 5 in 5 Animation Script for Translation English ->Korean video translation
IBM Gratis testen: Webanwendungen sicher überprüfen mit Rational AppScan. German->Korean
IBM DB2 V8 Price action announcement English ->Korean
IBM IBM Software Thought Leadership White Paper - Consolidating security across platforms with IBM System z English ->Korean
IBM IBM Sysplex Verification Package English ->Korean
IBM IBM DB2 10 for z/OS English ->Korean
IBM IBM Open Patent Policy English ->Korean
IBM IBM 2140632 data English ->Korean
IBM Lotus Chapter 6 English ->Korean
IBM Public certification service guide Korean ->Japanese
IBM Landing page English ->Korean
IBM Announcing new WebSphere English ->Korean
IBM InfoDyne English ->Korean
IBM Project Zero Overview English ->Korean
IBM Infosphere data English ->Korean
IBM IBM information on deamnd for dummies English ->Korean
IBM Allianz CRM Proposal Korean ->English
IBM Allianz CRM Proposal Korean->English Proofreading
IBM the smarter cities program English ->Korean
IBM IBM e-Catalog English ->Korean
IBM IBM Website TAB English ->Korean
IBM IMPACT 2010 English ->Korean
IBM Smarter Cities Shanghai, China English ->Korean
IBM Smarter Work in Action English ->Korean
IBM Webcast Transcript English ->Korean
IBM HP Call Guide English ->Korean
IBM MadScience II Video Translation English ->Korean video translation
IBM MadScience II Video Dictation English ->Korean video translation
IBM SPSs predictive analysis software data English ->Korean
IBM ILOG Industry Solution English ->Korean
IBM Cloud Computing English ->Korean
IBM IBM Next 5 in 5 Video English ->Korean
IBM FINAL BPVIDEO English ->Korean
IBM IBM Tivoil sofrware English ->Korean
IBM IBM's approach English ->Korean
IBM IBM Turining up the power English ->Korean
IBM Mobile Phone's Factory Mode English ->Korean
IBM IBM A Mandate for Smart Work English ->Korean
IBM IBM Website L10N English ->Korean
IBM IBM Lotus Notes and Domino on IBM POWER 7 English ->Korean
IBM Taipei public transportation system data English->Korean
IBM AZLK Business Blueprint - Allianz Life Korea Korean ->English
IBM AZLK Business Blueprint - Allianz Life Korea Korean->English Proofreading
IBM IBM’s Web 2.0 solutions Landing page: Submission form: English->Korean
IBM HCM Brochure_GBB14015-USEN-00_July 2008 English->Korean
IBM Hanjin Shipping Co., Ltd. RFP Korean ->English
IBM IBM Website L10N English ->Korean
IBM IBM Tivoli StorageManager English ->Korean
IBM IBM Better Planning for insurance companies English ->Korean
IBM Strategy Workshop for ISVs - Participant Guide (Lotus Business Partner Program) English ->Korean
IBM Property Loan Attachment English ->Korean
IBM Source Code Escrow Attachment English ->Korean
IBM Participation Agreement English ->Korean
IBM Procurement Agreement for Exchange of Confidential info Supplement English ->Korean
IBM Supplement to Agreement for the Exchange of Confidential information English ->Korean
IBM Confidential Disclosure Agreement Supplement for Disclosure English ->Korean
IBM Procurement Agreement for Exchange of Confidential information English ->Korean
IBM Agreement for the Exchange of Confidential info English ->Korean
IBM Confidential Disclosure Agreement English ->Korean
IBM Software Evaluation Agreement English ->Korean
IBM Equipment & Program Loan Agreement English ->Korean
IBM Supplier Third Party Purchase Authorization English ->Korean
IBM Third Party Purchase Authorization English ->Korean
IBM Replenishment Statement of Work English ->Korean
IBM Attachment to Equipment and Program Loan Agreement English ->Korean
IBM Supplement to Property Loan Attachment English ->Korean
IBM Replenishment Logistics Attachment (MPA/PPA Compatible) English ->Korean
IBM Replenishment Logistics Attachment (GA Compatible) English ->Korean
IBM Developed Works Agreement Statement of Work English ->Korean
IBM Procurement Technical Services Agreement Statement of Work English ->Korean
IBM Non-Technical Services Agreement Statement of Work English ->Korean
IBM Licensed & Developed Works Agreement Statement of Work English ->Korean
IBM Licensed Works Agreement Statement of Work English ->Korean
IBM Internal Licensed & Developed Works Agreement Statement of Work English ->Korean
IBM Customer Solutions Agreement Statement of Work English ->Korean
IBM Internal Solutions Agreement Statement of Work English ->Korean
IBM Goods Agreement Statement of Work English ->Korean
IBM Developed Works Agreement English ->Korean
IBM Internal Licensed & Developed Works Agreement English ->Korean
IBM Licensed Works Agreement English ->Korean
IBM Licensed & Developed Works Agreement English ->Korean
IBM Customer Solutions Agreement English ->Korean
IBM Internal Solution Agreement English ->Korean
IBM Technical Services Agreement English ->Korean
IBM Goods Agreement English ->Korean
IBM Distribution Agreement English ->Korean
IBM Non-Technical Services Agreement English ->Korean
IBM Business Planning for Growth and Profit English ->Korean
IBM Managing the Company English ->Korean
IBM Company Organization English ->Korean
IBM Managing Growth for Profitability Workshop English ->Korean
IBM Managing Growth for Profitability Workshop Part 2 English ->Korean
IBM Problem Resolution Exercise A, B, C & Report English ->Korean
IBM Consulting Firm Loses Control at USD $3-Million (A Case Study by Thomas F. Siegel, Jr.) English ->Korean
IBM Title (Don’t be green about your visa strategy” - Regulations for professional foreign nationals) English ->Korean
IBM Doing Business in the U.S. (Prepared for International IBM/Lotus Business Partners English ->Korean
IBM Mainline Consulting Faces the Challenges of Rapid Growth English ->Korean
IBM Managing Growth for Profitability Workshop Part 1 English ->Korean
IBM IBM/LOTUS BUSINESS PARTNER WORKSHOP REPORT English ->Korean
IBM Business Intelligence Solutions English ->Korean
IBM For greater manageablity and choice IBM 4690 Operating System Version 2 English ->Korean
IBM e-business changes everything ? English ->Korean
IBM Introducing PartnerWorld (e-business partners logo) English ->Korean